1 00:00:05,680 --> 00:00:09,280 WELCOME ALL OF YOU BACK FOR DAY 2 00:00:09,280 --> 00:00:14,320 TWO OF OUR VIRTUAL 179th 3 00:00:14,320 --> 00:00:20,360 MEETING AT THE NICHD ADVISORY 4 00:00:20,360 --> 00:00:24,600 COUNCIL. 5 00:00:24,600 --> 00:00:25,880 FIRST I WILL TURN OVER TO MAGGIE 6 00:00:25,880 --> 00:00:27,640 TO GO OVER THE STATEMENT OF 7 00:00:27,640 --> 00:00:27,960 UNDERSTANDING. 8 00:00:27,960 --> 00:00:28,920 THAT BEEN 1st. 9 00:00:28,920 --> 00:00:31,240 A REMINDER, THE FIRST HOUR AND A 10 00:00:31,240 --> 00:00:32,640 QUARTER IS OPEN AND THEN WE'LL 11 00:00:32,640 --> 00:00:35,760 CONVERT TO A CLOSED MEETING SO 12 00:00:35,760 --> 00:00:37,240 MAGGIE, OVER TO YOU. 13 00:00:37,240 --> 00:00:37,560 THERE YOU ARE. 14 00:00:37,560 --> 00:00:39,320 >> YES, HERE I AM. 15 00:00:39,320 --> 00:00:40,640 GOOD AFTERNOON, MY NAME IS 16 00:00:40,640 --> 00:00:45,560 MAGGIE YOUNG, I'M CHIEF GRANTS 17 00:00:45,560 --> 00:00:48,480 MANAGEMENT OFFICER OF NICHD 18 00:00:48,480 --> 00:00:49,480 BRANCH MANAGEMENT BRANCH AND 19 00:00:49,480 --> 00:00:51,760 GILL OVER THE 2022 STATEMENT OF 20 00:00:51,760 --> 00:00:52,400 UNDERSTANDING. 21 00:00:52,400 --> 00:00:54,600 EACH YEAR WE ASK FOR YOUR 22 00:00:54,600 --> 00:00:56,200 APPROVAL OF THE NICHD STATEMENT 23 00:00:56,200 --> 00:00:58,200 OF UNDERSTANDING WHICH OUTLINES 24 00:00:58,200 --> 00:00:59,960 THE GENERAL PROCEDURE TO BE USE 25 00:00:59,960 --> 00:01:00,840 FORD SECOND LEFT. 26 00:01:00,840 --> 00:01:02,040 THE STATEMENT OF UNDERSTANDING 27 00:01:02,040 --> 00:01:04,880 ADDRESSES THE FOLLOWING: 28 00:01:04,880 --> 00:01:06,640 COUNCIL MEMBERSHIP AND 29 00:01:06,640 --> 00:01:07,040 STRUCTURE. 30 00:01:07,040 --> 00:01:09,640 PROCEDURES FOR SECONDARY REVIEW 31 00:01:09,640 --> 00:01:11,120 OF GRANT APPLICATIONS DURING THE 32 00:01:11,120 --> 00:01:12,520 CLOSED SESSION. 33 00:01:12,520 --> 00:01:13,800 ADMINISTRATIVE DECISIONS AND 34 00:01:13,800 --> 00:01:16,200 ACTIONS THAT DO NOT REQUIRE 35 00:01:16,200 --> 00:01:17,400 COUNCIL RECOMMENDATION. 36 00:01:17,400 --> 00:01:20,800 VOTING OPTIONS AVAILABLE TO THE 37 00:01:20,800 --> 00:01:21,680 COUNCIL. 38 00:01:21,680 --> 00:01:23,840 EXPEDITED REVIEW OF HIGHLY 39 00:01:23,840 --> 00:01:26,280 MERITORIOUS APPLICATIONS. 40 00:01:26,280 --> 00:01:26,480 INTER. 41 00:01:26,480 --> 00:01:28,640 ARE YOU REVIEW MEETINGS. 42 00:01:28,640 --> 00:01:31,280 PROCEDURES FOR CONCEPT CLEARANCE 43 00:01:31,280 --> 00:01:33,160 DURING OPEN SESSION. 44 00:01:33,160 --> 00:01:35,320 EMERGENCY PROCEDURES. 45 00:01:35,320 --> 00:01:37,000 ONLINE TEXT IN THE STATEMENT OF 46 00:01:37,000 --> 00:01:38,000 UNDERSTANDING WAS PROVIDED TO 47 00:01:38,000 --> 00:01:39,600 YOU PRIOR TO THE MEETING AND MAY 48 00:01:39,600 --> 00:01:42,280 ALSO BE VIEWED NOW ON THE 49 00:01:42,280 --> 00:01:43,960 COUNCILMEMBER WEBSITE. 50 00:01:43,960 --> 00:01:45,040 ARE THERE ANY QUESTIONS ABOUT 51 00:01:45,040 --> 00:01:55,760 THE STATEMENT OF UNDERSTANDING? 52 00:01:55,760 --> 00:01:57,480 >> THANK YOU, MAGGIE. 53 00:01:57,480 --> 00:01:59,040 IF THERE ARE NO QUESTIONS, AT 54 00:01:59,040 --> 00:02:03,400 THIS TIME, MAY I HAVE A MOTION 55 00:02:03,400 --> 00:02:05,920 TO APPROVE THE STATE OF 56 00:02:05,920 --> 00:02:06,240 UNDERSTANDING. 57 00:02:06,240 --> 00:02:08,200 >> I MAKE A MOTION TO APPROVE 58 00:02:08,200 --> 00:02:09,120 THE STATEMENT OF UNDERSTANDING. 59 00:02:09,120 --> 00:02:09,640 >> THANK YOU. 60 00:02:09,640 --> 00:02:10,640 MAY YOU HAVE A SECOND? 61 00:02:10,640 --> 00:02:11,080 >> SECOND. 62 00:02:11,080 --> 00:02:12,120 >> OKAY. 63 00:02:12,120 --> 00:02:14,200 PLEASE VOTE ON YOUR ZOOM SCREEN 64 00:02:14,200 --> 00:02:16,280 FOR OR AGAINST OR ABSTAIN USING 65 00:02:16,280 --> 00:02:18,720 THE BUTTONS AT THE BOTTOM OF THE 66 00:02:18,720 --> 00:02:28,840 SCREEN. 67 00:02:36,920 --> 00:02:44,200 >> I'M SHOWING 1 14 QUESTIONS. 68 00:02:44,200 --> 00:02:45,880 >> OKAY, I THINK THAT'S PROBABLY 69 00:02:45,880 --> 00:02:46,280 WHAT WE HAVE. 70 00:02:46,280 --> 00:02:47,080 >> THANK YOU. 71 00:02:47,080 --> 00:02:50,320 AIL NOW TURN THE FLOOR BACK OVER 72 00:02:50,320 --> 00:02:52,920 TO DR. BIANCHI. 73 00:02:52,920 --> 00:02:54,080 >> THANK YOU, DENNIS. 74 00:02:54,080 --> 00:02:55,360 NEXT WE WOULD LIKE TO FOLLOW UP 75 00:02:55,360 --> 00:02:58,920 ON A QUESTION RAISED YESTERDAY 76 00:02:58,920 --> 00:03:03,160 BY DR. AKITA AFTER ALEXIS 77 00:03:03,160 --> 00:03:04,320 CLARK'S EXCELLENT PRESENTATION 78 00:03:04,320 --> 00:03:05,760 ON THE BUDGET. 79 00:03:05,760 --> 00:03:07,600 ASKED HOW MUCH OF THE BUDGET IS 80 00:03:07,600 --> 00:03:09,600 CURRENTLY SPENT ON NETWORKS AND 81 00:03:09,600 --> 00:03:13,240 CENTERS SO I'M GOING TO ASK 82 00:03:13,240 --> 00:03:13,960 ALEXUS, CAN YOU PLEASE SHARE 83 00:03:13,960 --> 00:03:18,320 WHAT YOU DID LAST NIGHT AND WHAT 84 00:03:18,320 --> 00:03:19,080 YOU FOUND SUIT IN I HAD HELP, SO 85 00:03:19,080 --> 00:03:21,360 THAT'S THE FIRST THING. 86 00:03:21,360 --> 00:03:23,760 BUT SO WE DID SOME DIGGING INTO 87 00:03:23,760 --> 00:03:28,760 SOME OF OUR END OF YEAR '21 88 00:03:28,760 --> 00:03:30,120 DOCUMENTATION. 89 00:03:30,120 --> 00:03:34,120 WE KNOW, DR. BARKIN IT ASKED A 90 00:03:34,120 --> 00:03:35,520 QUESTION IN THE CHAT YESTERDAY, 91 00:03:35,520 --> 00:03:37,480 A WELL, SO WE'RE HOPING THIS 92 00:03:37,480 --> 00:03:39,360 ADDRESSES BOTH OF THOSE THINGS. 93 00:03:39,360 --> 00:03:41,320 THE CHALLENGE IS, WHAT IS YOUR 94 00:03:41,320 --> 00:03:43,280 DEFINITION OF A NETWORK AND A 95 00:03:43,280 --> 00:03:43,520 CENTER. 96 00:03:43,520 --> 00:03:45,560 WE DID DO A FAIRLY BROAD 97 00:03:45,560 --> 00:03:47,520 DEFINITION AND LOOKED AT BOTH 98 00:03:47,520 --> 00:03:52,680 NETWORKS AND CENTERS THAT WE AT 99 00:03:52,680 --> 00:03:54,640 NICHD SORT OF OWN, WE ARE THE 100 00:03:54,640 --> 00:03:57,040 LEAD IC BUT ALSO CO-FUND WE 101 00:03:57,040 --> 00:03:59,440 PROVIDE TO OTHER ICs FOR OTHER 102 00:03:59,440 --> 00:04:04,680 NETWORKS AND CENTERS, SUCH AS IN 103 00:04:04,680 --> 00:04:06,440 AIDS OR -- WELL MOST OF THE BIG 104 00:04:06,440 --> 00:04:10,240 ONES ARE IN AIDS, TO BE HONEST. 105 00:04:10,240 --> 00:04:13,400 SO WHEN WE DID THAT, WE CAME UP 106 00:04:13,400 --> 00:04:16,160 WITH A GRANT TOTAL, SO THIS DOES 107 00:04:16,160 --> 00:04:21,480 NOT INCLUDE CONTRACTS. 108 00:04:21,480 --> 00:04:23,680 A GRANT TOTAL BEFORE $182 109 00:04:23,680 --> 00:04:24,560 MILLION IN 2021. 110 00:04:24,560 --> 00:04:27,280 THAT IS A LITTLE OVER 11% OF THE 111 00:04:27,280 --> 00:04:29,280 TOTAL APPROPRIATION, WHAT WAS 112 00:04:29,280 --> 00:04:31,760 SPENT IN 2021. 113 00:04:31,760 --> 00:04:34,840 WE DO HAVE A FEW NETWORKS THAT 114 00:04:34,840 --> 00:04:42,680 WE FUND USING CONTRACTS, NOT 115 00:04:42,680 --> 00:04:42,920 GRANTS. 116 00:04:42,920 --> 00:04:44,520 ONE OF THOSE, THE PRIDE I CAN'T 117 00:04:44,520 --> 00:04:47,440 TELL PARTICULAR TRIAL NETWORK, 118 00:04:47,440 --> 00:04:48,800 WE FUND COLLABORATION WITH ABOUT 119 00:04:48,800 --> 00:04:52,280 20 OTHER ICs SO WE COLLECT 120 00:04:52,280 --> 00:04:54,800 MONEY FROM THOSE ICs TO FUND 121 00:04:54,800 --> 00:04:56,560 THE PEDIATRIC TRIAL NETWORK SO 122 00:04:56,560 --> 00:04:58,840 NOT A LOT OF OUR DIRECT FUNDS GO 123 00:04:58,840 --> 00:05:02,880 INTO THAT CONTRACT NETWORK. 124 00:05:02,880 --> 00:05:05,120 BUT, AS I SAID IN GRANT DOLLARS, 125 00:05:05,120 --> 00:05:08,120 IT IS ABOUT 182 MILLION FROM 126 00:05:08,120 --> 00:05:09,000 LAST YEAR. 127 00:05:09,000 --> 00:05:10,760 AS AN ESTIMATE. 128 00:05:10,760 --> 00:05:12,360 ASSUMING YOU LIKE OUR 129 00:05:12,360 --> 00:05:15,120 DEFINITION. 130 00:05:15,120 --> 00:05:21,800 SO, I HOPE THAT HELPS, DR. TITA 131 00:05:21,800 --> 00:05:25,400 AND DR. BARKIN, WE'RE HOPING 132 00:05:25,400 --> 00:05:27,640 THAT MIGHT ADDRESS YOUR 133 00:05:27,640 --> 00:05:29,000 QUESTION, AS WELL. 134 00:05:29,000 --> 00:05:31,240 AND DR. JANE HAS HIS HAND UP. 135 00:05:31,240 --> 00:05:36,520 >> DIANA, CAN I CAN I ASK A QUK 136 00:05:36,520 --> 00:05:37,040 QUESTION. 137 00:05:37,040 --> 00:05:38,720 I DIDN'T REALIZE ALEXIS WAS 138 00:05:38,720 --> 00:05:39,920 GOING TO BE HERE THIS MORNING 139 00:05:39,920 --> 00:05:40,680 I'M ALWAYS HERE. 140 00:05:40,680 --> 00:05:42,120 >> A QUICK QUESTION FOR YOU, 141 00:05:42,120 --> 00:05:43,520 YESTERDAY IN YOUR PRESENTATION 142 00:05:43,520 --> 00:05:47,880 YOU SHOWED THE DISTRIBUTION OF 143 00:05:47,880 --> 00:05:50,600 FUNDS, PARTICULARLY AS THEY 144 00:05:50,600 --> 00:05:53,120 RELATE TO ADMINISTRATIVE BUDGETS 145 00:05:53,120 --> 00:05:56,400 AND INTRAMURAL ALLOCATION, 5% 146 00:05:56,400 --> 00:05:59,040 AND 14% FOR THE NICHD. 147 00:05:59,040 --> 00:06:02,400 HOW DOES THAT COMPARE WITH OTHER 148 00:06:02,400 --> 00:06:04,360 MAJOR INSTITUTES WITHIN NIH. 149 00:06:04,360 --> 00:06:07,760 >> SO THAT'S A VERY GOOD 150 00:06:07,760 --> 00:06:08,200 QUESTION. 151 00:06:08,200 --> 00:06:11,560 SOIL SAY ACROSS NIH, BECAUSE OF 152 00:06:11,560 --> 00:06:12,680 CONGRESSIONAL INTEREST, RIGHT 153 00:06:12,680 --> 00:06:14,520 THERE SORT OF SOME ALMOST -- 154 00:06:14,520 --> 00:06:16,160 THEY'RE NOT UNSPOKEN, BECAUSE WE 155 00:06:16,160 --> 00:06:19,000 KNOW WHAT THEY ARE, BUT MOST 156 00:06:19,000 --> 00:06:21,600 ICs TRY KEEP THEIR RMS 157 00:06:21,600 --> 00:06:23,720 SPENDING THAT ADMINISTRATIVE 158 00:06:23,720 --> 00:06:25,000 AMOUNT, AROUND 5%. 159 00:06:25,000 --> 00:06:27,080 YOU KNOW, DEPEND ON THE 160 00:06:27,080 --> 00:06:29,480 SPECIFICS OF HOW AN IC FUNCTIONS 161 00:06:29,480 --> 00:06:31,000 THAT AMOUNT CAN FLUCTUATE A 162 00:06:31,000 --> 00:06:35,040 LITTLE BIT UP OR DOWN. 163 00:06:35,040 --> 00:06:36,600 FOR INTRAMURAL PROGRAMS, THERE 164 00:06:36,600 --> 00:06:38,880 IS A MUCH WIDER RANGE AND IT 165 00:06:38,880 --> 00:06:40,960 ALSO -- IF YOU EVER LOOK AT THE 166 00:06:40,960 --> 00:06:42,480 NATIONAL LIBRARY OF MEDICINE, 167 00:06:42,480 --> 00:06:45,520 MUCH OF THEIR BUDGET, ALMOST 80% 168 00:06:45,520 --> 00:06:47,920 IS CONSIDERED INTRAMURAL, EVEN 169 00:06:47,920 --> 00:06:50,360 THOUGH IT IS NOT A LOT OF ACTUAL 170 00:06:50,360 --> 00:06:50,640 LABS. 171 00:06:50,640 --> 00:06:53,400 SO THEY HAVE THE VERY FAR END. 172 00:06:53,400 --> 00:06:56,680 BUT SOME OTHER ICs HAVE VERY 173 00:06:56,680 --> 00:06:58,880 SMALL INTRAMURAL PROGRAMS DOWN 174 00:06:58,880 --> 00:07:00,120 TO 1% OR ZERO. 175 00:07:00,120 --> 00:07:02,480 SOME ICs DO NOT HAVE 176 00:07:02,480 --> 00:07:03,880 INTRAMURAL PROGRAMS. 177 00:07:03,880 --> 00:07:08,360 FOR US AT 14%, WE ARE NOT -- WE 178 00:07:08,360 --> 00:07:10,560 ARE NOT AT THE TOP BUT WE ARE, 179 00:07:10,560 --> 00:07:13,000 YOU KNOW, IN THE UPPER THIRD, I 180 00:07:13,000 --> 00:07:16,480 WOULD SAY, GENERALLY SPEAKING. 181 00:07:16,480 --> 00:07:20,360 CONGRESS AS A WHOLE FOR NIH, SO 182 00:07:20,360 --> 00:07:23,440 ON AVERAGE, LOOKS FOR INTRAMURAL 183 00:07:23,440 --> 00:07:27,040 TO BE CLOSER TO 10% FOR ALL OF 184 00:07:27,040 --> 00:07:29,000 NIH SO SOME OF THOSE ICs THAT 185 00:07:29,000 --> 00:07:30,640 DON'T HAVE A PROBLEM HELP 186 00:07:30,640 --> 00:07:31,880 BALANCE US OUT. 187 00:07:31,880 --> 00:07:33,920 SO THOSE ARE SORT OF THE -- I 188 00:07:33,920 --> 00:07:35,960 HOPE THAT ANSWERS YOUR QUESTION. 189 00:07:35,960 --> 00:07:38,200 >> YES, THANK YOU. 190 00:07:38,200 --> 00:07:42,760 WE KNEW SOME OF THIS INFORMATION 191 00:07:42,760 --> 00:07:46,080 FROM THE INFORMATION DR. BIANCHI 192 00:07:46,080 --> 00:07:47,680 PROVIDED AS YOU COUPLE YEARS 193 00:07:47,680 --> 00:07:47,880 AGO. 194 00:07:47,880 --> 00:07:49,440 JUST WANTED TO SEE IF THERE'S 195 00:07:49,440 --> 00:07:50,240 ANY UPDATES. 196 00:07:50,240 --> 00:07:51,760 THIS IS VERY HELPFUL. 197 00:07:51,760 --> 00:07:52,840 THANK YOU, ALEXIS. 198 00:07:52,840 --> 00:07:54,080 >> YOU'RE WELCOME. 199 00:07:54,080 --> 00:07:55,400 >> I WANTED TO THE JUMP IN AND 200 00:07:55,400 --> 00:07:59,280 THANK YOU FOR A VERY, YOU KNOW, 201 00:07:59,280 --> 00:08:00,840 RAPID RESPONSE. 202 00:08:00,840 --> 00:08:02,200 THAT REALLY LOOKS VERY 203 00:08:02,200 --> 00:08:03,840 REASONABLE TO ME. 204 00:08:03,840 --> 00:08:05,160 IT'S GREAT. 205 00:08:05,160 --> 00:08:07,200 AND I AM, YOU KNOW, VERY HAPPY 206 00:08:07,200 --> 00:08:08,760 WITH THE RESPONSE. 207 00:08:08,760 --> 00:08:11,040 NOW, IF YOU MAY NOT HAVE THIS, 208 00:08:11,040 --> 00:08:13,120 I'M JUST CURIOUS, YOU SAID THERE 209 00:08:13,120 --> 00:08:14,640 WERE TWO TYPES, RIGHT? 210 00:08:14,640 --> 00:08:17,400 THE ONES BY NICHD AND THE ONES 211 00:08:17,400 --> 00:08:17,640 OUTSIDE. 212 00:08:17,640 --> 00:08:20,640 DO YOU HAVE THE BREAK DOWN OF -- 213 00:08:20,640 --> 00:08:24,240 >> I DON'T HAVE THAT EXPLICITLY 214 00:08:24,240 --> 00:08:25,920 BUT SOME EXAMPLES OF SOME OF THE 215 00:08:25,920 --> 00:08:28,480 ONES THAT ARE OUTSIDE, FOR 216 00:08:28,480 --> 00:08:31,680 EXAMPLE, THE NIAID IMPACT 217 00:08:31,680 --> 00:08:34,200 NETWORK FOR AIDS, THE CENTERS 218 00:08:34,200 --> 00:08:37,280 FOR AIDS RESEARCH, WHICH IS ALSO 219 00:08:37,280 --> 00:08:45,120 RUN OUT OF NIAID. 220 00:08:45,120 --> 00:08:47,440 THERE ARE ALSO SOME STUDIES RUN 221 00:08:47,440 --> 00:08:50,160 OUT OF NIAID AND WE ALSO PROVIDE 222 00:08:50,160 --> 00:08:54,520 SOME FUNDING TO THE RARE DISEASE 223 00:08:54,520 --> 00:08:59,000 NETWORK, WHICH IS NOT OUT OF 224 00:08:59,000 --> 00:09:00,760 NICHD AND WE COLLABORATE WITH 225 00:09:00,760 --> 00:09:03,920 THREE ICs ON THE WELLSTONE 226 00:09:03,920 --> 00:09:05,440 MUSCULAR DYSTROPHY PROGRAM, SO 227 00:09:05,440 --> 00:09:07,080 ON SOME OF THOSE GRANTS WE ARE 228 00:09:07,080 --> 00:09:09,600 THE LEAD AND ON OTHER GRANTS 229 00:09:09,600 --> 00:09:14,800 DIFFERENT ICs, NIAMS IS ONE OF 230 00:09:14,800 --> 00:09:16,600 THEM AND I'M UNFORTUNATELY 231 00:09:16,600 --> 00:09:18,000 BLANKING ON THE THIRD, THEY ARE 232 00:09:18,000 --> 00:09:19,840 THE LEAD SO THOSE ARE EXAMPLES 233 00:09:19,840 --> 00:09:22,240 OF THE LARGER PROGRAMS WHERE WE 234 00:09:22,240 --> 00:09:23,000 PROVIDE CO-FUNDING. 235 00:09:23,000 --> 00:09:23,480 >> GREAT. 236 00:09:23,480 --> 00:09:23,920 THANK YOU SO MUCH. 237 00:09:23,920 --> 00:09:24,840 >> YOU'RE WELCOME. 238 00:09:24,840 --> 00:09:26,720 >> THANK YOU, ALEXIS. 239 00:09:26,720 --> 00:09:28,480 I JUST WANT TO CLARIFY, YOU SAID 240 00:09:28,480 --> 00:09:30,560 THAT THIS WAS A LITTLE BIT OVER 241 00:09:30,560 --> 00:09:32,960 11% OF THE TOTAL APPROPRIATION. 242 00:09:32,960 --> 00:09:37,240 SO IF WE TOOK OUT DIR, THE 243 00:09:37,240 --> 00:09:40,280 PERCENTAGE OF OUR DER BUDGET 244 00:09:40,280 --> 00:09:41,160 WOULD BE EVEN HIGHER. 245 00:09:41,160 --> 00:09:41,600 >> CORRECT. 246 00:09:41,600 --> 00:09:42,280 >> CORRECT? 247 00:09:42,280 --> 00:09:42,920 >> CORRECT. 248 00:09:42,920 --> 00:09:44,880 IT WOULD BE A HIGHER PERCENTAGE 249 00:09:44,880 --> 00:09:50,080 OF JUST THE EXTRAMURAL FUNDING 250 00:09:50,080 --> 00:09:54,360 IF WE EXCLUDED THE FUNDING AND 251 00:09:54,360 --> 00:09:54,760 INTRAMURAL, YES. 252 00:09:54,760 --> 00:09:57,200 >> IT IS A SIGNIFICANT 253 00:09:57,200 --> 00:09:57,520 PERCENTAGE. 254 00:09:57,520 --> 00:09:59,680 >> I DID IT OUT OF THE TOTAL 255 00:09:59,680 --> 00:10:01,680 BECAUSE THAT PIE CHART THAT WAS 256 00:10:01,680 --> 00:10:04,320 IN THE SLIDE SHOW HAD THE TOTAL 257 00:10:04,320 --> 00:10:05,000 APPROPRIATION AND WE WERE 258 00:10:05,000 --> 00:10:06,480 TALKING ABOUT CENTERS AND 259 00:10:06,480 --> 00:10:08,320 NETWORKS ON THAT PIE CHART ONLY 260 00:10:08,320 --> 00:10:10,080 LOOK TO BE ABOUT 6%. 261 00:10:10,080 --> 00:10:12,800 BUT AS I SAID THERE GRANTS IN 262 00:10:12,800 --> 00:10:14,560 OTHER MECHANISM LINES WHICH 263 00:10:14,560 --> 00:10:16,840 COULD BE INCLUDED SO OVERALL, 264 00:10:16,840 --> 00:10:19,520 FOR THAT CHART, IT WOULD BE 11%. 265 00:10:19,520 --> 00:10:20,560 >> GREAT. 266 00:10:20,560 --> 00:10:24,960 AND THEN JUST FOR EVERYTHING'S S 267 00:10:24,960 --> 00:10:26,920 AWARENESS, WE DO HAVE A 268 00:10:26,920 --> 00:10:28,120 RELATIVELY BIG INTRAMURAL 269 00:10:28,120 --> 00:10:32,080 PROGRAM AND THAT IS A POINT OF 270 00:10:32,080 --> 00:10:33,600 DISCUSSION FOR OUR NEW 271 00:10:33,600 --> 00:10:35,800 SCIENTIFIC DIRECTOR, WHOEVER HE 272 00:10:35,800 --> 00:10:37,840 OR SHE MAY BE. 273 00:10:37,840 --> 00:10:39,720 I THINK CHRIS McBAIN HAS 274 00:10:39,720 --> 00:10:41,320 SHARED WE ARE THE 6th BIGGEST 275 00:10:41,320 --> 00:10:44,080 IN TERMS OF TOTAL BUDGET. 276 00:10:44,080 --> 00:10:48,760 SO 14% OF THE TOTAL IS THE 6th 277 00:10:48,760 --> 00:10:50,520 LARGEST AMOUNT COMPARED TO OTHER 278 00:10:50,520 --> 00:10:52,160 INSTITUTES AND CENTERS. 279 00:10:52,160 --> 00:10:53,920 SO WE ARE SPENDING QUITE A BIT 280 00:10:53,920 --> 00:10:56,080 ON OUR INTRAMURAL RESEARCH 281 00:10:56,080 --> 00:10:56,320 PROGRAM. 282 00:10:56,320 --> 00:11:00,880 AND IT IS ONLY ONE PIE, SO, YOU 283 00:11:00,880 --> 00:11:02,640 KNOW, IF WE'RE SPENDING THERE WE 284 00:11:02,640 --> 00:11:04,080 DON'T HAVE MONEY ELSE WHERE SO 285 00:11:04,080 --> 00:11:06,080 THAT IS SOMETHING WE'RE ALWAYS 286 00:11:06,080 --> 00:11:06,440 AWARE OF. 287 00:11:06,440 --> 00:11:12,040 THANK YOU, ALEXIS. 288 00:11:12,040 --> 00:11:13,880 YES, KATHERINE, DO YOU WANT TO 289 00:11:13,880 --> 00:11:15,640 COME OFF MUTE AND MAKE YOUR 290 00:11:15,640 --> 00:11:15,880 COMMENT. 291 00:11:15,880 --> 00:11:17,360 >> I LOST TRACK OF WHAT MEETING 292 00:11:17,360 --> 00:11:19,440 IS WHEN, BUT I KNOW WE HAD A 293 00:11:19,440 --> 00:11:22,160 WONDERFUL PRESENTATION FROM THE 294 00:11:22,160 --> 00:11:23,720 DIRECTOR OF INTRAMURAL RESEARCH 295 00:11:23,720 --> 00:11:26,360 AT A RELATIVELY RENT MEETING AND 296 00:11:26,360 --> 00:11:29,280 WE TALKED ABOUT PERCENTAGES AND 297 00:11:29,280 --> 00:11:30,840 HOW NICHD WAS ON THE HIGHER END 298 00:11:30,840 --> 00:11:32,800 BUT HOW A LOT OF THE WORK WAS 299 00:11:32,800 --> 00:11:34,640 REALLY IMPORTANT AND COULD ONLY 300 00:11:34,640 --> 00:11:36,480 BE DONE TRAIN MURALLY AND 301 00:11:36,480 --> 00:11:39,560 WOULDN'T BE ABLE TO BE DONE 302 00:11:39,560 --> 00:11:41,040 EXTRA MURALLY. 303 00:11:41,040 --> 00:11:42,160 >> YES. 304 00:11:42,160 --> 00:11:43,480 USUALLY IT IS THE SEPTEMBER 305 00:11:43,480 --> 00:11:45,320 COUNSEL WE DEVOTE A LOT OF TIME 306 00:11:45,320 --> 00:11:47,560 TO THE INTRAMURAL PROGRAM. 307 00:11:47,560 --> 00:11:49,360 WE HAVE TWO THINGS TO GET TO 308 00:11:49,360 --> 00:11:52,440 BEFORE WE HAVE THE CLOSED 309 00:11:52,440 --> 00:11:52,960 SESSION. 310 00:11:52,960 --> 00:11:55,720 ONE IS THE REPORT, WHICH IT JUST 311 00:11:55,720 --> 00:11:57,600 FLOWS BEAUTIFULLY FROM THE 312 00:11:57,600 --> 00:11:59,640 DISCUSSION REGARDING CENTERS AND 313 00:11:59,640 --> 00:12:00,200 NETWORKS. 314 00:12:00,200 --> 00:12:03,800 WE'RE GOING TO HAVE A REPORT BY 315 00:12:03,800 --> 00:12:05,240 DR. BOB TAMBURRO WHO IS GOING TO 316 00:12:05,240 --> 00:12:08,400 TAKE US THROUGH NICHD'S CLINICAL 317 00:12:08,400 --> 00:12:10,880 TRIAL NETWORKS SO BOB, OVER TO 318 00:12:10,880 --> 00:12:11,080 YOU. 319 00:12:11,080 --> 00:12:12,960 THERE YOU ARE. 320 00:12:12,960 --> 00:12:14,520 >> GOOD AFTERNOON ON THE EAST 321 00:12:14,520 --> 00:12:15,400 COAST AND GOOD MORNING TO THOSE 322 00:12:15,400 --> 00:12:17,720 IN THE REST OF THE COUNTRY. 323 00:12:17,720 --> 00:12:19,720 MY NAME IS BOB TAMBURRO AND I'M 324 00:12:19,720 --> 00:12:22,960 IN THE DIVISION OF EXTRA MURAL 325 00:12:22,960 --> 00:12:24,040 RESEARCH AND I WILL BE 326 00:12:24,040 --> 00:12:24,800 PRESENTING ON BEHALF OF THAT 327 00:12:24,800 --> 00:12:26,520 DIVISION OUR PROPOSAL FOR 328 00:12:26,520 --> 00:12:29,160 CONDUCTING MULTI-SITE CLUBCLE 329 00:12:29,160 --> 00:12:31,920 TRIALS UTILIZING NICHD NETWORK 330 00:12:31,920 --> 00:12:40,400 INFRASTRUCTURE. 331 00:12:40,400 --> 00:12:42,440 IT DOESN'T SEEM LIKE MY SLIDES 332 00:12:42,440 --> 00:12:43,120 ARE ADVANCING. 333 00:12:43,120 --> 00:12:44,640 >> TRY CLICKING ON THE SLIDES 334 00:12:44,640 --> 00:12:47,240 FIRST AND THEN USE THE SIDE 335 00:12:47,240 --> 00:12:47,480 ARROWS. 336 00:12:47,480 --> 00:12:56,640 >> OKAY. 337 00:12:56,640 --> 00:12:57,080 HOW ABOUT THAT. 338 00:12:57,080 --> 00:12:58,040 >> YUP. 339 00:12:58,040 --> 00:13:01,120 >> ALL RIGHT. 340 00:13:01,120 --> 00:13:04,360 SO I APOLOGIZE FOR THE TECHNICAL 341 00:13:04,360 --> 00:13:04,800 DIFFICULTIES. 342 00:13:04,800 --> 00:13:07,360 NICHD HAS HAD A LONG TRADITION 343 00:13:07,360 --> 00:13:09,400 OF SUPPORTING MULTI-SITE 344 00:13:09,400 --> 00:13:10,280 CLINICAL RESEARCH. 345 00:13:10,280 --> 00:13:11,600 HERE ON THE LEFT OF THE SCREEN, 346 00:13:11,600 --> 00:13:13,680 WE SEE A REPORT FROM NEARLY 50 347 00:13:13,680 --> 00:13:15,000 YEARS AGO WHICH THE NICHD 348 00:13:15,000 --> 00:13:16,960 SUPPORTED A NINE-CENTER STUDY 349 00:13:16,960 --> 00:13:19,840 ASSESSING THE VALUE OF THE AM 350 00:13:19,840 --> 00:13:26,800 AMNIOSENTISIS IN THE SECOND 351 00:13:26,800 --> 00:13:27,080 TRIMESTER. 352 00:13:27,080 --> 00:13:28,880 NOT LONG AFTER, CENTERS FOR 353 00:13:28,880 --> 00:13:30,840 CLINICAL RESEARCH BEGAN. 354 00:13:30,840 --> 00:13:33,480 IN 1985, THE NICHD FORMED THE 355 00:13:33,480 --> 00:13:35,200 FIRST TWO NETWORKS. 356 00:13:35,200 --> 00:13:40,080 THE NEO NATAL NETWORK AND THE 357 00:13:40,080 --> 00:13:43,360 MATERNAL UNITS TO PERFORM LARGE 358 00:13:43,360 --> 00:13:44,720 SCALE CLINICAL TRIALS AND 359 00:13:44,720 --> 00:13:47,640 PROVIDE A FASTER, MORE EFFECTIVE 360 00:13:47,640 --> 00:13:51,040 SYSTEM FOR EVALUATING NEO NATAL 361 00:13:51,040 --> 00:13:53,200 CARE AND MATERNAL TREATMENTS. 362 00:13:53,200 --> 00:13:55,840 IN THE ENSUING 35 YEARS, THESE 363 00:13:55,840 --> 00:13:57,480 NETWORKS CONDUCTED SEMINOLE 364 00:13:57,480 --> 00:13:59,880 RESEARCH THAT ADVANCED THESE 365 00:13:59,880 --> 00:14:02,480 SKILLED AND IMPACTED CLINICAL 366 00:14:02,480 --> 00:14:07,960 CARE AND PRACTICE. 367 00:14:07,960 --> 00:14:10,800 SINCE THEN, THE NICHD CONTINUED 368 00:14:10,800 --> 00:14:12,600 TO EXPAND ITS INFRASTRUCTURE 369 00:14:12,600 --> 00:14:15,160 SUPPORT OF MULTI CENTER CLINICAL 370 00:14:15,160 --> 00:14:17,000 TRIES, CREATING ADDITIONAL 371 00:14:17,000 --> 00:14:18,440 NETWORKS THAT ADDRESS OTHER 372 00:14:18,440 --> 00:14:20,080 ESSENTIAL AREAS OF HEALTH CARE 373 00:14:20,080 --> 00:14:21,520 RELATIVE TO OUR MISSION THIS 374 00:14:21,520 --> 00:14:22,480 INFRASTRUCTURE HAS SUPPORTED 375 00:14:22,480 --> 00:14:24,360 HUNDREDS OF CLINICAL RESEARCH 376 00:14:24,360 --> 00:14:25,880 PROJECTS AND TRIALS OVER THE 377 00:14:25,880 --> 00:14:27,400 YEARS INFORMING CARE, RESULTING 378 00:14:27,400 --> 00:14:29,400 IN CHANGES IN CLINICAL PRACTICE 379 00:14:29,400 --> 00:14:32,040 AND ADVANCING OUTCOMES, FOR 380 00:14:32,040 --> 00:14:34,400 INSTANCE, CHILDREN, ADOLESCENTS, 381 00:14:34,400 --> 00:14:37,240 AS WELL AS PREGNANT AND LOOK 382 00:14:37,240 --> 00:14:38,320 TATING INDIVIDUALS AND THOSE 383 00:14:38,320 --> 00:14:39,640 WITH DISABILITIES. 384 00:14:39,640 --> 00:14:42,720 BEGINNING IN 2016, THE NIH 385 00:14:42,720 --> 00:14:44,120 PROPOSED AND SUBSEQUENTLY 386 00:14:44,120 --> 00:14:45,840 IMPLEMENTED A SERIES OF REFORMS 387 00:14:45,840 --> 00:14:49,840 TO ENHANCE CLINICAL TRIAL 388 00:14:49,840 --> 00:14:51,640 STEWARDSHIP AND TRANSPARENCY AND 389 00:14:51,640 --> 00:14:53,040 THERE BY FURTHER ASSURE THE 390 00:14:53,040 --> 00:14:55,000 SUCCESS OF THE NIH CLINICAL 391 00:14:55,000 --> 00:14:56,080 TRIAL ENTERPRISE. 392 00:14:56,080 --> 00:14:58,720 AS PART OF THIS INITIATIVE AND 393 00:14:58,720 --> 00:15:00,920 TO PROCEED VIEW CENTERS 394 00:15:00,920 --> 00:15:01,800 FLEXIBILITIES ACROSS THEIR 395 00:15:01,800 --> 00:15:03,440 DIFFERENT SCIENTIFIC AREAS, 396 00:15:03,440 --> 00:15:04,760 INDIVIDUAL INSTITUTES AND 397 00:15:04,760 --> 00:15:06,600 CENTERS WERE ASKED TO DEVELOP 398 00:15:06,600 --> 00:15:08,560 THEIR OWN CLINICAL TRIAL FUNDING 399 00:15:08,560 --> 00:15:10,000 OPPORTUNITY ANNOUNCEMENTS TO 400 00:15:10,000 --> 00:15:12,400 JUST THEIR RESEARCH FUNDING 401 00:15:12,400 --> 00:15:13,800 PRIORITIES AND STRATEGIC GOALS 402 00:15:13,800 --> 00:15:16,120 IN RESPONSE, THE NICHD 403 00:15:16,120 --> 00:15:17,960 REAFFIRMED ITS COMMITMENT TO 404 00:15:17,960 --> 00:15:19,800 CONDUCTING RIGOROUS MULTI SITE 405 00:15:19,800 --> 00:15:21,560 CLINICAL TRIALS AND IDENTIFIED 406 00:15:21,560 --> 00:15:23,880 FOUR GUIDING PRINCIPLES OF THAT 407 00:15:23,880 --> 00:15:24,200 RESEARCH. 408 00:15:24,200 --> 00:15:27,680 IN THE FALL OF TO 19, THOSE 409 00:15:27,680 --> 00:15:30,520 PRINCIPLES -- OF 201, THOSE 410 00:15:30,520 --> 00:15:32,840 PRINCIPLES WERE EXPRESSED IN THE 411 00:15:32,840 --> 00:15:35,240 GUIDE NOTICE, INFRASTRUCTURE FOR 412 00:15:35,240 --> 00:15:37,080 NICHD MULTI SITE CLINICAL 413 00:15:37,080 --> 00:15:39,880 TRIALS, AS WELL AS IN A WEBINAR, 414 00:15:39,880 --> 00:15:42,320 STRATEGIC PLAN 2020 415 00:15:42,320 --> 00:15:42,680 IMPLEMENTATION. 416 00:15:42,680 --> 00:15:44,280 DAY'S VISION FOR MULTI SITE 417 00:15:44,280 --> 00:15:46,560 CLINICAL TRIALS INFRASTRUCTURE. 418 00:15:46,560 --> 00:15:48,000 THE FOUR GUIDING PRINCIPLES THAT 419 00:15:48,000 --> 00:15:49,840 WERE EXPRESSED AND EMPHASIZED IN 420 00:15:49,840 --> 00:15:51,960 THOSE FORUMS INCLUDED: 421 00:15:51,960 --> 00:15:54,320 TO ENHANCE THE RIGGER AND 422 00:15:54,320 --> 00:15:55,520 REPRODUCE ABILITY OF CLIN 423 00:15:55,520 --> 00:15:56,920 CRIMINAL TRIAL PROTOCOLS. 424 00:15:56,920 --> 00:15:59,000 TO PROMOTE GREATER AVAILABILITY 425 00:15:59,000 --> 00:16:02,080 OF MULTI SITE CLINICAL TRIAL 426 00:16:02,080 --> 00:16:02,960 INFRASTRUCTURE 0 TO SUPPORT 427 00:16:02,960 --> 00:16:08,960 TRIALS FROM A WIDER RANGE OF 428 00:16:08,960 --> 00:16:09,920 INVESTIGATORS TOMORROW 429 00:16:09,920 --> 00:16:11,080 OFFICIALLY EXPAND RESEARCH 430 00:16:11,080 --> 00:16:13,680 CAPACITY FOR ALL INVESTIGATORS. 431 00:16:13,680 --> 00:16:15,280 TO FACILITATE GREATER 432 00:16:15,280 --> 00:16:16,400 INVOLVEMENT OF DIVERSE 433 00:16:16,400 --> 00:16:18,120 POPULATIONS AND MULTI-SITE 434 00:16:18,120 --> 00:16:18,920 CLINICAL TRIALS. 435 00:16:18,920 --> 00:16:24,480 WE BELIEVE THAT ADHERING TO THEE 436 00:16:24,480 --> 00:16:26,640 PRINCIPLES ENSURE PROPER 437 00:16:26,640 --> 00:16:28,280 STEWARDSHIP OF PUBLIC FUNDS, 438 00:16:28,280 --> 00:16:29,000 INCREASES ACCOUNT. 439 00:16:29,000 --> 00:16:31,120 AND HELPS NICHD MAINTAIN THE 440 00:16:31,120 --> 00:16:32,640 PUBLIC'S TRUST. 441 00:16:32,640 --> 00:16:33,640 ACCORDINGLY, IT IS NOT 442 00:16:33,640 --> 00:16:35,600 SURPRISING THESE FOUR GUIDING 443 00:16:35,600 --> 00:16:37,880 PRINCIPLES WERE BOTH IMPLICITLY 444 00:16:37,880 --> 00:16:39,840 AND EXPLICITLY EXPRESSED IN 445 00:16:39,840 --> 00:16:42,680 SEVERAL OF THE SCIENTIFIC 446 00:16:42,680 --> 00:16:45,320 STEWARDSHIP GOALS DELINEATED IN 447 00:16:45,320 --> 00:16:46,880 THE 2020 STRATEGIC PLAN. 448 00:16:46,880 --> 00:16:49,480 HOWEVER, A PROCESS IS NEEDED TO 449 00:16:49,480 --> 00:16:50,760 OPERATIONALIZE THESE GUIDING 450 00:16:50,760 --> 00:16:51,080 PRINCIPLES. 451 00:16:51,080 --> 00:16:54,400 TO BEST INFORM THIS PROCESS AN 452 00:16:54,400 --> 00:16:56,040 EXTENSIVE ASSESSMENT WAS 453 00:16:56,040 --> 00:16:56,600 CONDUCTED. 454 00:16:56,600 --> 00:16:59,520 FIRST THE NICHD PUBLISHED A 455 00:16:59,520 --> 00:17:01,280 QUESTION FOR INFORMATION, 456 00:17:01,280 --> 00:17:05,840 FOLLOWING DR. BIANCHI'S WEBINAR 457 00:17:05,840 --> 00:17:07,760 IN 2019 WITH THE GOAL OF US 458 00:17:07,760 --> 00:17:08,800 HAVITYING INPUT FROM THE PUBLIC 459 00:17:08,800 --> 00:17:10,840 ON ITS VISION FOR SUPPORTING 460 00:17:10,840 --> 00:17:13,400 MULTI SITE CLINICAL TRIALS 461 00:17:13,400 --> 00:17:14,040 INFRASTRUCTURE. 462 00:17:14,040 --> 00:17:16,720 AS DR. CERNICH SHARED IN THE 463 00:17:16,720 --> 00:17:18,720 2020 COUNSEL SULL, THERE WAS A 464 00:17:18,720 --> 00:17:20,840 FARELY ROBUST RESPONSE TO THE 465 00:17:20,840 --> 00:17:23,080 RFI BUT THE TOTAL OF 79 466 00:17:23,080 --> 00:17:24,680 RESPONSES WE RECEIVED INCLUDING 467 00:17:24,680 --> 00:17:26,720 19 COORDNATALIED MESSAGES FROM 468 00:17:26,720 --> 00:17:28,240 PROFESSIONAL SOCIETIES AND 469 00:17:28,240 --> 00:17:28,680 ASSOCIATIONS. 470 00:17:28,680 --> 00:17:30,400 COMMON THEMES IDENTIFIED IN THE 471 00:17:30,400 --> 00:17:31,760 RESPONSES INCLUDE BE SUPPORTING 472 00:17:31,760 --> 00:17:34,680 MULTIPLE MODELS OF CLINICAL 473 00:17:34,680 --> 00:17:37,520 TRIAL INFRASTRUCTURE, SPONSORING 474 00:17:37,520 --> 00:17:40,200 MANY CLINICAL SITES TO ENSURE 475 00:17:40,200 --> 00:17:41,920 DIVERSITY OF ENROLLMENT, HAVING 476 00:17:41,920 --> 00:17:44,200 CORE SITES WITH WELL-TRAINED 477 00:17:44,200 --> 00:17:44,840 STAFF. 478 00:17:44,840 --> 00:17:47,040 INCREASING DIVERSE RESEARCHERS 479 00:17:47,040 --> 00:17:49,000 THAT HAVE ACCESS TO THE 480 00:17:49,000 --> 00:17:49,640 INFRASTRUCTURE. 481 00:17:49,640 --> 00:17:51,400 PROVIDING AN ENVIRONMENT OF 482 00:17:51,400 --> 00:17:53,120 RESEARCH, TRAINING OF YOUNG 483 00:17:53,120 --> 00:17:55,080 INVESTIGATORS. 484 00:17:55,080 --> 00:17:56,000 AND ENABLING FOLLOW UP BEYOND 485 00:17:56,000 --> 00:17:58,280 THE TRADITIONAL FIVE-YEAR GRANT 486 00:17:58,280 --> 00:17:58,520 PERIOD. 487 00:17:58,520 --> 00:18:00,560 IN ADDITION, A PREFERENCE FOR A 488 00:18:00,560 --> 00:18:01,560 CENTRALIZED APPROACH WHICH 489 00:18:01,560 --> 00:18:02,560 NETWORK INFRASTRUCTURE IS 490 00:18:02,560 --> 00:18:04,320 SUPPORTED OR AT LEAST A HYBRID 491 00:18:04,320 --> 00:18:05,960 MODEL THAT INCLUDES ACCESS TO 492 00:18:05,960 --> 00:18:08,560 THE CENTRALIZED MODEL WAS 493 00:18:08,560 --> 00:18:08,960 EXPRESSED. 494 00:18:08,960 --> 00:18:11,040 OTHER IDEAS SHARED IN THE RFI 495 00:18:11,040 --> 00:18:11,960 RESPONSIBILITIES INCLUDED 496 00:18:11,960 --> 00:18:14,360 CONDUCTING A LANDSCAPE ANALYSIS, 497 00:18:14,360 --> 00:18:15,400 THE BEST CLINICAL TRIAL 498 00:18:15,400 --> 00:18:18,040 PRACTICES ACROSS THE NIH AND 499 00:18:18,040 --> 00:18:21,440 CREATING A DEDICATED NICHD STUDY 500 00:18:21,440 --> 00:18:22,840 SECTION THAT ENHANCES EXTERNAL 501 00:18:22,840 --> 00:18:25,880 PEER REVIEW AND FOSTERS 502 00:18:25,880 --> 00:18:27,320 INCREASED OVERSIGHT AND 503 00:18:27,320 --> 00:18:29,960 DECREASED CONFLICTS OF INTEREST. 504 00:18:29,960 --> 00:18:31,920 CONSEQUENTLY AND SUBSEQUENTLY, A 505 00:18:31,920 --> 00:18:33,920 LANDSCAPE ANALYSIS OF OTHER 506 00:18:33,920 --> 00:18:36,080 PRACTICES ACROSS THE NIH WAS 507 00:18:36,080 --> 00:18:36,400 PERFORMED. 508 00:18:36,400 --> 00:18:37,960 BASED ON THIS FEEDBACK AND 509 00:18:37,960 --> 00:18:40,440 INPUT, THE NICHD HAS OPTED FOR A 510 00:18:40,440 --> 00:18:42,160 CENTRALIZED APPROACH IN WHICH 511 00:18:42,160 --> 00:18:44,160 NETWORK INFRASTRUCTURE IS 512 00:18:44,160 --> 00:18:44,600 SUPPORTED. 513 00:18:44,600 --> 00:18:46,440 AS PART OF THIS CENTRALIZED 514 00:18:46,440 --> 00:18:47,840 APPROACH, THE NICHD WILL 515 00:18:47,840 --> 00:18:50,040 CONTINUE TO SUPPORT NETWORK 516 00:18:50,040 --> 00:18:51,120 INFRASTRUCTURE, BUT WILL NOW 517 00:18:51,120 --> 00:18:52,880 PERMIT ACCESS TO THE NETWORK 518 00:18:52,880 --> 00:18:56,400 RESOURCES FROM ANY QUALIFIED 519 00:18:56,400 --> 00:18:59,000 INVESTIGATOR AND ALL NETWORK 520 00:18:59,000 --> 00:19:00,760 CLIN CRIMINAL TRIAL APPLICATIONS 521 00:19:00,760 --> 00:19:03,080 WILL UNDER GO NIH PEER REVIEW. 522 00:19:03,080 --> 00:19:05,120 WE BELIEVE THESE LAST TWO BULLET 523 00:19:05,120 --> 00:19:07,120 POINTS REPRESENT TWO OF THE MOST 524 00:19:07,120 --> 00:19:08,320 FUNDAMENTAL CHANGES OF THIS NEW 525 00:19:08,320 --> 00:19:08,720 APPROACH. 526 00:19:08,720 --> 00:19:09,960 THE CONGRESS SEPTEMBER BEING 527 00:19:09,960 --> 00:19:11,360 PROPOSED THAT THE COUNCIL IS FOR 528 00:19:11,360 --> 00:19:14,120 A DEDICATED FUNDING OPPORTUNITY 529 00:19:14,120 --> 00:19:15,640 ANNOUNCEMENT TO SOLICIT CLINICAL 530 00:19:15,640 --> 00:19:18,240 TRIAL APPLICATIONS TO LEVERAGE 531 00:19:18,240 --> 00:19:20,040 THE A2 NETWORK INFRASTRUCTURE 532 00:19:20,040 --> 00:19:22,200 AND TO OPERATIONALIZE THE 533 00:19:22,200 --> 00:19:24,160 RECEIVED INPUT AND THE FOUR 534 00:19:24,160 --> 00:19:26,440 GUIDING PRINCIPLES. 535 00:19:26,440 --> 00:19:29,840 FIRST, TO ENHANCE 536 00:19:29,840 --> 00:19:31,040 REPRODUCIBILITY, WE'RE 537 00:19:31,040 --> 00:19:32,480 DEVELOPING A NEW PROTOCOL 538 00:19:32,480 --> 00:19:34,520 PROPOSAL AND SELECTION PROCESS. 539 00:19:34,520 --> 00:19:36,840 WITHIN THIS INITIATIVE, FUTURE 540 00:19:36,840 --> 00:19:38,680 TRIAL WILL BE CONDUCTED WITHIN 541 00:19:38,680 --> 00:19:39,960 THE NETWORK INFRASTRUCTURE WILL 542 00:19:39,960 --> 00:19:41,840 BE SUB MISSED IN INDIVIDUAL AND 543 00:19:41,840 --> 00:19:44,760 NIH APPLICATIONS WILL UNDER GO 544 00:19:44,760 --> 00:19:46,200 NIH PEER REVIEW AND FUNDING 545 00:19:46,200 --> 00:19:47,960 DECISIONS WILL BE MADE BY THE 546 00:19:47,960 --> 00:19:49,920 NICHD LEADERSHIP WITH COUNCIL 547 00:19:49,920 --> 00:19:51,560 PROVIDING THE NECESSARY AND 548 00:19:51,560 --> 00:19:52,840 INFORMED SECOND LEVEL REVIEW AS 549 00:19:52,840 --> 00:19:57,360 YOU DO FOR ALL APPLICATIONS, 550 00:19:57,360 --> 00:20:03,080 PRIOR TO NICHD DECISION. 551 00:20:03,080 --> 00:20:04,840 SECOND, 0 TO PROMOTE GREATER 552 00:20:04,840 --> 00:20:06,880 AVAILABILITY OF MULTI SITE 553 00:20:06,880 --> 00:20:08,880 CLINICAL INFRASTRUCTURE TO A 554 00:20:08,880 --> 00:20:10,320 WIDER RANGE OF INVESTIGATORS. 555 00:20:10,320 --> 00:20:14,680 THIS NEW INITIATIVE WILL ALLOW 556 00:20:14,680 --> 00:20:16,720 ANY FROM THE EXTRA MURAL 557 00:20:16,720 --> 00:20:18,680 COMMUNITY TO PROPOSE STUDIED 558 00:20:18,680 --> 00:20:19,920 WITHIN THE NETWORK. 559 00:20:19,920 --> 00:20:21,640 CERTAINLY THOSE IN THE FUNDED 560 00:20:21,640 --> 00:20:23,520 NETWORK CLINICAL CENTERS WILL 561 00:20:23,520 --> 00:20:27,000 WILL BE ABLE TO PROPOSE COUNTS 562 00:20:27,000 --> 00:20:28,320 WITH THE FUNDING ANNOUNCEMENT 563 00:20:28,320 --> 00:20:29,960 AND WE ANTICIPATE A LARGE NUMBER 564 00:20:29,960 --> 00:20:32,880 OF PROPOSALS WILL STILL 565 00:20:32,880 --> 00:20:34,080 ORIGINATE FROM THIS SOURCE. 566 00:20:34,080 --> 00:20:35,400 INDEPENDENT OF THE SOURCE 567 00:20:35,400 --> 00:20:36,720 INVESTIGATOR, STUDIES WILL NEED 568 00:20:36,720 --> 00:20:38,560 TO ALIGN WITH THE PURPOSE, GOALS 569 00:20:38,560 --> 00:20:40,240 AND OBJECTIVES OF THE NETWORK 570 00:20:40,240 --> 00:20:43,080 AND WITH NICHD PRIORITIES. 571 00:20:43,080 --> 00:20:44,800 NEXT, FACILITATING DATA SHARING 572 00:20:44,800 --> 00:20:48,080 AND ACCESS TO BIO SPECIMENS LAB 573 00:20:48,080 --> 00:20:49,360 TOP PRIORITY OF THIS INITIATIVE. 574 00:20:49,360 --> 00:20:51,240 NETWORKS WILL BE REQUIRED TO 575 00:20:51,240 --> 00:20:53,320 SHARE DATA AND BIO SPES MONIES 576 00:20:53,320 --> 00:20:55,280 ACCORDING TO THE NIH POLICY FOR 577 00:20:55,280 --> 00:20:56,920 DATA MANAGEMENT AND SHARING. 578 00:20:56,920 --> 00:20:59,000 THE EFFECTIVE DATE FOR 579 00:20:59,000 --> 00:20:59,760 IMPLEMENTATION OF THE DATA 580 00:20:59,760 --> 00:21:03,600 MANAGEMENT AND SHARING POLICY IS 581 00:21:03,600 --> 00:21:04,640 JANUARY 25, 2023. 582 00:21:04,640 --> 00:21:06,520 IN ADDITION, CLIN CRIMINAL TRIAL 583 00:21:06,520 --> 00:21:07,960 STUDY CONSENT FORM WILL BE 584 00:21:07,960 --> 00:21:09,480 MODELED TO ALLOW BROAD SHARING 585 00:21:09,480 --> 00:21:12,760 AND FUTURE USE OF STUDY DATA. 586 00:21:12,760 --> 00:21:14,920 FURTHER, THE USE OF COMMON DATA 587 00:21:14,920 --> 00:21:16,480 ELEMENTS, BOTH WITHIN INDIVIDUAL 588 00:21:16,480 --> 00:21:18,760 NETWORKS AND ACROSS NICHD 589 00:21:18,760 --> 00:21:22,480 NETWORKS WILL BE A PRIORITY. 590 00:21:22,480 --> 00:21:24,200 FINALLY, AND IMPORTANTLY, IT IS 591 00:21:24,200 --> 00:21:25,880 CRITICAL THAT WE CONTINUE TO 592 00:21:25,880 --> 00:21:27,800 FACILITATE GREATER INVOLVEMENT, 593 00:21:27,800 --> 00:21:29,880 A DIVERSE POPULATIONS IN OUR 594 00:21:29,880 --> 00:21:31,560 MULTI SITE CLINICAL TRIALS, 595 00:21:31,560 --> 00:21:33,200 INCLUDING THOSE INDIVIDUALS WITH 596 00:21:33,200 --> 00:21:33,720 DISABILITIES. 597 00:21:33,720 --> 00:21:35,000 AND I SAY CONTINUE BECAUSE I 598 00:21:35,000 --> 00:21:37,560 BELIEVE THAT THIS HAS LONG BEEN 599 00:21:37,560 --> 00:21:38,440 AN IMPORTANT CONSIDERATION FOR 600 00:21:38,440 --> 00:21:40,400 OUR CLINICAL NETWORKS. 601 00:21:40,400 --> 00:21:42,440 ENSURE DIVERSITY IN MULTI SITE 602 00:21:42,440 --> 00:21:44,360 CLINICAL TRIALS INCLUDES BOTH, 603 00:21:44,360 --> 00:21:46,440 THE STUDY PARTICIPANTS OBVIOUSLY 604 00:21:46,440 --> 00:21:50,440 BUT ADDITIONALLY DIVERSITY AMONG 605 00:21:50,440 --> 00:21:52,160 THE INVESTIGATORS. 606 00:21:52,160 --> 00:21:54,240 NICHD TRIAL WILL BE EXPECTED TO 607 00:21:54,240 --> 00:21:55,920 MAXIMIZE INCLUSION OF DIVERSE 608 00:21:55,920 --> 00:21:57,400 STUDY PARTICIPANTS AND WE WILL 609 00:21:57,400 --> 00:21:59,160 WORK TO CONTINUE TO DEVELOP 610 00:21:59,160 --> 00:22:01,240 DIVERSITY IN THE WORKFORCE 611 00:22:01,240 --> 00:22:06,000 ASCRIBED IN GUIDE NOTICE OD-2 612 00:22:06,000 --> 00:22:06,360 OD-20-031. 613 00:22:06,360 --> 00:22:08,240 IN ORDER TO OPT MUSE THE 614 00:22:08,240 --> 00:22:09,400 SUCCESSFUL IMPLEMENTATION OF 615 00:22:09,400 --> 00:22:10,840 THIS NEW APPROACH, WE BELIEVE 616 00:22:10,840 --> 00:22:12,480 THAT THERE ARE FOUR MAIN 617 00:22:12,480 --> 00:22:14,040 COMPONENTS TO BE ADDRESSED. 618 00:22:14,040 --> 00:22:15,640 THEY INCLUDE: 619 00:22:15,640 --> 00:22:16,400 IDENTIFYING WHICH SCIENCE WE 620 00:22:16,400 --> 00:22:17,840 HOPE TO SUPPORT WITH THIS 621 00:22:17,840 --> 00:22:19,480 MECHANISM AND ASSURING ITS 622 00:22:19,480 --> 00:22:21,760 ALIGNMENT WITH THE APPROPRIATE 623 00:22:21,760 --> 00:22:22,200 NETWORKS. 624 00:22:22,200 --> 00:22:24,840 DEVELOPING AN IMPLEMENTING A 625 00:22:24,840 --> 00:22:25,720 RIGOROUS PREAPPLICATION 626 00:22:25,720 --> 00:22:27,040 SELECTION PROCESS. 627 00:22:27,040 --> 00:22:30,160 ASSURING A JUDICIAL PEER REVIEW 628 00:22:30,160 --> 00:22:31,720 PROCESS WITH THE NECESSARY 629 00:22:31,720 --> 00:22:33,440 EXPERTISE AND YET FREE FROM ANY 630 00:22:33,440 --> 00:22:35,200 CONFLICTS OR PERCEIVED CONFLICTS 631 00:22:35,200 --> 00:22:37,280 OF INTEREST IN KEEPING WITH THE 632 00:22:37,280 --> 00:22:38,600 LONG-STANDING EXCELLENCE OF NIH 633 00:22:38,600 --> 00:22:40,000 PEER REVIEW. 634 00:22:40,000 --> 00:22:41,320 AND, FINALLY, IDENTIFYING THE 635 00:22:41,320 --> 00:22:43,600 MOST EFFECTIVE AND 636 00:22:43,600 --> 00:22:45,280 COST-EFFICIENT METHOD OR METHODS 637 00:22:45,280 --> 00:22:47,240 TO FUND THIS RESEARCH. 638 00:22:47,240 --> 00:22:48,640 IN IDENTIFYING THE SCIENCE THAT 639 00:22:48,640 --> 00:22:50,400 WE HOPE TO SUPPORT WITH THIS 640 00:22:50,400 --> 00:22:52,120 INITIATIVE, THE PLAN IS TO START 641 00:22:52,120 --> 00:22:55,080 SMALL AND EXPAND PROGRESSIVELY. 642 00:22:55,080 --> 00:22:56,920 MOST MAJOR TRANSITIONS ARE 643 00:22:56,920 --> 00:22:59,520 ASSOCIATED WITH MANY HURDLED AND 644 00:22:59,520 --> 00:23:02,720 OBSTACLES, SOME ANTICIPATED AND 645 00:23:02,720 --> 00:23:05,120 NOT SOME NOT AND THIS WOULD 646 00:23:05,120 --> 00:23:07,320 APPEAR TO BE NO EXCEPTION. 647 00:23:07,320 --> 00:23:09,160 CONSEQUENTLY, OUR PLAN IS TO 648 00:23:09,160 --> 00:23:11,800 START SMALL, MONITOR AND RECESS 649 00:23:11,800 --> 00:23:13,320 FREQUENTLY, LEARN FROM OUR 650 00:23:13,320 --> 00:23:15,040 EXPERIENCES AND MODIFY AND 651 00:23:15,040 --> 00:23:16,600 PROGRESS ACCORDINGLY. 652 00:23:16,600 --> 00:23:17,920 WE PLAN TO BEGIN BY APPLYING 653 00:23:17,920 --> 00:23:19,760 THIS APPROACH TO ONLY A HANDFUL 654 00:23:19,760 --> 00:23:21,720 OF OUR NETWORKS, INCLUDING SOME 655 00:23:21,720 --> 00:23:23,280 UNDER GOING RECOVERTITION. 656 00:23:23,280 --> 00:23:26,000 IN DOING SO, WE HOPE TO IDENTIFY 657 00:23:26,000 --> 00:23:27,960 SYNERGIES BETWEEN THESE NETWORKS 658 00:23:27,960 --> 00:23:29,800 TO FURTHER OPTIMIZE OUR RESEARCH 659 00:23:29,800 --> 00:23:32,720 AND LEVERAGE OUR RESOURCES. 660 00:23:32,720 --> 00:23:35,160 I SUSPECT THAT MANY MEMBERS OF 661 00:23:35,160 --> 00:23:37,120 COUNCIL AND OTHER -- AND OUR 662 00:23:37,120 --> 00:23:39,320 PUBLIC AUDIENCE HAVE NOTED THE 663 00:23:39,320 --> 00:23:43,000 RFAs FOR BOTH THE MFNU AND OUR 664 00:23:43,000 --> 00:23:44,640 NETWORKS ARE CURRENTLY 665 00:23:44,640 --> 00:23:44,920 PUBLISHED. 666 00:23:44,920 --> 00:23:47,600 IN FACT, AS AN ASIDE, WE HAD TWO 667 00:23:47,600 --> 00:23:49,680 PUBLIC WEBINARS DISCUSSING THESE 668 00:23:49,680 --> 00:23:51,000 FUNDING OPPORTUNITIES JUST LAST 669 00:23:51,000 --> 00:23:51,200 WEEK. 670 00:23:51,200 --> 00:23:54,240 THOSE RFAs HAVE BEEN WRITTEN 671 00:23:54,240 --> 00:23:55,920 TO FACILITATE IMPLEMENTATION OF 672 00:23:55,920 --> 00:23:58,640 THIS NEW APPROACH BUT THE 673 00:23:58,640 --> 00:24:01,040 PROVISION FOR NON-NETWORK 674 00:24:01,040 --> 00:24:01,640 INVESTIGATOR PARTICIPATION AND 675 00:24:01,640 --> 00:24:04,160 THE NEED FOR NETWORK PROPOSALS 676 00:24:04,160 --> 00:24:06,320 TO UNDER GO NIH PYRE REVIEW. 677 00:24:06,320 --> 00:24:07,520 WE WILL CONTINUE TO DEVELOP 678 00:24:07,520 --> 00:24:09,320 RFAs IN A SIMILAR MANNER FOR 679 00:24:09,320 --> 00:24:11,120 OTHER NETWORKS AS WE MOVE 680 00:24:11,120 --> 00:24:14,040 FORWARD AND LEARN FROM OUR 681 00:24:14,040 --> 00:24:15,560 EXPERIENCES. 682 00:24:15,560 --> 00:24:17,640 ADDITIONALLY, THE CURRENT RFAs 683 00:24:17,640 --> 00:24:18,720 EXPLICITLY CALL FOR THE 684 00:24:18,720 --> 00:24:21,000 FORMATION OF AN EXTERNAL 685 00:24:21,000 --> 00:24:22,840 SCIENTIFIC COMMITTEE AND 686 00:24:22,840 --> 00:24:24,880 COMMUNITY ENGAGEMENT BOARD, IN 687 00:24:24,880 --> 00:24:26,800 ADDITION TO THE COMMITTEE TO 688 00:24:26,800 --> 00:24:28,320 FACILITATE WIDESPREAD UNFORMS 689 00:24:28,320 --> 00:24:29,960 INPUT TO BEST ASSURE THE 690 00:24:29,960 --> 00:24:31,720 DEVELOPMENT OF PRAGMATIC AND 691 00:24:31,720 --> 00:24:34,760 FEASIBLE PROTOCOLS OF THE MOST 692 00:24:34,760 --> 00:24:37,200 RELEVANT AND NEEDED SCIENCE. 693 00:24:37,200 --> 00:24:39,000 FINALLY, AND AS IS RECOMMENDED 694 00:24:39,000 --> 00:24:41,120 IN THE RESPONSE TO THE INITIAL 695 00:24:41,120 --> 00:24:42,880 RFI, THESE CURRENT NETWORK 696 00:24:42,880 --> 00:24:44,960 RFAs ARE FOR SEVEN-YEAR CYCLES 697 00:24:44,960 --> 00:24:48,400 RATHER THAN THE TRADITIONAL 698 00:24:48,400 --> 00:24:48,960 FIVE. 699 00:24:48,960 --> 00:24:50,280 NEXT, WE BELIEVE THAT THERE 700 00:24:50,280 --> 00:24:52,160 NEEDS TO BE A RIGOROUS 701 00:24:52,160 --> 00:24:53,080 PRE-APPLICATION PROCESS THAT 702 00:24:53,080 --> 00:24:54,320 WOULD NOT ONLY INCLUDE A 703 00:24:54,320 --> 00:24:55,400 FEASIBILITY ASSESSMENT TO 704 00:24:55,400 --> 00:24:56,960 DETERMINE IF THE PROJECT CAN 705 00:24:56,960 --> 00:24:58,600 LIKELY BE SUCCESSFULLY COMPLETED 706 00:24:58,600 --> 00:25:01,000 BY THE NETWORK, BUT WILL ALSO 707 00:25:01,000 --> 00:25:02,280 REVIEW THE SCIENCE TO BE SURE 708 00:25:02,280 --> 00:25:03,920 THAT IT IS RELEVANT TO THE 709 00:25:03,920 --> 00:25:06,760 CURRENT STATE OF THE FIELD, 710 00:25:06,760 --> 00:25:08,200 DEPRESSING SOCIETAL NEEDS TO THE 711 00:25:08,200 --> 00:25:11,800 KNELT WORK MISSION AND TO NICHD 712 00:25:11,800 --> 00:25:12,320 PRIORITIES. 713 00:25:12,320 --> 00:25:15,320 A THIRD KEY TO SUCCESSFULLY 714 00:25:15,320 --> 00:25:18,560 OPERATIONALIZING THIS NEW 715 00:25:18,560 --> 00:25:20,640 INITIATIVE WILL BE THE REVIEW 716 00:25:20,640 --> 00:25:20,880 PROCESS. 717 00:25:20,880 --> 00:25:22,840 AGAIN HAVING CLINICAL NETWORK 718 00:25:22,840 --> 00:25:24,240 TRIALS UNDER GOING NICHD PEER 719 00:25:24,240 --> 00:25:26,440 REVIEW AS A SEPARATE APPLICATION 720 00:25:26,440 --> 00:25:28,080 IS ONE OF THE FUNDAMENTAL 721 00:25:28,080 --> 00:25:29,640 CHANGES TO THIS INITIATIVE AND 722 00:25:29,640 --> 00:25:31,440 WILL GO A LONG WAY TO ENHANCE 723 00:25:31,440 --> 00:25:34,920 THE RIGOR AND TRANSPARENCY 724 00:25:34,920 --> 00:25:35,400 DESIRED. 725 00:25:35,400 --> 00:25:36,440 ALTHOUGH IT NEEDS TO BE 726 00:25:36,440 --> 00:25:37,800 FINALIZED IT WOULD I A PEER A 727 00:25:37,800 --> 00:25:39,880 SPECIAL PROCESS THAT MAINTAINS 728 00:25:39,880 --> 00:25:42,360 THE LONG-STANDING QUALITY OF NIH 729 00:25:42,360 --> 00:25:44,480 REVIEW AND ASSURES THE EXPERTISE 730 00:25:44,480 --> 00:25:46,520 TO REVIEW THE SCIENCE AND 731 00:25:46,520 --> 00:25:47,520 UNDERSTAND THE BASIC FUNCTIONING 732 00:25:47,520 --> 00:25:49,920 OF NIH-SUPPORTED NETWORKS WILL 733 00:25:49,920 --> 00:25:51,880 BE CRITICAL AND INTEGRAL TO THE 734 00:25:51,880 --> 00:25:52,840 PROCESS. 735 00:25:52,840 --> 00:25:54,160 FINALLY, THE FUNDING THIS 736 00:25:54,160 --> 00:25:55,480 INITIATIVE IS OBVIOUSLY A 737 00:25:55,480 --> 00:25:56,600 FUNDAMENTAL COMPONENT. 738 00:25:56,600 --> 00:25:59,200 TO BEGIN, THE GOAL IS TO REMAIN 739 00:25:59,200 --> 00:26:00,600 GROSSLY COST NEUTRAL WITH OUR 740 00:26:00,600 --> 00:26:02,000 CURRENT INVESTMENT IN MULE TIE 741 00:26:02,000 --> 00:26:03,320 SITE CLINICAL TRIALS. 742 00:26:03,320 --> 00:26:05,440 THAT SAID, THE HOPE BEING THAT 743 00:26:05,440 --> 00:26:07,160 WITH MORE EFFECTIVE UTILIZATION 744 00:26:07,160 --> 00:26:08,680 OF OUR CLINICAL NETWORK 745 00:26:08,680 --> 00:26:09,640 INFRASTRUCTURE, WE WILL BE ABLE 746 00:26:09,640 --> 00:26:11,680 TO OPTIMIZE OUR INVESTMENT SUCH 747 00:26:11,680 --> 00:26:13,080 THAT WE SUPPORT THE BEST SCIENCE 748 00:26:13,080 --> 00:26:15,120 AND THE MOST TIMELY AND COST 749 00:26:15,120 --> 00:26:17,000 EFFECTIVE MANNER POSSIBLE. 750 00:26:17,000 --> 00:26:19,160 IN ATTEMPTING TO IDENTIFY AND 751 00:26:19,160 --> 00:26:20,920 DEVELOP THAT MODEL OR MODELS 752 00:26:20,920 --> 00:26:23,520 WE'VE REACHED OUT TO OTHER NIH 753 00:26:23,520 --> 00:26:24,840 AND FEDERAL PROGRAMS AS 754 00:26:24,840 --> 00:26:27,040 SUGGESTED IN THE RFI RESPONSES. 755 00:26:27,040 --> 00:26:28,880 THE ULTIMATE GOAL WILL BE TO 756 00:26:28,880 --> 00:26:30,400 UTILIZE THE MODEL THAT OPTIMIZES 757 00:26:30,400 --> 00:26:33,720 OUR FUNDED NETWORK 758 00:26:33,720 --> 00:26:34,400 INFRASTRUCTURE. 759 00:26:34,400 --> 00:26:37,200 IN CLOSING, THERE REMAINS MUCH 760 00:26:37,200 --> 00:26:38,600 WORK TO BE DONE NOW AND LONG 761 00:26:38,600 --> 00:26:39,400 INTO THE FUTURE. 762 00:26:39,400 --> 00:26:41,240 WE ANTICIPATE THERE WILL BE MANY 763 00:26:41,240 --> 00:26:42,840 CHALLENGES AND OBSTACLES ALONG 764 00:26:42,840 --> 00:26:43,200 THE WAY. 765 00:26:43,200 --> 00:26:45,480 THAT SAID, WE BELIEVE THAT THIS 766 00:26:45,480 --> 00:26:47,560 NEW APPROACH HOLDS THE POTENTIAL 767 00:26:47,560 --> 00:26:50,720 TO EXPAND THE BREADTH AND 768 00:26:50,720 --> 00:26:52,840 DIVERSITY OF OUR SCIENCE AND 769 00:26:52,840 --> 00:26:53,480 INVESTIGATORS, OPEN CHANCE THE 770 00:26:53,480 --> 00:26:55,520 RIGOROUS TRANSPARENCY OF NETWORK 771 00:26:55,520 --> 00:26:58,640 AND CLINICAL TRIALS, ENABLE US 772 00:26:58,640 --> 00:27:00,680 TO PERFORM CLINICAL TRIALS IN 773 00:27:00,680 --> 00:27:02,760 THE MOST EFFICIENT AND COST 774 00:27:02,760 --> 00:27:05,800 EFFECT MANNER, ASSURE WE'RE IN 775 00:27:05,800 --> 00:27:07,560 LINE WITH THE STRATEGIC PLAN, 776 00:27:07,560 --> 00:27:09,840 IDENTIFY NOVEL AND INNOVATIVE 777 00:27:09,840 --> 00:27:11,400 INVESTIGATIONS, FOSTER EMERGING 778 00:27:11,400 --> 00:27:13,120 HEALTH CRISISES AS WE HAVE 779 00:27:13,120 --> 00:27:14,760 RECENTLY LIVED AND ULTIMATELY 780 00:27:14,760 --> 00:27:16,480 AUGMENT THE IMPACT OF THE 781 00:27:16,480 --> 00:27:17,440 SCIENCE WE SUPPORT. 782 00:27:17,440 --> 00:27:19,240 MUCH LIKE ANY GOOD RESEARCH 783 00:27:19,240 --> 00:27:20,480 PROGRAM, THIS INITIATIVE REQUIRE 784 00:27:20,480 --> 00:27:22,160 AS TEAM AND WE HAVE BEEN BLESSED 785 00:27:22,160 --> 00:27:26,240 TO HAVE THE YOU UNYIELDING SUPT 786 00:27:26,240 --> 00:27:29,720 AND INPUT OF OUR MANY DIVISIONS 787 00:27:29,720 --> 00:27:31,800 OF EXTRA MURAL RESEARCH. 788 00:27:31,800 --> 00:27:34,080 INCLUDING OUR BRANCH MANAGEMENT 789 00:27:34,080 --> 00:27:35,600 AND SPECIALISTS, BUDGET OFFICES 790 00:27:35,600 --> 00:27:37,160 AND FINANCIAL MANAGEMENT BRANCH. 791 00:27:37,160 --> 00:27:39,200 CURRENT NETWORK PROGRAM 792 00:27:39,200 --> 00:27:39,480 OFFICIALS. 793 00:27:39,480 --> 00:27:42,200 OUR SCIENTIFIC PROGRAMMATIC 794 00:27:42,200 --> 00:27:44,000 BRAND CHIEFS. 795 00:27:44,000 --> 00:27:48,840 OUR CLCLINICAL TRIALS WORKING G. 796 00:27:48,840 --> 00:27:50,560 I PARTICULARLY WANT TO RECOGNIZE 797 00:27:50,560 --> 00:27:53,960 DR. JOT JANIS FROM THE PROGRAM. 798 00:27:53,960 --> 00:27:56,240 IN THE END, IT HAS BEEN THE 799 00:27:56,240 --> 00:27:59,960 MANTRA SHARED WITH US THROUGHOUT 800 00:27:59,960 --> 00:28:04,120 BY DR. HASCROFT AND HIS 801 00:28:04,120 --> 00:28:05,480 LEADERSHIP IN THIS ENDEAVOR. 802 00:28:05,480 --> 00:28:06,840 IT IS NOT IMPORTANT THAT ANY OF 803 00:28:06,840 --> 00:28:09,360 US VISUALLY BE RIGHT BUT THAT WE 804 00:28:09,360 --> 00:28:10,560 COLLECTIVELY GET IT RIGHT. 805 00:28:10,560 --> 00:28:12,440 AS SUCH, WE LOOK TO THIS COUNCIL 806 00:28:12,440 --> 00:28:14,720 FOR FURTHER UNFORMED, DIVERSE 807 00:28:14,720 --> 00:28:16,200 AND INSIGHTFUL INPUT AND WE HOPE 808 00:28:16,200 --> 00:28:17,880 FOR A ROBUST DISCUSSION TODAY. 809 00:28:17,880 --> 00:28:28,360 AND WITH THAT, I THANK YOU. 810 00:28:33,320 --> 00:28:34,080 IS ANYONE STILL AWAKE? 811 00:28:34,080 --> 00:28:35,240 >> WE ARE. 812 00:28:35,240 --> 00:28:35,520 QUESTIONS? 813 00:28:35,520 --> 00:28:38,840 BY THE WAY, I LOVE THE JIMMY 814 00:28:38,840 --> 00:28:42,680 FALLON THANK YOU CARD THAT WAS A 815 00:28:42,680 --> 00:28:46,400 CUTE TOUCH. 816 00:28:46,400 --> 00:28:46,600 ALLEN. 817 00:28:46,600 --> 00:28:48,640 >> YES, THANK YOU. 818 00:28:48,640 --> 00:28:51,080 REALLY, THANK YOU SO MUCH, 819 00:28:51,080 --> 00:28:52,720 DR. TAMBURRO, FOR THAT 820 00:28:52,720 --> 00:28:53,160 PRESENTATION. 821 00:28:53,160 --> 00:28:55,120 IT'S -- I'M KIND OF GETTING 822 00:28:55,120 --> 00:28:57,200 DATED BECAUSE MY VERY FIRST 823 00:28:57,200 --> 00:28:59,080 MEETING AS ON COUNCIL REALLY HAD 824 00:28:59,080 --> 00:29:01,760 TO DO WITH NETWORKS AND IT'S 825 00:29:01,760 --> 00:29:03,960 AMAZING HOW THINGS HAVE EVOLVED. 826 00:29:03,960 --> 00:29:05,720 I WANT TO THANK YOU AND THANK 827 00:29:05,720 --> 00:29:08,120 THE TEAM THAT, YOU KNOW, HAS 828 00:29:08,120 --> 00:29:09,960 WORKED ON THIS OVER THE YEARS. 829 00:29:09,960 --> 00:29:12,600 I KNOW LOTS OF EMOTIONS, SWEAT 830 00:29:12,600 --> 00:29:14,640 AND YOU KNOW, ALL THE GROUND 831 00:29:14,640 --> 00:29:17,040 WORK THAT YOU OUTLINED, YOU KNOW 832 00:29:17,040 --> 00:29:20,440 HAVE GONE INTO THIS. 833 00:29:20,440 --> 00:29:21,320 AND I REALLY LIKE AND FROM 834 00:29:21,320 --> 00:29:23,040 TALKING TO, YOU KNOW, SOME OF 835 00:29:23,040 --> 00:29:26,640 THE COMMUNITY MEMBERS, LIKE THE 836 00:29:26,640 --> 00:29:28,960 PRODUCT, THE RFA THAT WAS PUT 837 00:29:28,960 --> 00:29:29,120 OUT. 838 00:29:29,120 --> 00:29:30,600 I THINK THERE ARE SOME REALLY 839 00:29:30,600 --> 00:29:33,440 GREAT NUGGETS AND THE 840 00:29:33,440 --> 00:29:34,880 PRINCIPLES, REALLY, YOU KNOW, 841 00:29:34,880 --> 00:29:39,240 MAKE A LOT OF SENSE FOR 842 00:29:39,240 --> 00:29:39,720 INNOVATION. 843 00:29:39,720 --> 00:29:44,560 SO REALLY, CONGRATULATIONS TO 844 00:29:44,560 --> 00:29:45,120 EVERYONE. 845 00:29:45,120 --> 00:29:48,400 I WANTED TO JUST -- I THINK 846 00:29:48,400 --> 00:29:51,000 DETAILS WILL BE FIGURED OUT WITH 847 00:29:51,000 --> 00:29:53,400 THE KEY, I THINK THE KEY IS THE 848 00:29:53,400 --> 00:29:57,440 PEER REVIEW THAT WILL BE DONE 849 00:29:57,440 --> 00:30:00,520 THAT WILL GO TO, YOU KNOW, NIH 850 00:30:00,520 --> 00:30:00,840 PANEL. 851 00:30:00,840 --> 00:30:02,480 AND I THINK DETAILS WILL BE 852 00:30:02,480 --> 00:30:03,240 SORTED OUT. 853 00:30:03,240 --> 00:30:04,880 BUT I JUST WANTED TO RAISE SOME 854 00:30:04,880 --> 00:30:07,720 CONCERNS THAT I'M SURE WE'LL BE 855 00:30:07,720 --> 00:30:08,480 LOOKING TO. 856 00:30:08,480 --> 00:30:11,440 IT IS THAT OF BEING NIMBLE AND 857 00:30:11,440 --> 00:30:13,120 BEING EFFICIENT AND AVOIDING 858 00:30:13,120 --> 00:30:15,280 SOME BOTTLE NECKS WITH HAVING, 859 00:30:15,280 --> 00:30:20,960 SAY, A ONE-YEAR ROUNDS OF REVIEW 860 00:30:20,960 --> 00:30:22,240 BEFORE SOMETHING IS FUNDED. 861 00:30:22,240 --> 00:30:25,000 SO IS THERE A WAY THAT, IF THIS 862 00:30:25,000 --> 00:30:27,400 WENT OUT FOR PEER REVIEW, 863 00:30:27,400 --> 00:30:28,400 DECISIONS COULD BE MADE WITHIN 864 00:30:28,400 --> 00:30:31,560 FOUR MONTHS, FOR EXAMPLE. 865 00:30:31,560 --> 00:30:32,960 BECAUSE THE PREP PROCESS FOR 866 00:30:32,960 --> 00:30:34,600 THIS, AS WELL AS YOU KNOW, 867 00:30:34,600 --> 00:30:36,600 TAKES, YOU KNOW, NINE MONTHS IS 868 00:30:36,600 --> 00:30:38,080 GREAT FOR ACTUALLY PREPPING THE 869 00:30:38,080 --> 00:30:39,640 PROJECT WITHIN SOME OF THE 870 00:30:39,640 --> 00:30:41,480 NETWORKS AND THEN IF YOU ADD THE 871 00:30:41,480 --> 00:30:43,000 ADDITIONAL TIME, IT IS, YOU 872 00:30:43,000 --> 00:30:45,720 KNOW, MAYBE, YOU KNOW, UP TO TWO 873 00:30:45,720 --> 00:30:47,920 YEARS SO COULD THIS BE DONE IN A 874 00:30:47,920 --> 00:30:53,040 VERY NIMBLE WAY PEER REVIEW AND 875 00:30:53,040 --> 00:30:53,680 ITS --, FOR EXAMPLE. 876 00:30:53,680 --> 00:30:55,240 >> IT IS A GREAT QUESTION AND 877 00:30:55,240 --> 00:30:57,640 CERTAINLY ONE THAT, YOU KNOW, 878 00:30:57,640 --> 00:30:58,760 WE'RE THINKING THROUGH. 879 00:30:58,760 --> 00:31:00,360 AND WE'VE BEEN HAVING REGULAR 880 00:31:00,360 --> 00:31:04,080 MEETINGS WITH OUR SCIENTIFIC 881 00:31:04,080 --> 00:31:05,640 REVIEW TO GAIN SOME INSIGHT. 882 00:31:05,640 --> 00:31:07,560 I THINK, YOU KNOW, IT'S A TOUGH 883 00:31:07,560 --> 00:31:08,640 BALANCE BECAUSE YOU DO WANT TO 884 00:31:08,640 --> 00:31:10,640 MAKE THINGS HAPPEN IN A TIMELY 885 00:31:10,640 --> 00:31:12,160 MANNER BUT WE ALSO WANT TO 886 00:31:12,160 --> 00:31:13,680 MAINTAIN THE REGULAR RUSS NIH 887 00:31:13,680 --> 00:31:15,440 PEER REVIEW PROCESS. 888 00:31:15,440 --> 00:31:22,120 WE'VE TALKED TO OTHER FEDERAL 889 00:31:22,120 --> 00:31:25,280 PROGRAMS AND THEY'RE DOING 890 00:31:25,280 --> 00:31:26,160 INTERESTING THINGS. 891 00:31:26,160 --> 00:31:27,440 I THINK THE BEST I COULD SHARE 892 00:31:27,440 --> 00:31:28,960 WITH YOU TODAY IS, WE 893 00:31:28,960 --> 00:31:31,600 APPRECIATE, YOU KNOW, YOUR 894 00:31:31,600 --> 00:31:33,120 CONCERN AND SHARE IT WITH YOU 895 00:31:33,120 --> 00:31:34,000 AND ARE DOING EVERYTHING WE CAN 896 00:31:34,000 --> 00:31:35,880 TO TRY TO EXPEDITE THAT PROCESS 897 00:31:35,880 --> 00:31:38,480 TO KEEP THINGS MOVING IN AN 898 00:31:38,480 --> 00:31:39,680 EFFICIENT MANNER. 899 00:31:39,680 --> 00:31:40,440 WING LEARNED FROM COVID THAT 900 00:31:40,440 --> 00:31:42,040 SOMETIMES YOU NEED TO MAKE 901 00:31:42,040 --> 00:31:44,920 THINGS HAPPEN IN A MUCH MORE 902 00:31:44,920 --> 00:31:47,200 RAPID TIME THAN THE TRADITIONAL 903 00:31:47,200 --> 00:31:48,720 NIH PROCESS. 904 00:31:48,720 --> 00:31:50,480 AND WE HAVE SEEN EXAMPLES OF 905 00:31:50,480 --> 00:31:52,320 THAT HAPPENING IN A MORE TIMELY 906 00:31:52,320 --> 00:31:53,520 MANNER COVID. 907 00:31:53,520 --> 00:31:55,600 BUT I APPRECIATE THE QUESTION. 908 00:31:55,600 --> 00:31:58,760 CERTAINLY ON OUR RADAR SCREEN, 909 00:31:58,760 --> 00:31:59,680 CERTAINLY SOMETHING WE'RE 910 00:31:59,680 --> 00:32:00,960 WORKING ON AND I HOPE WE WILL 911 00:32:00,960 --> 00:32:02,280 COME UP WITH A GOOD ANSWER THAT 912 00:32:02,280 --> 00:32:05,800 IS SATISFYING TO INVESTIGATORS 913 00:32:05,800 --> 00:32:07,000 ACROSS THE EXTRA MURAL 914 00:32:07,000 --> 00:32:07,240 COMMUNITY. 915 00:32:07,240 --> 00:32:07,720 >> THANK YOU. 916 00:32:07,720 --> 00:32:09,480 THAT WILL BE, YOU KNOW, IT WILL 917 00:32:09,480 --> 00:32:11,880 BE TERRIFIC TO CONTINUE TO LOOK 918 00:32:11,880 --> 00:32:12,600 INTO THAT. 919 00:32:12,600 --> 00:32:16,000 I THINK IT'S REALLY, MAYBE IT IS 920 00:32:16,000 --> 00:32:17,280 GOING TO BE REALLY CRUCIAL, THEN 921 00:32:17,280 --> 00:32:19,040 JUST TWO, YOU KNOW, QUICK, ONE 922 00:32:19,040 --> 00:32:22,080 IS A COMMENT, IS JUST THAT THE 923 00:32:22,080 --> 00:32:23,280 INVESTIGATORS DON'T SEE 924 00:32:23,280 --> 00:32:25,600 THEMSELVES AS JUST COMING TO DO 925 00:32:25,600 --> 00:32:28,200 WORK FOR OTHERS AND A PART OF 926 00:32:28,200 --> 00:32:30,080 THIS SCIENTIFIC THING, YOU 927 00:32:30,080 --> 00:32:31,040 EMPHASIZED THAT SOME OF THIS 928 00:32:31,040 --> 00:32:32,800 WILL COME FROM THE 929 00:32:32,800 --> 00:32:33,160 INVESTIGATORS. 930 00:32:33,160 --> 00:32:35,080 I THINK THAT WILL BE IMPORTANT. 931 00:32:35,080 --> 00:32:37,720 THEN, FINALLY, BACK TO THE 932 00:32:37,720 --> 00:32:40,000 BUDGET QUESTION EARLIER AND YOU 933 00:32:40,000 --> 00:32:41,240 SAYING COST NEUTRAL. 934 00:32:41,240 --> 00:32:46,560 THIS WILL BRING ADDITIONAL 935 00:32:46,560 --> 00:32:48,840 GRANTS IN THAT WOULD HAVE GONE 936 00:32:48,840 --> 00:32:50,240 OUTSIDE OF THE NETWORK. 937 00:32:50,240 --> 00:32:53,240 SO I THINK COST NEUTRAL WILL 938 00:32:53,240 --> 00:32:55,280 MEAN -- IT DOESN'T MEAN WHAT IS 939 00:32:55,280 --> 00:32:57,120 CURRENTLY LOCATED LOCATED IN THK 940 00:32:57,120 --> 00:33:00,880 WHAT COULD GO TO ADDITIONAL 941 00:33:00,880 --> 00:33:11,040 PROJECTS. 942 00:33:11,680 --> 00:33:12,880 >> THE DIFFERENCE BEING TO FUND 943 00:33:12,880 --> 00:33:16,480 THE INDIVIDUAL PROTOCOLS WILL BE 944 00:33:16,480 --> 00:33:19,960 THROUGH A SEPARATE OPPORTUNITY 945 00:33:19,960 --> 00:33:21,600 ANNOUNCEMENT AND GOING TO PEER 946 00:33:21,600 --> 00:33:21,840 REVIEW. 947 00:33:21,840 --> 00:33:24,000 >> WILL THAT GROW WITH OUTSIDE 948 00:33:24,000 --> 00:33:24,320 INVESTIGATORS? 949 00:33:24,320 --> 00:33:25,000 >> ABSOLUTELY. 950 00:33:25,000 --> 00:33:25,720 >> GREAT, THANK YOU. 951 00:33:25,720 --> 00:33:26,920 >> NO, THANK YOU. 952 00:33:26,920 --> 00:33:28,680 I WILL LOVE YOUR ENTHUSIASM, AND 953 00:33:28,680 --> 00:33:31,000 WE'RE CERTAINLY ON THE SAME 954 00:33:31,000 --> 00:33:31,240 PAGE. 955 00:33:31,240 --> 00:33:32,720 MAKE THIS HAPPEN FASTER, SO 956 00:33:32,720 --> 00:33:33,120 THANK YOU. 957 00:33:33,120 --> 00:33:39,560 >> THANK YOU. 958 00:33:39,560 --> 00:33:42,560 >> WE HAD ADAM RESNIK WAS NUMBER 959 00:33:42,560 --> 00:33:44,360 TWO BUT HE DROPPED OFF. 960 00:33:44,360 --> 00:33:45,600 THERE YOU ARE. 961 00:33:45,600 --> 00:33:45,920 OKAY, ADAM. 962 00:33:45,920 --> 00:33:48,160 >> I'M SORRY, I WAS LOWERING MY 963 00:33:48,160 --> 00:33:48,400 HAND. 964 00:33:48,400 --> 00:33:50,200 LET ME ALSO REITERATE MY -- CAN 965 00:33:50,200 --> 00:33:51,200 YOU HEAR ME OKAY? 966 00:33:51,200 --> 00:33:52,280 I WANT TO MAKE SURE. 967 00:33:52,280 --> 00:33:55,120 >> WE CAN HEAR YOU PERFECTLY. 968 00:33:55,120 --> 00:33:56,240 >> OKAY. 969 00:33:56,240 --> 00:34:01,120 MY ENTHUSIASM IN THIS, SUCH AN 970 00:34:01,120 --> 00:34:03,680 OPPORTUNITY NICHD IS TAKING TO 971 00:34:03,680 --> 00:34:05,400 REALLY HARNESS AN APPROACH LIKE 972 00:34:05,400 --> 00:34:06,800 THIS AND IT IS VERY TIMELY. 973 00:34:06,800 --> 00:34:08,240 I WANTED TO ASK A COUPLE 974 00:34:08,240 --> 00:34:09,760 QUESTIONS RELATED TO SORT OF 975 00:34:09,760 --> 00:34:11,840 YOUR FOUR POINTS OF IMPACT AND 976 00:34:11,840 --> 00:34:13,160 ESPECIALLY SOME OF THE THINGS 977 00:34:13,160 --> 00:34:16,640 THAT WE'VE SEEN CAN BE 978 00:34:16,640 --> 00:34:18,520 TRANSFORMATIVE BUT ALSO LIKELY 979 00:34:18,520 --> 00:34:20,200 REQUIRE FROM CHANGE MANAGEMENT 980 00:34:20,200 --> 00:34:22,000 IN THE CONTEXT OF NETWORKS. 981 00:34:22,000 --> 00:34:25,240 THAT IS, ON THE DATA SIDE, AND 982 00:34:25,240 --> 00:34:27,680 BY SPECIMENS AND WORK FLOWS, 983 00:34:27,680 --> 00:34:30,960 THERE IS REALLY A -- YOU KNOW 984 00:34:30,960 --> 00:34:33,360 MANY OF THESE NETWORKS AND 985 00:34:33,360 --> 00:34:35,080 CLINICAL TRIAL FRAMEWORKS 986 00:34:35,080 --> 00:34:37,160 EMERGED PRIOR TO THE ADVENT OF 987 00:34:37,160 --> 00:34:39,120 TECHNOLOGIES THAT SUPPORT AND 988 00:34:39,120 --> 00:34:40,560 OPTIMIZE DATA FLOWS AND STREAMS 989 00:34:40,560 --> 00:34:41,680 AND OPTIMIZATION. 990 00:34:41,680 --> 00:34:43,480 HOW ARE YOU THINKING ABOUT THE 991 00:34:43,480 --> 00:34:45,160 INTERSECTION BETWEEN A 992 00:34:45,160 --> 00:34:46,560 CENTRALIZED APPROACH AND, YOU 993 00:34:46,560 --> 00:34:49,520 KNOW, THE OTHER EFFORTS WITHIN 994 00:34:49,520 --> 00:34:54,640 NICHD RELATED TO DATA MANAGEMENT 995 00:34:54,640 --> 00:34:56,280 FROM AN INFRASTRUCTURE 996 00:34:56,280 --> 00:34:57,600 PERSPECTIVE, WHETHER THAT IS ON 997 00:34:57,600 --> 00:34:59,440 THE DASH SIDE OR ANYWHERE ELSE. 998 00:34:59,440 --> 00:35:02,040 HOW DO THOSE TWO PIECES COME 999 00:35:02,040 --> 00:35:04,240 TOGETHER BETWEEN SUPPORTING A 1000 00:35:04,240 --> 00:35:04,920 CENTRALIZED FRAMEWORK FOR 1001 00:35:04,920 --> 00:35:07,880 CLINICAL TRIALS AND THE 1002 00:35:07,880 --> 00:35:16,120 RECOGNIZE QUREQUISITEINFRASTRUC. 1003 00:35:16,120 --> 00:35:20,120 >> YEAH, A GREAT QUESTION, AND 1004 00:35:20,120 --> 00:35:21,400 CERTAINLY THAT SHARING AS WE 1005 00:35:21,400 --> 00:35:22,960 MOVE FORWARD IS GOING TO BE A 1006 00:35:22,960 --> 00:35:26,840 HUGE PART OF OUR, YOU KNOW, 1007 00:35:26,840 --> 00:35:29,400 CLINICAL, NETWORK CLINICAL TRIAL 1008 00:35:29,400 --> 00:35:30,120 ENTERPRISE. 1009 00:35:30,120 --> 00:35:33,520 I'M GOING TO LOOK DR. REBECCA 1010 00:35:33,520 --> 00:35:35,600 ROSEN AND DR. VALERIE COTTON 1011 00:35:35,600 --> 00:35:37,560 FROM OUR OFFICE OF DATA SAFETY 1012 00:35:37,560 --> 00:35:39,640 AND SHARING FOR THAT GUIDANCE. 1013 00:35:39,640 --> 00:35:41,400 BUT YOU'RE ABSOLUTELY RIGHT. 1014 00:35:41,400 --> 00:35:42,880 MAKING SURE THAT OUR DATA 1015 00:35:42,880 --> 00:35:45,760 COORDINATING CENTERS ARE 1016 00:35:45,760 --> 00:35:48,160 COLLECTING, STORING AND 1017 00:35:48,160 --> 00:35:49,560 PROTECTING -- SHARING AND 1018 00:35:49,560 --> 00:35:51,120 PROTECTING THE DATA IN THE MOST 1019 00:35:51,120 --> 00:35:53,160 UP-TO-DATE MANNER IS GOING TO BE 1020 00:35:53,160 --> 00:35:53,440 INTEGRAL. 1021 00:35:53,440 --> 00:35:56,080 IN SOME WAYS HAVING THE 1022 00:35:56,080 --> 00:35:57,320 CENTRALIZED APPROACH WILL HELP 1023 00:35:57,320 --> 00:35:58,760 OPTIMIZE THAT RATHER THAN JUST 1024 00:35:58,760 --> 00:36:00,480 HAVING, YOU KNOW, INVESTIGATORS 1025 00:36:00,480 --> 00:36:02,360 AT LARGE COMING IN WITHOUT A 1026 00:36:02,360 --> 00:36:03,760 CENTRALIZED APPROACH. 1027 00:36:03,760 --> 00:36:05,840 BUT REALLY, I THINK A GREAT 1028 00:36:05,840 --> 00:36:06,320 QUESTION. 1029 00:36:06,320 --> 00:36:09,040 AND I WOULD ASK YOU, DR. RESNIK, 1030 00:36:09,040 --> 00:36:10,640 THOUGHTS YOU WOULD HAVE TO SHARE 1031 00:36:10,640 --> 00:36:11,880 SOME INSIGHT, MAYBE YOU COULD 1032 00:36:11,880 --> 00:36:13,600 PROVIDE TO HELP US AS WE WORK 1033 00:36:13,600 --> 00:36:14,120 THROUGH THAT. 1034 00:36:14,120 --> 00:36:16,760 IT REALLY IS AN IMPORTANT POINT. 1035 00:36:16,760 --> 00:36:18,200 >> ONE I WOULD ACTUALLY JUST 1036 00:36:18,200 --> 00:36:20,040 SAY, YOU'VE IDENTIFIED THE RIGHT 1037 00:36:20,040 --> 00:36:21,440 PEOPLE TO GUIDE YOU AND IT IS HE 1038 00:36:21,440 --> 00:36:27,160 WILL VERY TIMELY FOR NICHD TO LD 1039 00:36:27,160 --> 00:36:29,400 FROM THAT PERSPECTIVE AND IT 1040 00:36:29,400 --> 00:36:32,720 RELATES TO SOME OF THE 1041 00:36:32,720 --> 00:36:35,120 DISCUSSIONS YESTERDAY AROUND 1042 00:36:35,120 --> 00:36:36,640 MPERC AND OTHER PERSPECTIVES. 1043 00:36:36,640 --> 00:36:39,240 >> REBECCA ROSEN HAS PUT 1044 00:36:39,240 --> 00:36:40,320 SOMETHING IN THE CHAT BOX. 1045 00:36:40,320 --> 00:36:41,800 I DON'T KNOW IF YOU WANT TO COME 1046 00:36:41,800 --> 00:36:43,200 OFF FUTURE SO PEOPLE CAN AT 1047 00:36:43,200 --> 00:36:43,640 LEAST SEE YOU. 1048 00:36:43,640 --> 00:36:44,680 >> ABSOLUTELY. 1049 00:36:44,680 --> 00:36:45,920 THANK YOU, ADAM, FOR THE 1050 00:36:45,920 --> 00:36:46,280 QUESTION. 1051 00:36:46,280 --> 00:36:50,280 THIS FITS RIGHT INTO OUR 1052 00:36:50,280 --> 00:36:52,480 EXISTING DATA SHARING PRIME 1053 00:36:52,480 --> 00:36:54,880 WORK, MAYBE LESS SO WITH 1054 00:36:54,880 --> 00:36:56,840 MANAGEMENT, BUT THE EXPECTATION, 1055 00:36:56,840 --> 00:36:58,600 WRITTEN INTO THE DATA FUNDING 1056 00:36:58,600 --> 00:36:59,360 ANNOUNCEMENT, THE DATA 1057 00:36:59,360 --> 00:37:01,120 COORDINATING CENTER IS 1058 00:37:01,120 --> 00:37:03,520 RESPONSIBLE FOR CURATING AND 1059 00:37:03,520 --> 00:37:11,360 SUBMITTING THE DATA TO A A ANIH 1060 00:37:11,360 --> 00:37:12,520 DATA REPOSITORY. 1061 00:37:12,520 --> 00:37:13,440 THEY SHOULD BE ABLE TO TAKE IN 1062 00:37:13,440 --> 00:37:14,840 MOST OF THE DATA THAT ARE 1063 00:37:14,840 --> 00:37:17,160 MANAGED AND CURATED BY THE DATA 1064 00:37:17,160 --> 00:37:18,560 COORDINATING CENTERS FOR THE 1065 00:37:18,560 --> 00:37:20,200 VARIOUS CLINICAL TRIALS. 1066 00:37:20,200 --> 00:37:22,480 IF THOSE DATA ARE NOT 1067 00:37:22,480 --> 00:37:23,720 APPROPRIATE FOR DASH, FOR 1068 00:37:23,720 --> 00:37:25,680 EXAMPLE IMAGING DATA MAY NOT BE 1069 00:37:25,680 --> 00:37:29,040 BEST CURATED AND SEARCHED IN 1070 00:37:29,040 --> 00:37:32,000 DASH, WE WILL FIND BE ANOTHER 1071 00:37:32,000 --> 00:37:34,320 APPROPRIATE DESIGNATE REPOSITORY 1072 00:37:34,320 --> 00:37:40,080 FOR THOSE DATA BUT THE CURITIEDD 1073 00:37:40,080 --> 00:37:41,000 MANAGEMENT PIECE WILL STILL SIT 1074 00:37:41,000 --> 00:37:42,720 IN THE DATA CENTER. 1075 00:37:42,720 --> 00:37:43,960 TIMELINES ARE IMPORTANT, AS 1076 00:37:43,960 --> 00:37:44,160 WELL. 1077 00:37:44,160 --> 00:37:46,240 I WANT TO POINT OUT WITH THE NEW 1078 00:37:46,240 --> 00:37:48,200 DATA MANAGEMENT SHARING POLICY, 1079 00:37:48,200 --> 00:37:49,600 DATA WILL BE SHARED AT THE 1080 00:37:49,600 --> 00:37:51,440 LATEST AT THE TIME OF 1081 00:37:51,440 --> 00:37:52,440 PUBLICATION. 1082 00:37:52,440 --> 00:37:53,640 UNPUBLISHED DATA WILL BE SHARED 1083 00:37:53,640 --> 00:37:56,240 AT THE END OF AN AWARD PERIOD, 1084 00:37:56,240 --> 00:37:57,320 WHATEVER HAPPENS FIRST. 1085 00:37:57,320 --> 00:37:59,200 >> THANK YOU. 1086 00:37:59,200 --> 00:38:00,160 ANOTHER PART -- YEAH. 1087 00:38:00,160 --> 00:38:02,040 ANOTHER RELATED PART OF THAT ARE 1088 00:38:02,040 --> 00:38:04,640 THE BIO SPECIMENS, WHICH YOU 1089 00:38:04,640 --> 00:38:06,160 KNOW IN THE PREVIOUS ITERATION 1090 00:38:06,160 --> 00:38:09,000 OF THE NETWORKS, YOU KNOW, 1091 00:38:09,000 --> 00:38:10,640 INVESTIGATORS FELT THAT THEY HAD 1092 00:38:10,640 --> 00:38:12,760 OWNERSHIP OVER THOSE BIO 1093 00:38:12,760 --> 00:38:13,000 SPECIMENS. 1094 00:38:13,000 --> 00:38:14,280 I THINK THEY WERE TRYING TO 1095 00:38:14,280 --> 00:38:17,440 ALIGN OUR INSTITUTE WITH OVER 1096 00:38:17,440 --> 00:38:19,720 ALL NIH POLICY THAT BOTH 1097 00:38:19,720 --> 00:38:21,680 SPECIMENS AND DATA WILL BE 1098 00:38:21,680 --> 00:38:24,080 FREELY SHAREABLE. 1099 00:38:24,080 --> 00:38:26,080 SO, I DON'T KNOW, REBECCA, IF 1100 00:38:26,080 --> 00:38:27,120 YOU WANT TO COMMENT ON THAT. 1101 00:38:27,120 --> 00:38:28,680 >> I WILL ACKNOWLEDGE, I MEAN, 1102 00:38:28,680 --> 00:38:30,880 WE HAVE ROOM TO EXPAND ON DASH 1103 00:38:30,880 --> 00:38:32,280 TO ACCOMMODATE THIS AND WE ARE. 1104 00:38:32,280 --> 00:38:34,360 THIS IS A TOP PRIORITY, SO DASH 1105 00:38:34,360 --> 00:38:37,840 IS NOW IN MY OFFICE AND WE ARE 1106 00:38:37,840 --> 00:38:39,360 LOOKING TO -- WE ARE, WE HAVE 1107 00:38:39,360 --> 00:38:42,560 PLANS AND WE HAVE RESOURCES TO 1108 00:38:42,560 --> 00:38:44,960 EXPAND AND MOPPED EARNIZE DASH 1109 00:38:44,960 --> 00:38:48,200 TO ACCOMMODATE RAPID 1110 00:38:48,200 --> 00:38:49,320 DATA-SHARING CYCLES. 1111 00:38:49,320 --> 00:38:50,760 YOU DON'T NEED TO WAIT UNTIL THE 1112 00:38:50,760 --> 00:38:52,680 STUDY IS COMPLETE TO SHARE THE 1113 00:38:52,680 --> 00:38:53,120 DATA. 1114 00:38:53,120 --> 00:38:55,840 WE WANT TO SHARE ITERATIONS 1115 00:38:55,840 --> 00:38:58,840 ASSOCIATED WITH CURATED 1116 00:38:58,840 --> 00:38:59,080 CASSETTES. 1117 00:38:59,080 --> 00:39:04,480 HE WE WANT TO TAKE IN AND EXPOSE 1118 00:39:04,480 --> 00:39:05,720 DATA STANDARDS AND WE WILL DO IT 1119 00:39:05,720 --> 00:39:10,720 BASED ON THE NEEDS OF THE 1120 00:39:10,720 --> 00:39:13,160 RESEARCHERS, CLINICAL TRIALS AND 1121 00:39:13,160 --> 00:39:14,600 THE OFFICE OF NIH STRATEGY. 1122 00:39:14,600 --> 00:39:16,400 >> IT IS SUCH A TREMENDOUS 1123 00:39:16,400 --> 00:39:17,960 OPPORTUNITY TO REALLY LEAD A NEW 1124 00:39:17,960 --> 00:39:19,240 MODEL OF DOING THIS. 1125 00:39:19,240 --> 00:39:22,720 I'M NOT SURE I'VE SEEN LIKE TRUE 1126 00:39:22,720 --> 00:39:24,680 SUCCESS AT NIH AROUND THIS SO IT 1127 00:39:24,680 --> 00:39:26,480 IS A REAL OPPORTUNITY. 1128 00:39:26,480 --> 00:39:28,520 >> THANK YOU, ADAM. 1129 00:39:28,520 --> 00:39:36,600 LET'S GO TO GENEVIEVE NEIL-PERRY 1130 00:39:36,600 --> 00:39:36,840 NEXT. 1131 00:39:36,840 --> 00:39:39,440 >> THANK YOU FOR THAT 1132 00:39:39,440 --> 00:39:39,960 PRESENTATION, BOB. 1133 00:39:39,960 --> 00:39:41,080 THAT WAS GREAT. 1134 00:39:41,080 --> 00:39:41,640 VERY EXCITING. 1135 00:39:41,640 --> 00:39:43,480 I HAVE A QUESTION, HOW WILL 1136 00:39:43,480 --> 00:39:44,920 ADVERTISEMENT FOR THESE 1137 00:39:44,920 --> 00:39:45,360 OPPORTUNITIES OCCUR? 1138 00:39:45,360 --> 00:39:47,400 WILL THEY OCCUR THROUGH CENTERS? 1139 00:39:47,400 --> 00:39:50,720 HOW WILL IT ACHIEVE BROAD 1140 00:39:50,720 --> 00:39:50,960 REACHOUT? 1141 00:39:50,960 --> 00:39:53,200 >> GREAT QUESTION, AND THANK YOU 1142 00:39:53,200 --> 00:39:56,240 FOR THAT AND FOR THE KIND WORDS. 1143 00:39:56,240 --> 00:39:58,200 WHAT WE'RE HOPING IS WITH OUR 1144 00:39:58,200 --> 00:39:59,840 CONCEPT PROPOSAL TODAY IS TO 1145 00:39:59,840 --> 00:40:02,160 PREPARE A DEDICATED FUNDING 1146 00:40:02,160 --> 00:40:03,880 OPPORTUNITY ANNOUNCEMENT THAT 1147 00:40:03,880 --> 00:40:04,680 WE'LL DISTRIBUTE WIDELY THROUGH 1148 00:40:04,680 --> 00:40:06,640 THE GUIDE AS WE DO WITH ANY 1149 00:40:06,640 --> 00:40:08,160 OTHER FUNDING OPPORTUNITY 1150 00:40:08,160 --> 00:40:09,680 ANNOUNCEMENT, AND YOU KNOW, 1151 00:40:09,680 --> 00:40:12,440 START HITTING THE ROADS. 1152 00:40:12,440 --> 00:40:14,600 SHARING THESE IDEAS AS WE DO 1153 00:40:14,600 --> 00:40:15,800 WITH OUR DIFFERENT ORGANIZATIONS 1154 00:40:15,800 --> 00:40:17,440 AND SO FORTH. 1155 00:40:17,440 --> 00:40:19,560 BUT DISSEMINATING IT WADELY IS 1156 00:40:19,560 --> 00:40:20,520 CERTAINLY GOING TO BE A GOAL 1157 00:40:20,520 --> 00:40:23,000 WITH THIS AND STARTING WITH THE 1158 00:40:23,000 --> 00:40:24,120 FUNDING OPPORTUNITY ANNOUNCEMENT 1159 00:40:24,120 --> 00:40:24,760 SPECIFICALLY FOR THIS WILL BE 1160 00:40:24,760 --> 00:40:25,280 THE FIRST STEP. 1161 00:40:25,280 --> 00:40:28,600 >> AND MAY NEXT QUESTION IS, WIL 1162 00:40:28,600 --> 00:40:30,880 THERE BE ANY EMPHASIS ON EARLY 1163 00:40:30,880 --> 00:40:32,240 STAGE OR NEW INVESTIGATORS AND 1164 00:40:32,240 --> 00:40:33,840 THINKING ABOUT THIS AS A WAY TO 1165 00:40:33,840 --> 00:40:35,200 PRIME THE PIPELINE? 1166 00:40:35,200 --> 00:40:36,120 >> ABSOLUTELY. 1167 00:40:36,120 --> 00:40:39,480 AS YOU SAW IN SOME OF THE RFE 1168 00:40:39,480 --> 00:40:40,800 RESPONSES, TRAINING AND 1169 00:40:40,800 --> 00:40:42,680 MENTORING YOUNG INVESTIGATORS IS 1170 00:40:42,680 --> 00:40:43,680 GOING TO BE IMPORTANT. 1171 00:40:43,680 --> 00:40:45,720 YOU HEARD US MENTION, YOU KNOW, 1172 00:40:45,720 --> 00:40:46,920 FREQUENTLY THE DIVERSITY NOT 1173 00:40:46,920 --> 00:40:48,800 ONLY OF THE STUDY PARTICIPANTS 1174 00:40:48,800 --> 00:40:50,840 BUT OF THE INVESTIGATORS, AND I 1175 00:40:50,840 --> 00:40:52,280 WOULD CERTAINLY INCLUDE, YOU 1176 00:40:52,280 --> 00:40:53,920 KNOW, AGE AND PROFESSIONAL 1177 00:40:53,920 --> 00:40:55,640 EXPERIENCE IN THAT DIVERSITY. 1178 00:40:55,640 --> 00:40:58,600 AND THING MODEL REALLY HOLDS THE 1179 00:40:58,600 --> 00:41:00,160 POTENTIAL WHERE YOU CAN' LINE 1180 00:41:00,160 --> 00:41:01,800 SENIOR EXPERIENCED INVESTIGATORS 1181 00:41:01,800 --> 00:41:03,080 WITH YOUNG JUNIOR INVESTIGATORS 1182 00:41:03,080 --> 00:41:05,600 TO HELP THEM, YOU KNOW, GROW AND 1183 00:41:05,600 --> 00:41:06,160 DEVELOP. 1184 00:41:06,160 --> 00:41:07,240 SO ABSOLUTELY. 1185 00:41:07,240 --> 00:41:10,200 GREAT QUESTION AND WE ENSURE 1186 00:41:10,200 --> 00:41:12,080 YOUR ENTHUSIASM FOR 1187 00:41:12,080 --> 00:41:12,920 INCORPORATING YOUNG 1188 00:41:12,920 --> 00:41:14,400 INVESTIGATORS INTO THIS PROCESS. 1189 00:41:14,400 --> 00:41:15,200 >> THANK YOU. 1190 00:41:15,200 --> 00:41:16,000 >> THANK YOU. 1191 00:41:16,000 --> 00:41:17,720 >> GREAT. 1192 00:41:17,720 --> 00:41:21,520 I SEE DAVID ROWICH, MICHELLE, 1193 00:41:21,520 --> 00:41:23,520 LUCKY JANE, AND MELISSA MILLER. 1194 00:41:23,520 --> 00:41:28,880 WE WILL CUT IT OFF AFTER MELISSA 1195 00:41:28,880 --> 00:41:29,360 TO STAY ON TIME. 1196 00:41:29,360 --> 00:41:32,240 >> I'LL TRY TO BE BRIEF. 1197 00:41:32,240 --> 00:41:33,360 THANK YOU, DR. TAMBURRO. 1198 00:41:33,360 --> 00:41:36,040 I WELCOME THE NEW THINKING ABOUT 1199 00:41:36,040 --> 00:41:37,600 CLINICAL TRIALS DELIVERY. 1200 00:41:37,600 --> 00:41:39,360 KEY TO THE MISSION OF NICHD IS 1201 00:41:39,360 --> 00:41:40,640 HOW WE CAN SHOW ADVANCES IN 1202 00:41:40,640 --> 00:41:40,840 CARE. 1203 00:41:40,840 --> 00:41:42,200 AND YOUR GOALS THAT I THINK WERE 1204 00:41:42,200 --> 00:41:44,480 MAYBE ON THE THIRD TO LAST 1205 00:41:44,480 --> 00:41:46,880 SLIDE, POSSIBLY A COUPLE AHEAD 1206 00:41:46,880 --> 00:41:52,120 OF THE LATE NIGHT TV SHOW CARD 1207 00:41:52,120 --> 00:41:53,480 WAS THEY'RE LAUDABLE AND I 1208 00:41:53,480 --> 00:41:55,600 WONDER IF THEY COULD ALSO BE 1209 00:41:55,600 --> 00:41:56,960 CONSIDERED AT KEY PERFORMANCE 1210 00:41:56,960 --> 00:41:59,440 INDICATORS AND CAN YOU USE THOSE 1211 00:41:59,440 --> 00:42:02,040 GOALS TO DELIVER, TO DEVELOP 1212 00:42:02,040 --> 00:42:03,360 MEASURABLES, SUCH THAT, YOU 1213 00:42:03,360 --> 00:42:04,800 KNOW, THE IMPACT OF THIS PROGRAM 1214 00:42:04,800 --> 00:42:06,640 CAN REALLY BE DEMONSTRATED. 1215 00:42:06,640 --> 00:42:08,080 I THINK IT'S PROBABLY THE WAY 1216 00:42:08,080 --> 00:42:09,160 YOU'RE THINKING ABOUT IT. 1217 00:42:09,160 --> 00:42:10,400 I DIDN'T HEAR THAT ARTICULATED 1218 00:42:10,400 --> 00:42:12,280 SO THAT IS A SUGGESTION THAT IT 1219 00:42:12,280 --> 00:42:13,640 WOULD BE GREAT TO HEAR AS THE 1220 00:42:13,640 --> 00:42:15,840 PROGRAM MATURES HOW YOU'RE DOING 1221 00:42:15,840 --> 00:42:17,120 AGAINST GOALS. 1222 00:42:17,120 --> 00:42:18,880 SUCH AS NIMBLENESS, INNOVATION 1223 00:42:18,880 --> 00:42:20,520 AND A NUMBER OF THOSE OTHER 1224 00:42:20,520 --> 00:42:21,800 GOALS THAT I WOULD AGREE WITH 1225 00:42:21,800 --> 00:42:23,160 THAT YOU ARTICULATED. 1226 00:42:23,160 --> 00:42:23,440 THANK YOU. 1227 00:42:23,440 --> 00:42:24,520 >> NO, THANK YOU. 1228 00:42:24,520 --> 00:42:25,680 AND GREAT POINTS. 1229 00:42:25,680 --> 00:42:27,240 I WOULD AGREE, AND I DIDN'T GO 1230 00:42:27,240 --> 00:42:29,360 INTO A LOT OF DETAIL BUT ONE OF 1231 00:42:29,360 --> 00:42:31,240 THE THINGS THAT, YOU KNOW, WE'VE 1232 00:42:31,240 --> 00:42:33,160 TALKED ABOUT IS MONITORING AND 1233 00:42:33,160 --> 00:42:33,960 REASSESSING FREQUENTLY. 1234 00:42:33,960 --> 00:42:35,680 I REALLY LIKE THE WAY YOU SAID 1235 00:42:35,680 --> 00:42:36,920 THAT, IF YOU DON'T KEEP SCORE, 1236 00:42:36,920 --> 00:42:38,560 IF YOU DON'T HAVE A SCORE CARD, 1237 00:42:38,560 --> 00:42:40,040 YOU REALLY DON'T KNOW WHAT 1238 00:42:40,040 --> 00:42:40,600 YOU'RE DOING. 1239 00:42:40,600 --> 00:42:42,800 SO I THINK OBJECTTYIFYING THESE 1240 00:42:42,800 --> 00:42:44,640 RATHER THAN JUST HAVING 1241 00:42:44,640 --> 00:42:45,840 SUBJECTIVE PARAMETERS WILL BE 1242 00:42:45,840 --> 00:42:49,360 USED AS WE TRY TO EVOLVE AND 1243 00:42:49,360 --> 00:42:51,760 OVERCOME THE OBSTACLES AND 1244 00:42:51,760 --> 00:42:53,840 HURDLES WE KNOW WILL BE OUT 1245 00:42:53,840 --> 00:42:54,040 THERE. 1246 00:42:54,040 --> 00:42:58,720 GREAT POINT AND WE WILL TRY TO 1247 00:42:58,720 --> 00:43:01,080 OBJECTTYIFY THOSE ASSESSMENTS AS 1248 00:43:01,080 --> 00:43:01,800 MUCH AS POSSIBLE. 1249 00:43:01,800 --> 00:43:02,120 >> THANK YOU. 1250 00:43:02,120 --> 00:43:02,680 >> THANK YOU. 1251 00:43:02,680 --> 00:43:03,720 LET'S GO TO MICHELLE NEXT. 1252 00:43:03,720 --> 00:43:05,520 >> THANK YOU FOR THAT 1253 00:43:05,520 --> 00:43:06,480 PRESENTATION AND I THINK IT IS 1254 00:43:06,480 --> 00:43:08,360 GREAT TO LEVERAGE THE NETWORKS 1255 00:43:08,360 --> 00:43:10,200 TO MEET NICHD'S STRATEGIC GOALS 1256 00:43:10,200 --> 00:43:11,920 AND PLANS FOR INCLUSION. 1257 00:43:11,920 --> 00:43:13,680 I HAVE A QUESTION THAT SORT OF 1258 00:43:13,680 --> 00:43:16,520 FOLLOWING FROM DR. NEIL-PERRY. 1259 00:43:16,520 --> 00:43:19,040 SEA YOU HAVE AN OUTSIDE 1260 00:43:19,040 --> 00:43:19,400 INVESTIGATOR. 1261 00:43:19,400 --> 00:43:21,760 IS THERE ANY PLAN FROM NICHD TO 1262 00:43:21,760 --> 00:43:24,440 HELP CONNECT NEW MAY HAVE A 1263 00:43:24,440 --> 00:43:25,480 YOUNG OUTSIDE INVESTIGATOR, IS 1264 00:43:25,480 --> 00:43:27,680 THERE A PLAN TO CONNECT THEM 1265 00:43:27,680 --> 00:43:29,240 WITH THE NETWORK OR AND RESOURCE 1266 00:43:29,240 --> 00:43:30,000 FOR THAT? 1267 00:43:30,000 --> 00:43:32,160 IF NOT WILL NICHD ACTUALLY 1268 00:43:32,160 --> 00:43:33,800 PUBLISH SORT OF THESE 1269 00:43:33,800 --> 00:43:35,120 REQUIREMENTS FOR ENGAGEMENT 1270 00:43:35,120 --> 00:43:36,680 BETWEEN THE TWO? 1271 00:43:36,680 --> 00:43:38,080 BECAUSE I CAN ENVISION A NEW 1272 00:43:38,080 --> 00:43:39,520 INVESTIGATOR WHO WANTS TO DO 1273 00:43:39,520 --> 00:43:42,440 SOME SORT OF A CLINICAL TRIAL 1274 00:43:42,440 --> 00:43:43,960 AND HAVING DIFFICULTY MAYBE 1275 00:43:43,960 --> 00:43:48,640 CONNECT WAG NETWORK TO HAVE 1276 00:43:48,640 --> 00:43:49,680 THEIR -- SO THANKS. 1277 00:43:49,680 --> 00:43:50,200 >> THANK YOU. 1278 00:43:50,200 --> 00:43:52,400 A GREAT QUESTION. 1279 00:43:52,400 --> 00:43:54,440 OBVIOUSLY, TRYING TO CONNECT OUR 1280 00:43:54,440 --> 00:43:55,760 YOUNG INVESTIGATORS WITH OUR 1281 00:43:55,760 --> 00:43:58,280 ESTABLISHED INVESTIGATORS IS 1282 00:43:58,280 --> 00:44:01,120 GOING TO BE A KEY COMPONENT OF 1283 00:44:01,120 --> 00:44:01,400 THIS. 1284 00:44:01,400 --> 00:44:02,880 HOW BEST TO DO THAT, I THINK 1285 00:44:02,880 --> 00:44:04,280 WE'RE STILL TRYING TO SORT 1286 00:44:04,280 --> 00:44:04,520 THROUGH. 1287 00:44:04,520 --> 00:44:05,920 YOU KNOW, IT IS LIKE SO MANY 1288 00:44:05,920 --> 00:44:07,240 THINGS IN THIS WORLD, WE KNOW IT 1289 00:44:07,240 --> 00:44:09,120 IS A GOOD IDEA BUT MATERIALIZED 1290 00:44:09,120 --> 00:44:10,840 IT OR OPERATIONALIZING IT WILL 1291 00:44:10,840 --> 00:44:12,240 BE A CHALLENGE. 1292 00:44:12,240 --> 00:44:17,200 WE'VE GIVEN IT SOME THOUGHTS. 1293 00:44:17,200 --> 00:44:18,920 I WOULD SEE WHAT THOUGHT US 1294 00:44:18,920 --> 00:44:20,120 MIGHT BE WILLING TO SHARE ABOUT 1295 00:44:20,120 --> 00:44:20,440 THAT. 1296 00:44:20,440 --> 00:44:21,840 WE'RE CERTAINLY OPEN TO IT AND 1297 00:44:21,840 --> 00:44:23,400 REALLY WANT TO MAKE THIS, JUST 1298 00:44:23,400 --> 00:44:24,680 AS YOU DESCRIBE, SOMETHING OPEN 1299 00:44:24,680 --> 00:44:26,040 TO THE JUNIOR INVESTIGATORS. 1300 00:44:26,040 --> 00:44:27,120 SO ANY THOUGHTS THAT YOU WOULD 1301 00:44:27,120 --> 00:44:31,440 BE WILLING TO SHARE WITH THE 1302 00:44:31,440 --> 00:44:31,640 GROUP? 1303 00:44:31,640 --> 00:44:33,000 >> I WAS JUST THINKING IN ORDER 1304 00:44:33,000 --> 00:44:34,960 TO -- ALLOT OF TIMES YOU HAVE 1305 00:44:34,960 --> 00:44:37,080 THESE LARGER NETWORKS THAT ARE 1306 00:44:37,080 --> 00:44:44,720 SORT OF LARGER INSTITUTIONS, I 1307 00:44:44,720 --> 00:44:46,440 DON'T KNOW WHAT THE PLAN IS TO 1308 00:44:46,440 --> 00:44:48,280 ENGAGE WITH THE OUTSIDE 1309 00:44:48,280 --> 00:44:49,520 INVESTIGATORS, MAYBE A PORTAL 1310 00:44:49,520 --> 00:44:53,880 ARRANGEMENT WITH A GIVE AND TAKE 1311 00:44:53,880 --> 00:44:56,800 BETWEEN THE TWO SO IF YOU HAVE 1312 00:44:56,800 --> 00:44:58,320 BRAND NEW INVESTIGATOR WHO IS 1313 00:44:58,320 --> 00:44:59,560 NOVEL TO THE FIELD OR WHATEVER, 1314 00:44:59,560 --> 00:45:01,200 THEY MAY BE HESITANT TO APPROACH 1315 00:45:01,200 --> 00:45:02,720 ONE OF THESE LARGER NETWORKS SO 1316 00:45:02,720 --> 00:45:04,800 SOME WAY TO FACILITATE THOSE 1317 00:45:04,800 --> 00:45:06,000 CONNECTIONS, WHETHER IT IS IN 1318 00:45:06,000 --> 00:45:07,960 THE ANNOUNCEMENTS OR THROUGH 1319 00:45:07,960 --> 00:45:10,040 SOME SORT OF A PORTAL OR 1320 00:45:10,040 --> 00:45:10,880 PROFESSIONAL CONNECTIONS. 1321 00:45:10,880 --> 00:45:13,840 >> NO, IT MAKES A TON OF SENSE. 1322 00:45:13,840 --> 00:45:15,160 AND REALLY I THINK IT IS GOING 1323 00:45:15,160 --> 00:45:16,680 TO BE IMPORTANT. 1324 00:45:16,680 --> 00:45:17,920 I THINK ONCE THE JUNIOR 1325 00:45:17,920 --> 00:45:19,200 INVESTIGATORS GET CONNECTED WITH 1326 00:45:19,200 --> 00:45:20,400 THE NETWORK, YOU THINK IT WILL 1327 00:45:20,400 --> 00:45:21,960 BE A GOOD, POSITIVE 1328 00:45:21,960 --> 00:45:22,280 RELATIONSHIP. 1329 00:45:22,280 --> 00:45:23,560 I THINK YOUR POINT IS A GOOD 1330 00:45:23,560 --> 00:45:25,200 ONE, TO GET THAT INITIAL STEP, 1331 00:45:25,200 --> 00:45:26,760 YOU KNOW THAT INITIAL CONNECTION 1332 00:45:26,760 --> 00:45:27,720 IS GOING TO BE IMPORTANT. 1333 00:45:27,720 --> 00:45:29,600 SO I THINK IT IS SOMETHING, YOU 1334 00:45:29,600 --> 00:45:31,200 KNOW THAT WE, YOU KNOW, ARE 1335 00:45:31,200 --> 00:45:32,440 BEGINNING TO PROCESS. 1336 00:45:32,440 --> 00:45:34,040 I THINK REACHING OUT TO THE 1337 00:45:34,040 --> 00:45:35,600 NETWORKS AND HAVING THEM, YOU 1338 00:45:35,600 --> 00:45:37,440 KNOW, REACH OUT TO JUNIOR 1339 00:45:37,440 --> 00:45:39,480 INVESTIGATORS IN THEIR FIELD 1340 00:45:39,480 --> 00:45:40,160 WILL BE IMPORTANT. 1341 00:45:40,160 --> 00:45:41,800 I SAW IN THE CHAT, SOMEONE 1342 00:45:41,800 --> 00:45:43,440 MENTIONED PROFESSIONAL 1343 00:45:43,440 --> 00:45:44,080 ORGANIZATIONS, WHICH IS ANOTHER 1344 00:45:44,080 --> 00:45:45,400 GOOD WAY TO DO IT. 1345 00:45:45,400 --> 00:45:48,040 GREAT POINT AND WE WELCOME YOURS 1346 00:45:48,040 --> 00:45:50,000 AND OTHER'S THOUGHTS ON HOW BEST 1347 00:45:50,000 --> 00:45:51,160 TO DO THAT. 1348 00:45:51,160 --> 00:45:53,280 I DO THINK THAT IS A KEY 1349 00:45:53,280 --> 00:45:54,680 COMPONENT BE THE SUCCESS WE WANT 1350 00:45:54,680 --> 00:45:56,200 TO BE IN TERMS OF BRINGING 1351 00:45:56,200 --> 00:45:58,280 JUNIOR AND LESS-CONNECT THE 1352 00:45:58,280 --> 00:45:59,600 INVESTIGATORS INTO OUR NETWORK 1353 00:45:59,600 --> 00:46:00,680 INFRASTRUCTURE SO THANK YOU. 1354 00:46:00,680 --> 00:46:01,440 >> THANK YOU. 1355 00:46:01,440 --> 00:46:02,120 >> THANK YOU. 1356 00:46:02,120 --> 00:46:06,040 LET'S GO TO LUCKY JANE NEXT. 1357 00:46:06,040 --> 00:46:09,440 >> THANK YOU, DR. BIANCHI. 1358 00:46:09,440 --> 00:46:10,080 BOB, THANK YOU SO MUCH. 1359 00:46:10,080 --> 00:46:11,640 IF I UNDERSTAND THIS CORRECTLY, 1360 00:46:11,640 --> 00:46:14,800 THIS IS BRILLIANT. 1361 00:46:14,800 --> 00:46:18,680 IT SEEKS TO, YOU KNOW, CREATE 1362 00:46:18,680 --> 00:46:21,240 THE BEST OF BOTH WORLDS IN SOME 1363 00:46:21,240 --> 00:46:22,720 WAYS, LEVERAGING WHAT THE 1364 00:46:22,720 --> 00:46:29,440 NETWORK CENTERS CAN DO BUT ALSO 1365 00:46:29,440 --> 00:46:30,960 INVITING INNOVATIVE PROPOSALS 1366 00:46:30,960 --> 00:46:32,800 FROM ALL OVER TO BRING THE BEST 1367 00:46:32,800 --> 00:46:34,960 CLINICAL TRIALS TO THE BEDSIDE. 1368 00:46:34,960 --> 00:46:39,320 I HAVE TWO FUNDING QUESTIONS. 1369 00:46:39,320 --> 00:46:41,240 FIRST OF ALL, IN THE RFA THAT 1370 00:46:41,240 --> 00:46:44,400 WAS ANNOUNCED, DOES THAT RFA 1371 00:46:44,400 --> 00:46:46,360 PERTAIN TO THE NETWORK SITES 1372 00:46:46,360 --> 00:46:56,160 ONLY, OR IS IT ALL INCLUSIVE OF 1373 00:46:56,160 --> 00:46:58,560 CLINICAL TRIALS THAT WILL BE 1374 00:46:58,560 --> 00:46:59,920 SOUGHT OUTSIDE THE NETWORK. 1375 00:46:59,920 --> 00:47:01,120 THAT'S THE FIRST QUESTION. 1376 00:47:01,120 --> 00:47:03,040 THE SECOND QUESTION, BOB, 1377 00:47:03,040 --> 00:47:04,680 TYPICALLY NETWORK SITES IN ALL 1378 00:47:04,680 --> 00:47:08,840 NETWORKS WHETHER IT IS PCARN OR 1379 00:47:08,840 --> 00:47:14,560 ARDS NETWORK, NRN, MFU NETWORK, 1380 00:47:14,560 --> 00:47:17,600 THE HOST INSTITUTIONS END UP 1381 00:47:17,600 --> 00:47:20,320 PUTTING UP A FAIR AMOUNT OF 1382 00:47:20,320 --> 00:47:22,640 RESOURCES FROM WITHIN THE 1383 00:47:22,640 --> 00:47:25,320 INSTITUTION TO PEAT PARTICIPATN 1384 00:47:25,320 --> 00:47:27,960 WHAT IS CONSIDERED TO BE A 1385 00:47:27,960 --> 00:47:29,160 HIGHLY-PRESTIGIOUS AWARD, 1386 00:47:29,160 --> 00:47:30,560 PARTICIPATING IN THE NETWORK. 1387 00:47:30,560 --> 00:47:33,520 FOR US OVER HERE, THE 1388 00:47:33,520 --> 00:47:35,160 INSTITUTIONS I'VE BEEN INVOLVED 1389 00:47:35,160 --> 00:47:37,920 IN, BEING PART OF AN NIH NET 1390 00:47:37,920 --> 00:47:44,800 WORK A LINE OF SCRI IS A HUGE RT 1391 00:47:44,800 --> 00:47:48,720 TOOL FOR THE CLINICAL TRIAL 1392 00:47:48,720 --> 00:47:49,160 LIST. 1393 00:47:49,160 --> 00:47:50,560 ARE WE STILL GOING TO HAVE THAT 1394 00:47:50,560 --> 00:47:52,440 LEVERAGE IN GETTING THE CENTERS 1395 00:47:52,440 --> 00:47:54,480 TO PARTICIPATE IN DOUBLING THE 1396 00:47:54,480 --> 00:47:56,360 IMPACT OF THE MONEY, IF YOU 1397 00:47:56,360 --> 00:47:56,840 WILL. 1398 00:47:56,840 --> 00:47:59,080 >> YEAH, GREAT QUESTION AND 1399 00:47:59,080 --> 00:48:00,360 CERTAINLY ONE, YOU KNOW, THAT 1400 00:48:00,360 --> 00:48:02,800 YOU THINK WE NEED TO BE 1401 00:48:02,800 --> 00:48:03,680 COGNIZANT OF. 1402 00:48:03,680 --> 00:48:05,200 YOU'RE RIGHT, RIGHT NOW THERE IS 1403 00:48:05,200 --> 00:48:07,040 A TON OF PRESTIGE THAT GOES 1404 00:48:07,040 --> 00:48:10,440 ALONG WITH BEING AN NICHD OR ANY 1405 00:48:10,440 --> 00:48:13,040 NIH OR FEDERAL CLINICAL RESEARCH 1406 00:48:13,040 --> 00:48:13,280 NETWORK. 1407 00:48:13,280 --> 00:48:15,800 I THINK IT CAN BE EVEN THAT MUCH 1408 00:48:15,800 --> 00:48:17,640 MORE PRESTIGIOUS BECAUSE NOW 1409 00:48:17,640 --> 00:48:19,400 YOU'RE GOING TO BE PART OF THE 1410 00:48:19,400 --> 00:48:21,240 NETWORK THAT IS EMBRACING 1411 00:48:21,240 --> 00:48:22,640 DIVERSITY, THAT IS BRINGING IN 1412 00:48:22,640 --> 00:48:23,840 JUNIOR INVESTIGATORS, THAT IS 1413 00:48:23,840 --> 00:48:26,120 WILLING TO TAKE AN INNOVATIVE 1414 00:48:26,120 --> 00:48:27,800 IDEA FROM ANYWHERE ACROSS THE 1415 00:48:27,800 --> 00:48:28,760 COUNTRY AND YOU'RE STILL GOING 1416 00:48:28,760 --> 00:48:30,760 TO HAVE A SEAT AT THAT TABLE. 1417 00:48:30,760 --> 00:48:32,600 YOU WILL SEE THE APPLICATIONS, 1418 00:48:32,600 --> 00:48:34,360 THOSE PROTOCOL CONCEPTS AS THEY 1419 00:48:34,360 --> 00:48:35,840 COME IN AND HAVE THE PRIVILEGE 1420 00:48:35,840 --> 00:48:36,840 WORK THROUGH AND MAKE A GOOD 1421 00:48:36,840 --> 00:48:38,520 IDEA INTO A GREAT PROTOCOL. 1422 00:48:38,520 --> 00:48:39,920 SO I THINK IT IS A GREAT 1423 00:48:39,920 --> 00:48:42,080 QUESTION, IT IS A LEGITIMATE 1424 00:48:42,080 --> 00:48:43,320 CONCERN THAT CERTAINLY I KNOW 1425 00:48:43,320 --> 00:48:45,360 KEEPS ME AWAKE AT NIGHT, BUT I 1426 00:48:45,360 --> 00:48:46,600 REALLY THINK AT THE END OF THE 1427 00:48:46,600 --> 00:48:49,200 DAY IT IS GOING TO BE THAT MUCH 1428 00:48:49,200 --> 00:49:00,360 MORE PRPTHAT MORE PRESTIGIOUS. 1429 00:49:00,360 --> 00:49:02,640 I WANT TO MAKE SURE, THE NEW 1430 00:49:02,640 --> 00:49:03,480 FUNDING OPPORTUNITY ANNOUNCEMENT 1431 00:49:03,480 --> 00:49:05,040 WE WILL BE PROPOSING AS A 1432 00:49:05,040 --> 00:49:06,760 CONCEPT IN A FEW MINUTES THAT 1433 00:49:06,760 --> 00:49:09,080 WILL BE AVAILABLE TO ANYBODY IN 1434 00:49:09,080 --> 00:49:10,200 THE EXTRA MURAL COMMUNITY THAT 1435 00:49:10,200 --> 00:49:11,920 HAS A CLINICAL TRIAL THEY WANT 1436 00:49:11,920 --> 00:49:14,200 TO RUN THROUGH ONE OF OUR 1437 00:49:14,200 --> 00:49:14,960 NETWORKS AND THAT THEIR SCIENCE 1438 00:49:14,960 --> 00:49:17,480 THE ALIGNS WITH THE SCIENCE OF 1439 00:49:17,480 --> 00:49:19,440 THE NETWORK. 1440 00:49:19,440 --> 00:49:21,240 DID THAT ANSWER THE QUESTION? 1441 00:49:21,240 --> 00:49:24,160 >> WELL, YES, BOB. 1442 00:49:24,160 --> 00:49:26,120 I MEAN, MY SORT OF QUESTION IN 1443 00:49:26,120 --> 00:49:28,200 MY MIND, MAYBE I'M 1444 00:49:28,200 --> 00:49:30,160 MISUNDERSTANDING THIS, THAT 1445 00:49:30,160 --> 00:49:32,480 THERE ARE -- THERE'S STAY 1446 00:49:32,480 --> 00:49:35,840 NETWORK THAT YOU WILL ASSIGN 1447 00:49:35,840 --> 00:49:36,680 PRIMARY RESPONSIBILITY OF 1448 00:49:36,680 --> 00:49:39,000 RUNNING CLINICAL TRIALS, EVEN 1449 00:49:39,000 --> 00:49:42,080 THOUGH THE IDEA ORIGINATED FROM 1450 00:49:42,080 --> 00:49:45,120 ONE CENTER, WHICH WAS OUTSIDE OF 1451 00:49:45,120 --> 00:49:46,440 THE NETWORK, RIGHT? 1452 00:49:46,440 --> 00:49:46,840 >> YES. 1453 00:49:46,840 --> 00:49:48,840 >> SO THE QUESTION IS, THE RFA, 1454 00:49:48,840 --> 00:49:52,600 LET'S SAY FOR 2023, THE NRN HAS 1455 00:49:52,600 --> 00:49:57,160 $5 MILLION ALLOCATED OR X AMOUNT 1456 00:49:57,160 --> 00:50:03,120 ALLOCATED, IS THAT INCLUSIVE OF 1457 00:50:03,120 --> 00:50:05,520 ALL NETWORK -- THE PRIMARY 1458 00:50:05,520 --> 00:50:06,840 NETWORK THAT IS ESTABLISHED PLUS 1459 00:50:06,840 --> 00:50:09,800 THE CLINICAL TRIAL THAT WILL BE 1460 00:50:09,800 --> 00:50:11,480 RUN THROUGH THE NETWORK? 1461 00:50:11,480 --> 00:50:12,960 >> SO I THINK I'M UNDERSTANDING 1462 00:50:12,960 --> 00:50:13,600 THE QUESTION. 1463 00:50:13,600 --> 00:50:15,560 SO WE WILL CONTINUE TO SUPPLY 1464 00:50:15,560 --> 00:50:19,520 THE FUNDING FOR THE NETWORK 1465 00:50:19,520 --> 00:50:20,840 INFRASTRUCTURE, AND THEN THE 1466 00:50:20,840 --> 00:50:22,560 NETWORK CENTER PEAT WILLING HAVE 1467 00:50:22,560 --> 00:50:25,600 THE OPPORTUNITY TO SUBMIT TO 1468 00:50:25,600 --> 00:50:29,800 THIS FUNDING OPPORTUNITY 1469 00:50:29,800 --> 00:50:30,400 ANNOUNCEMENT PROCEED COMES 1470 00:50:30,400 --> 00:50:31,600 WITHIN THAT INFRASTRUCTURE AND 1471 00:50:31,600 --> 00:50:33,240 THEY WILL GET THE FUNDING FOR 1472 00:50:33,240 --> 00:50:35,440 THOSE PROTOCOLS FROM THIS NEW 1473 00:50:35,440 --> 00:50:36,240 FUNDING OPPORTUNITY ANNOUNCEMENT 1474 00:50:36,240 --> 00:50:37,640 THAT WE'RE PROPOSING. 1475 00:50:37,640 --> 00:50:38,520 >> YEAH, GREAT. 1476 00:50:38,520 --> 00:50:39,160 THANK YOU, BOB. 1477 00:50:39,160 --> 00:50:40,080 >> NO, THANK YOU. 1478 00:50:40,080 --> 00:50:42,320 >> THIS IS MORE OFF LINE 1479 00:50:42,320 --> 00:50:43,880 CONVERSATION, I JUST NEED TO 1480 00:50:43,880 --> 00:50:46,280 UNDERSTAND THE MECHANICS AT SOME 1481 00:50:46,280 --> 00:50:47,800 POINT, BUT THIS IS BRILLIANT. 1482 00:50:47,800 --> 00:50:53,160 I MEAN, I'M REALLY HAPPY THAT 1483 00:50:53,160 --> 00:50:54,680 DR. BIANCHI FOUND A WAY TO 1484 00:50:54,680 --> 00:50:56,880 CONTINUE TO PUSH THIS IMPORTANT 1485 00:50:56,880 --> 00:50:59,800 PART OF WHAT WE ARE HERE FOR TO 1486 00:50:59,800 --> 00:51:02,120 TAKE INNOVATIVE BASIC SCIENCE 1487 00:51:02,120 --> 00:51:05,280 IDEAS TO THE BEDSIDE. 1488 00:51:05,280 --> 00:51:07,440 BECAUSE UNTIL AND UNLESS SOME OF 1489 00:51:07,440 --> 00:51:10,720 THESE BRILLIANT FINDINGS IN THE 1490 00:51:10,720 --> 00:51:12,360 LABORATORY GET TO OUR PATIENTS, 1491 00:51:12,360 --> 00:51:15,080 WE'RE NOT REALLY ABLE TO -- I 1492 00:51:15,080 --> 00:51:16,400 MEAN, EVERYTHING ELSE IS A MEANS 1493 00:51:16,400 --> 00:51:19,040 TO AN END, AND THAT END IS TO 1494 00:51:19,040 --> 00:51:20,360 IMPROVE LIVESES RIGHT? 1495 00:51:20,360 --> 00:51:21,960 >> ABSOLUTELY. 1496 00:51:21,960 --> 00:51:23,720 >> SO I JUST WANT TO INDICATE 1497 00:51:23,720 --> 00:51:25,920 THIS IS AN INCREDIBLE TEAM 1498 00:51:25,920 --> 00:51:27,200 EFFORT AND THIS IS SOMETHING 1499 00:51:27,200 --> 00:51:29,840 THAT HAS BEEN DISCUSSED, AS YOU 1500 00:51:29,840 --> 00:51:32,600 KNOW, FOR SEVERAL YEARS AND 1501 00:51:32,600 --> 00:51:35,840 REALLY REPRESENTS A MAJOR EFFORT 1502 00:51:35,840 --> 00:51:37,680 TO BALANCE THE NEEDS OF 1503 00:51:37,680 --> 00:51:42,520 DIFFERENT STAKEHOLDERS AND YET 1504 00:51:42,520 --> 00:51:44,680 CONTINUE TO PUSH SOME OF THESE 1505 00:51:44,680 --> 00:51:47,440 CORE PRINCIPLES FORWARD AND 1506 00:51:47,440 --> 00:51:49,280 REALLY THE TEAM SHOWN IN BOB'S 1507 00:51:49,280 --> 00:51:51,800 SLIDE HAS WORKED INCREDIBLY WELL 1508 00:51:51,800 --> 00:51:53,880 TO ADDRESS ALL OF THESE ISSUES. 1509 00:51:53,880 --> 00:51:56,840 AND YOU KNOW, COME UP WITH A 1510 00:51:56,840 --> 00:51:57,800 SOLUTION. 1511 00:51:57,800 --> 00:51:59,560 SO, LET'S JUST ADDRESS MELISSA'S 1512 00:51:59,560 --> 00:52:01,400 QUESTION AND THEN, BOB, IF YOU 1513 00:52:01,400 --> 00:52:02,960 WOULDN'T MIND WHEN YOU'RE DONE 1514 00:52:02,960 --> 00:52:04,920 ANSWERING IN THE CHAT BOX THE 1515 00:52:04,920 --> 00:52:06,640 QUESTIONS, JUST SO WE DON'T GET 1516 00:52:06,640 --> 00:52:08,200 TOO FAR OFF SCHEDULE. 1517 00:52:08,200 --> 00:52:09,440 >> ABSOLUTELY, ABSOLUTELY. 1518 00:52:09,440 --> 00:52:11,280 >> LET'S GO TO MELISSA. 1519 00:52:11,280 --> 00:52:13,200 >> SURE. 1520 00:52:13,200 --> 00:52:14,480 I'LL BE VERY QUICK. 1521 00:52:14,480 --> 00:52:15,920 AS SOMEONE WHO HAS BEEN INVOLVED 1522 00:52:15,920 --> 00:52:20,720 IN A NUMBER OF MULTI-SITE 1523 00:52:20,720 --> 00:52:22,360 STUDIES, NOT WITH THE NIH BUT 1524 00:52:22,360 --> 00:52:25,200 THROUGH THE DOD PROCESSES, I 1525 00:52:25,200 --> 00:52:26,640 KNOW THAT IT'S VERY DIFFICULT, 1526 00:52:26,640 --> 00:52:28,120 ONE OF THE MOST DIFFICULT PARTS 1527 00:52:28,120 --> 00:52:30,880 OF GETTING THESE NETWORKS UP AND 1528 00:52:30,880 --> 00:52:33,280 RUNNING IS THAT FIRST STAGE OF 1529 00:52:33,280 --> 00:52:35,160 INTEGRATING THE NETWORKS 1530 00:52:35,160 --> 00:52:35,560 TOGETHER. 1531 00:52:35,560 --> 00:52:38,160 SO THE FACT THAT YOU PLAN TO 1532 00:52:38,160 --> 00:52:41,920 LEVERAGE ON GOING NETWORKS IS 1533 00:52:41,920 --> 00:52:45,040 FANTASTIC, BUT IT BRINGS IN A 1534 00:52:45,040 --> 00:52:48,120 WILD CARD, POTENTIALLY THAT NEW 1535 00:52:48,120 --> 00:52:50,840 PROJECTS WILL BE COMING IN FROM 1536 00:52:50,840 --> 00:52:52,840 INSTITUTIONS THAT ARE NOT 1537 00:52:52,840 --> 00:52:54,800 INVOLVED IN THE NETWORK. 1538 00:52:54,800 --> 00:52:57,200 SO, A COMPLICATING FACTOR. 1539 00:52:57,200 --> 00:53:00,120 I WANTED TO TOUCH -- OR ASK YOU 1540 00:53:00,120 --> 00:53:02,640 ABOUT THIS PRE-APPLICATION 1541 00:53:02,640 --> 00:53:04,400 PROCESS WHERE YOU WILL BE 1542 00:53:04,400 --> 00:53:05,600 EVALUATING THE FEASIBILITY OF 1543 00:53:05,600 --> 00:53:07,760 THESE PROJECTS. 1544 00:53:07,760 --> 00:53:10,840 AND ASK, WHO WILL BE PROVIDING 1545 00:53:10,840 --> 00:53:13,440 THE INPUT REGARDING THE 1546 00:53:13,440 --> 00:53:15,840 FEASIBILITY OF THE PROJECTS FOR 1547 00:53:15,840 --> 00:53:16,880 THE CENTERS. 1548 00:53:16,880 --> 00:53:18,680 >> I DON'T WANT TO GO INTO A LOT 1549 00:53:18,680 --> 00:53:21,440 OF DETAIL AS WE'RE FINALIZING 1550 00:53:21,440 --> 00:53:24,280 THAT, BUT YOUR POINT IS A GOOD 1551 00:53:24,280 --> 00:53:24,840 ONE. 1552 00:53:24,840 --> 00:53:28,880 WHAT I THINK IT'S GOT TO BE IS A 1553 00:53:28,880 --> 00:53:29,840 MULTI-GROUP PARTICIPATION. 1554 00:53:29,840 --> 00:53:33,520 I MENTIONED IN MY TALK, OUR 1555 00:53:33,520 --> 00:53:35,640 NETWORK STEERING COMMITTEES, AS 1556 00:53:35,640 --> 00:53:37,600 THEY'VE ALWAYS BEEN, PROTOCOL 1557 00:53:37,600 --> 00:53:39,360 REVIEW COMMITTEES ARE PART OF 1558 00:53:39,360 --> 00:53:39,560 THIS. 1559 00:53:39,560 --> 00:53:40,960 THEY KNOW WHAT THE NETWORK CAN 1560 00:53:40,960 --> 00:53:43,720 DO AND CAN'T DO. 1561 00:53:43,720 --> 00:53:46,200 THE DCC BEING PART OF THAT. 1562 00:53:46,200 --> 00:53:48,600 WE WANT THEM TO HAVE THEIR 1563 00:53:48,600 --> 00:53:50,600 EXTERNAL SCIENTIFIC GROUPS, 1564 00:53:50,600 --> 00:53:52,360 WHICH THEY'VE ALWAYS. 1565 00:53:52,360 --> 00:53:54,200 WHEN LOOKING AT IT SAYING YES,, 1566 00:53:54,200 --> 00:53:56,400 THIS IS IN ALINE WITH THE NEEDS 1567 00:53:56,400 --> 00:53:56,960 RIGHT NOW. 1568 00:53:56,960 --> 00:53:59,080 IN ADDITION WE WANT TO MAKE SURE 1569 00:53:59,080 --> 00:54:00,720 THEY ALL HAVE COMMUNITY 1570 00:54:00,720 --> 00:54:01,520 ENGAGEMENT BOARD. 1571 00:54:01,520 --> 00:54:04,040 WHAT DO WE MEAN BY THAT? 1572 00:54:04,040 --> 00:54:05,240 BRINGING THE PUBLIC IN. 1573 00:54:05,240 --> 00:54:06,960 WHAT DO YOU WANT TO SEE OUT OF 1574 00:54:06,960 --> 00:54:08,120 THESE NETWORKS? 1575 00:54:08,120 --> 00:54:09,280 WHAT IS IMPORTANT TO YOU AS 1576 00:54:09,280 --> 00:54:11,320 HEALTH RECIPIENTS AND UTILIZERS 1577 00:54:11,320 --> 00:54:12,120 OF THE SYSTEM. 1578 00:54:12,120 --> 00:54:14,160 AND THEN, FINALLY, YOU THINK WE 1579 00:54:14,160 --> 00:54:16,160 AT NICHD NEED TO HAVE SOME 1580 00:54:16,160 --> 00:54:17,000 INPUT, AS WELL. 1581 00:54:17,000 --> 00:54:17,360 RIGHT? 1582 00:54:17,360 --> 00:54:19,840 WE WANT TO MAKE SURE THESE 1583 00:54:19,840 --> 00:54:21,320 PROTOCOLS ARE ALIGNED WITH OUR 1584 00:54:21,320 --> 00:54:22,680 STRATEGIC MISSION SO WE'RE 1585 00:54:22,680 --> 00:54:28,680 OPTIMIZING THE RESOURCES THAT 1586 00:54:28,680 --> 00:54:29,680 CONGRATULATIONS GRACIOUSLY 1587 00:54:29,680 --> 00:54:30,720 PROVIDES US. 1588 00:54:30,720 --> 00:54:31,880 I THINK THAT'S THE QUESTION. 1589 00:54:31,880 --> 00:54:33,400 THAT'S WHERE THE RUBBER MEETS 1590 00:54:33,400 --> 00:54:35,400 THE ROAD WHEN YOU BRING IN THESE 1591 00:54:35,400 --> 00:54:38,240 GROUPS AND HAVE VERY CANDID 1592 00:54:38,240 --> 00:54:38,520 DISCUSSIONS. 1593 00:54:38,520 --> 00:54:40,720 THERE ARE TEAMS WE HAVE TO SAY, 1594 00:54:40,720 --> 00:54:42,720 GREAT IDEA BUT THIS NETWORK 1595 00:54:42,720 --> 00:54:45,920 CAN'T DO, THIS TOO LARGE, TOO 1596 00:54:45,920 --> 00:54:47,080 EXPENSIVE, WRONG POPULATION, 1597 00:54:47,080 --> 00:54:48,520 WHATEVER THE CASE MAY BE BUT 1598 00:54:48,520 --> 00:54:50,480 THAT IS REALLY THE CHALLENGE 1599 00:54:50,480 --> 00:54:52,200 THIS, WHEN WE START THE 1600 00:54:52,200 --> 00:54:53,640 INTERACTIONS HOW CAN WE MAKE 1601 00:54:53,640 --> 00:54:54,960 SURE SERVE WORKING TOGETHER SO 1602 00:54:54,960 --> 00:54:56,920 WE GET THE BEST PRODUCT IN THE 1603 00:54:56,920 --> 00:54:57,360 END. 1604 00:54:57,360 --> 00:54:58,640 GREAT INSIGHT, SO THANK YOU. 1605 00:54:58,640 --> 00:55:05,800 >> SO, THIS IS A GREAT 1606 00:55:05,800 --> 00:55:08,720 PRESENTATION. 1607 00:55:08,720 --> 00:55:11,280 GENERATED A LOT OF ENGAGEMENT. 1608 00:55:11,280 --> 00:55:13,000 I WANT TO THANK THE 1609 00:55:13,000 --> 00:55:14,120 COUNCILMEMBERS FOR THEIR 1610 00:55:14,120 --> 00:55:15,080 INSIGHTS AND WE WILL ADDRESS 1611 00:55:15,080 --> 00:55:16,520 SOME OF THE THINGS IN THE CHAT. 1612 00:55:16,520 --> 00:55:18,320 BOB IF YOU WOULD BE SO KIND TO 1613 00:55:18,320 --> 00:55:20,440 DO THAT ONCE WE RELIEVE YOU OF 1614 00:55:20,440 --> 00:55:21,120 THE SCREEN. 1615 00:55:21,120 --> 00:55:23,920 NOW I WILL HAND OVER THE VIRTUAL 1616 00:55:23,920 --> 00:55:27,960 MICROPHONE TO DR. TWOMBLY. 1617 00:55:27,960 --> 00:55:28,280 >> THANK YOU. 1618 00:55:28,280 --> 00:55:30,160 >> THANK YOU, BOB, BEAUTIFUL 1619 00:55:30,160 --> 00:55:30,320 JOB. 1620 00:55:30,320 --> 00:55:34,280 SO WE NOW COME TO THE CONCEPT 1621 00:55:34,280 --> 00:55:36,040 CLEARANCE PART OF THE OPEN 1622 00:55:36,040 --> 00:55:36,280 SESSION. 1623 00:55:36,280 --> 00:55:38,360 WE WILL BE PRESENTING 10 1624 00:55:38,360 --> 00:55:39,680 CONCEPTS FOR YOUR CONSIDERATION 1625 00:55:39,680 --> 00:55:39,920 TODAY. 1626 00:55:39,920 --> 00:55:41,400 FOR EACH CONCEPT, I WILL ASK THE 1627 00:55:41,400 --> 00:55:43,480 STAFF TO PROVIDE A BRIEF 1628 00:55:43,480 --> 00:55:45,320 OVERVIEW OF THE INITIATIVE AND 1629 00:55:45,320 --> 00:55:46,640 THEN ASK COUNCIL FOR ANY 1630 00:55:46,640 --> 00:55:48,400 DISCUSSION REGARDING THE 1631 00:55:48,400 --> 00:55:48,640 CONCEPT. 1632 00:55:48,640 --> 00:55:50,000 AT CONCLUSION OF THE DISCUSSION 1633 00:55:50,000 --> 00:55:52,720 FOR EACH CONCEPT, SKILL 1634 00:55:52,720 --> 00:55:54,520 COUNCILMEMBERS WHETHER OR NOT 1635 00:55:54,520 --> 00:55:55,360 THEY CONCUR. 1636 00:55:55,360 --> 00:55:57,560 OUR FIRST ONE WILL BE FROM 1637 00:55:57,560 --> 00:55:58,640 DR. TAMBURRO FROM THE DIVISION 1638 00:55:58,640 --> 00:55:59,800 OF EXTRA MURAL RESEARCH. 1639 00:55:59,800 --> 00:56:01,720 HE WILL PRESENT THE FIRST 1640 00:56:01,720 --> 00:56:03,560 CONCEPT ENTITLED MULTICENTER 1641 00:56:03,560 --> 00:56:06,000 CLINICAL TRIALS, LEVERAGING 1642 00:56:06,000 --> 00:56:06,960 NETWORK INFRASTRUCTURE TO 1643 00:56:06,960 --> 00:56:09,280 ADVANCE RESEARCH AND OUTCOMES. 1644 00:56:09,280 --> 00:56:10,640 BOB. 1645 00:56:10,640 --> 00:56:20,880 >> THANK YOU. 1646 00:56:22,720 --> 00:56:23,720 JUST WHEN YOU THOUGHT YOU HAD 1647 00:56:23,720 --> 00:56:26,200 GOTTEN RID OF ME, I'M GLAD FOR 1648 00:56:26,200 --> 00:56:28,240 THE OPPORTUNITY OUR PROPOSAL. 1649 00:56:28,240 --> 00:56:31,600 SO, BASICALLY, PROGRAM SEEKS 1650 00:56:31,600 --> 00:56:33,680 COUNCIL APPROVAL FOR A PROJECT 1651 00:56:33,680 --> 00:56:35,760 ENTITLED MULTI CENTER CLINICAL 1652 00:56:35,760 --> 00:56:37,400 TRIALS, LEVERAGING NETWORK 1653 00:56:37,400 --> 00:56:38,160 INFRASTRUCTURE TO ADVANCE 1654 00:56:38,160 --> 00:56:39,400 RESEARCH AND OUTCOMES. 1655 00:56:39,400 --> 00:56:43,440 THE NICHD HAS RECENTLY AFFIRMED 1656 00:56:43,440 --> 00:56:44,160 PUBLICLY AND BOTH THE GUIDE 1657 00:56:44,160 --> 00:56:46,240 NOTICE AND WEBINAR A PLAN FOR 1658 00:56:46,240 --> 00:56:48,640 ITS CONTINUED COMMITMENT FOR 1659 00:56:48,640 --> 00:56:50,640 INFRASTRUCTURE SUPPORT FOR MULTI 1660 00:56:50,640 --> 00:56:53,800 SITE CLINICAL TRIALS PURPORTING 1661 00:56:53,800 --> 00:56:56,320 FOUR PRINCIPLES. 1662 00:56:56,320 --> 00:56:57,680 ENHANCING CLINICAL TRIAL 1663 00:56:57,680 --> 00:56:59,560 PROTOCOLS, GREATER AVAILABILITY 1664 00:56:59,560 --> 00:57:01,960 OF MULTI SITE INFRASTRUCTURE TO 1665 00:57:01,960 --> 00:57:03,720 SUPPORT TRIALS FROM A WIDE 1666 00:57:03,720 --> 00:57:06,560 ARRANGEMENT OF INVESTIGATOR TO 1667 00:57:06,560 --> 00:57:07,960 FACILITATE DATA SHARING AND BILE 1668 00:57:07,960 --> 00:57:11,360 OH SPECIMENS AND OFFICIALLY 1669 00:57:11,360 --> 00:57:12,560 EXPAND RESEARCH CAPACITY FOR ALL 1670 00:57:12,560 --> 00:57:17,800 INVESTIGATORS AND FACILITATE 1671 00:57:17,800 --> 00:57:23,280 GREATER INVOLVEMENT OF DIVERSITY 1672 00:57:23,280 --> 00:57:25,480 FOR CLINICAL TRIALS THIS PROVIDE 1673 00:57:25,480 --> 00:57:28,520 AS FUNDING OPPORTUNITY 1674 00:57:28,520 --> 00:57:30,040 ANNOUNCEMENT THAT WILL ACCEPT 1675 00:57:30,040 --> 00:57:31,800 APPLICATIONS TO CONDUCT 1676 00:57:31,800 --> 00:57:32,840 MULTI-SITE CLINICAL TRIALS FROM 1677 00:57:32,840 --> 00:57:34,520 ANY INVESTIGATOR OF THE EXTRA 1678 00:57:34,520 --> 00:57:35,960 MURAL RESEARCH COMMUNITY. 1679 00:57:35,960 --> 00:57:38,760 THESE APPLICATIONS WILL UNDER GO 1680 00:57:38,760 --> 00:57:42,520 NIH PEAR REVIEW AND HAVING 1681 00:57:42,520 --> 00:57:43,800 MERITORIOUS TRIALS WILL BE 1682 00:57:43,800 --> 00:57:45,000 FUNDED IN INDIVIDUAL WARDS. 1683 00:57:45,000 --> 00:57:46,200 IN CONNECTION THIS FUNDING 1684 00:57:46,200 --> 00:57:47,280 OPPORTUNITY ANNOUNCEMENT WILL 1685 00:57:47,280 --> 00:57:49,160 MANDATE THE TIMELY SHARING OF 1686 00:57:49,160 --> 00:57:51,760 INFORMATION AND BIO SPECIMENS 1687 00:57:51,760 --> 00:57:54,400 VIA THE NICHD DATA AND SPECIMEN 1688 00:57:54,400 --> 00:57:56,040 HUB OR OTHER APPROPRIATE 1689 00:57:56,040 --> 00:57:58,680 PLATFORMS AND A RIGOROUS 1690 00:57:58,680 --> 00:58:01,480 PRE-APPLICATION REVIEW TO 1691 00:58:01,480 --> 00:58:04,200 PRO-ACTIVE ASSURE DIVERSITY OF 1692 00:58:04,200 --> 00:58:04,520 ENROLLMENT. 1693 00:58:04,520 --> 00:58:06,440 THANK YOU. 1694 00:58:06,440 --> 00:58:07,160 >> THANK YOU, BOB. 1695 00:58:07,160 --> 00:58:09,600 WE HAD A LOT OF GOOD QUESTIONS 1696 00:58:09,600 --> 00:58:11,400 IN THE MAIN PART OF THIS 1697 00:58:11,400 --> 00:58:11,760 PRESENTATION. 1698 00:58:11,760 --> 00:58:14,920 BUT IS THERE ANY MORE DISCUSSION 1699 00:58:14,920 --> 00:58:18,440 ON THIS? 1700 00:58:18,440 --> 00:58:25,040 >> YES. 1701 00:58:25,040 --> 00:58:26,280 >> GO AHEAD. 1702 00:58:26,280 --> 00:58:28,160 >> I WANTED TO MOVE TO APPROVE. 1703 00:58:28,160 --> 00:58:30,680 >> OH, I'M SORRY. 1704 00:58:30,680 --> 00:58:32,720 >> JUST A QUICK COMMENT. 1705 00:58:32,720 --> 00:58:35,240 THAT BILL FOR DISCUSSION WE'VE 1706 00:58:35,240 --> 00:58:36,880 HAD, THIS IS ALLINA, SUPPORT 1707 00:58:36,880 --> 00:58:37,840 TESTIFY OF THIS. 1708 00:58:37,840 --> 00:58:40,920 BUT GIVEN THE DISCUSSION WE HAVE 1709 00:58:40,920 --> 00:58:42,880 WOULD SUGGEST THAT THE 1710 00:58:42,880 --> 00:58:45,160 PRE-APPLICATION PROCESS FOR THIS 1711 00:58:45,160 --> 00:58:46,800 BE TIED INTO THE NETWORK 1712 00:58:46,800 --> 00:58:49,120 PROCESSES SO THAT THAT IS 1713 00:58:49,120 --> 00:58:51,520 SHORTENED AND THEY'RE NOT, YOU 1714 00:58:51,520 --> 00:58:59,440 KNOW, END TO TO -TO-END AND WOUD 1715 00:58:59,440 --> 00:59:00,680 SUGGEST LOOKING AT SHORTENING 1716 00:59:00,680 --> 00:59:02,240 THE REVIEW PROCESS. 1717 00:59:02,240 --> 00:59:03,640 I THINK IT IS IMPORTANT AT THE 1718 00:59:03,640 --> 00:59:04,840 BEGINNING OF THE NETWORK WHEN 1719 00:59:04,840 --> 00:59:06,320 THE SEATS ARE LOOKING FOR THINGS 1720 00:59:06,320 --> 00:59:08,240 TO DO AND THIS COULD TAKE ONE TO 1721 00:59:08,240 --> 00:59:10,280 TWO YEARS TO HAVE A REAL 1722 00:59:10,280 --> 00:59:11,440 DEVELOPED PROJECT. 1723 00:59:11,440 --> 00:59:13,560 SO JUST SOME SUGGESTIONS BUT 1724 00:59:13,560 --> 00:59:15,240 SUPPORTIVE. 1725 00:59:15,240 --> 00:59:20,000 >> THANK YOU. 1726 00:59:20,000 --> 00:59:20,280 OKAY. 1727 00:59:20,280 --> 00:59:22,520 ANY OTHER COMMENTS? 1728 00:59:22,520 --> 00:59:22,920 IF NOT -- 1729 00:59:22,920 --> 00:59:27,760 >> THIS IS SHERRY BARKIN. 1730 00:59:27,760 --> 00:59:29,320 I HAVE A REALLY QUICK COMMENT. 1731 00:59:29,320 --> 00:59:30,240 I THINK EXCELLENT COMMENTS WERE 1732 00:59:30,240 --> 00:59:32,000 MADE IN THE CHAT BOX AND I KNOW 1733 00:59:32,000 --> 00:59:33,080 DR. TAMBURRO IS GOING TO TAKE A 1734 00:59:33,080 --> 00:59:33,960 LOOK AT THAT. 1735 00:59:33,960 --> 00:59:36,080 I THINK THOSE NEED TO BE 1736 00:59:36,080 --> 00:59:36,600 CONSIDERED. 1737 00:59:36,600 --> 00:59:39,560 I'M VERY SUPPORTIVE OF THIS 1738 00:59:39,560 --> 00:59:40,720 PROPOSAL, I JUST WANT TO MAKE 1739 00:59:40,720 --> 00:59:42,720 SURE WE CONSIDER THOSE THINGS, 1740 00:59:42,720 --> 00:59:42,920 AS WELL. 1741 00:59:42,920 --> 00:59:43,200 THANK YOU. 1742 00:59:43,200 --> 00:59:48,360 >> THANK YOU. 1743 00:59:48,360 --> 00:59:50,240 >> OKAY, IF NO FURTHER 1744 00:59:50,240 --> 00:59:53,200 DISCUSSION, MAY I HAVE A NOTION 1745 00:59:53,200 --> 01:00:01,640 APPROVE: 1746 01:00:01,640 --> 01:00:02,000 SO MOVED. 1747 01:00:02,000 --> 01:00:03,240 >> SECOND. 1748 01:00:03,240 --> 01:00:05,120 >> COULD YOU PLEASE USE YOUR 1749 01:00:05,120 --> 01:00:07,200 ZOOM SCREEN VOTING TO REAMING 1750 01:00:07,200 --> 01:00:09,200 OFFICER YOUR APPROVAL OR NOT 1751 01:00:09,200 --> 01:00:19,600 APPROVAL OR ABSTENTION. 1752 01:00:21,440 --> 01:00:29,000 >> I'M SHOWING 1 14 YES YESES. 1753 01:00:29,000 --> 01:00:35,800 >> VERY GOOD, THANK YOU. 1754 01:00:35,800 --> 01:00:36,880 NEXT WE HAVE DR.ING DOWN PRESENT 1755 01:00:36,880 --> 01:00:39,400 THE COORDINATING CENTER FOR THE 1756 01:00:39,400 --> 01:00:42,040 NICHD POPULATION DYNAMIC CENTERS 1757 01:00:42,040 --> 01:00:43,520 RESEARCH INFRASTRUCTURE PROGRAM. 1758 01:00:43,520 --> 01:00:44,320 ALL RIGHT. 1759 01:00:44,320 --> 01:00:45,160 GOOD MORNING. 1760 01:00:45,160 --> 01:00:46,800 OUR GOOD AFTERNOON, AS 1761 01:00:46,800 --> 01:00:52,160 APPROPRIATE TO YOUR LOCATION. 1762 01:00:52,160 --> 01:00:54,040 PROGRAM SEEKS COUNCIL APPROVAL 1763 01:00:54,040 --> 01:00:55,760 FOR THE TITLE COORDINATING 1764 01:00:55,760 --> 01:00:58,720 CENTER FOR THE NICHD RESEARCH 1765 01:00:58,720 --> 01:00:59,560 INFRASTRUCTURE PROGRAM. 1766 01:00:59,560 --> 01:01:02,200 THE POPULATION DYNAMICS RESEARCH 1767 01:01:02,200 --> 01:01:04,280 INFRASTRUCTURE PROGRAM PROVIDES 1768 01:01:04,280 --> 01:01:07,800 ESTABLISHED CENTERS WITH SUPPORT 1769 01:01:07,800 --> 01:01:13,280 FOR RESEARCH, DEMOGRAPHY, 1770 01:01:13,280 --> 01:01:18,080 POPULATION HEALTH AND BEHAVIORAL 1771 01:01:18,080 --> 01:01:19,360 AND SOCIAL HEALTH. 1772 01:01:19,360 --> 01:01:20,760 THE PRIMARY OBJECTIVES OF THE 1773 01:01:20,760 --> 01:01:22,640 COORDINATING CENTER ARE TO 1774 01:01:22,640 --> 01:01:26,760 IMPROVE THE TRANSLATION AND 1775 01:01:26,760 --> 01:01:28,840 DISSEMINATION FROM POPULATIONS 1776 01:01:28,840 --> 01:01:31,200 RESEARCH AND ENHANCE COOPERATION 1777 01:01:31,200 --> 01:01:34,800 AND COMMUNICATION CROSS PDRI 1778 01:01:34,800 --> 01:01:35,120 RECIPIENTS. 1779 01:01:35,120 --> 01:01:37,560 IT SIGNIFICANTLY AFFECTS HUMAN 1780 01:01:37,560 --> 01:01:40,840 HEALTH AND DEVELOPMENT. 1781 01:01:40,840 --> 01:01:42,240 POPULATION DYNAMICS RESEARCH IS 1782 01:01:42,240 --> 01:01:45,280 AT THE FOREFRONT OF HEALTH AND 1783 01:01:45,280 --> 01:01:47,040 PRODUCTIVITY ACROSS THE LIFE ARE 1784 01:01:47,040 --> 01:01:49,080 AFFECTED BY NON-MEDICAL FACTORS 1785 01:01:49,080 --> 01:01:51,080 SUCH AS THE SOCIAL DETERMINANTS 1786 01:01:51,080 --> 01:01:52,800 OF HEALTH AND THEIR INTERACTION 1787 01:01:52,800 --> 01:01:55,880 AT MULTIPLE LEVELS FROM GENES TO 1788 01:01:55,880 --> 01:01:56,160 ENVIRONMENT. 1789 01:01:56,160 --> 01:01:59,120 BY SUPPORTING A CENTRALIZED 1790 01:01:59,120 --> 01:02:01,920 RESEARCH FOR DISSEMINATION AND 1791 01:02:01,920 --> 01:02:02,640 COORDINATING ACTIVITIES THIS 1792 01:02:02,640 --> 01:02:04,160 INCREASES THE PRODUCTIVITY OF 1793 01:02:04,160 --> 01:02:05,360 CENTERS AND INDIVIDUAL 1794 01:02:05,360 --> 01:02:06,680 RESEARCHERS BY FREEING UP THEIR 1795 01:02:06,680 --> 01:02:08,560 TIME FOR RESEARCH, RESEARCH 1796 01:02:08,560 --> 01:02:09,600 TRAINING AND RESEARCH 1797 01:02:09,600 --> 01:02:09,920 DEVELOPMENT. 1798 01:02:09,920 --> 01:02:12,040 THIS IS INITIATIVE WILL ALSO 1799 01:02:12,040 --> 01:02:13,680 IMPROVE THE QUALITY AND IMPACT 1800 01:02:13,680 --> 01:02:15,080 OF DISSEMINATION ACTIVITY 1801 01:02:15,080 --> 01:02:17,640 BUSINESS PROVIDING TRANSLATIONAL 1802 01:02:17,640 --> 01:02:19,040 EXPERTISE AND GUIDANCE THAT IS 1803 01:02:19,040 --> 01:02:21,200 UNLIKELY TO BE AVAILABLE TO 1804 01:02:21,200 --> 01:02:23,400 CENTERS AND INDIVIDUAL 1805 01:02:23,400 --> 01:02:23,680 RESEARCHERS. 1806 01:02:23,680 --> 01:02:25,040 THIS PROPOSED INITIATIVE IS 1807 01:02:25,040 --> 01:02:26,240 CRITICAL TO ADVANCING THE 1808 01:02:26,240 --> 01:02:28,120 SCIENTIFIC PRIORITIES TO THE 1809 01:02:28,120 --> 01:02:29,080 POPULATIONS DYNAMICS BRANCH AND 1810 01:02:29,080 --> 01:02:32,000 THUS IT ALIGNS WITH NICHD'S 1811 01:02:32,000 --> 01:02:34,960 STRATEGIC PLAN 3 AND 4, 1812 01:02:34,960 --> 01:02:36,520 CROSS-CUTTING HEALTH 1813 01:02:36,520 --> 01:02:37,680 DISPARITIES, DISEASE PREVENTION 1814 01:02:37,680 --> 01:02:38,720 AND GLOBAL HEALTH. 1815 01:02:38,720 --> 01:02:40,560 THE ASPIRATIONAL GOAL OF 1816 01:02:40,560 --> 01:02:45,120 TRAINING THE NEXT GENERATION OF 1817 01:02:45,120 --> 01:02:47,440 SCIENTISTS AND PROMOTING AN 1818 01:02:47,440 --> 01:02:53,640 INCLUE SINCLUSIVE SCIENTIFIC WO. 1819 01:02:53,640 --> 01:02:54,080 THANK YOU. 1820 01:02:54,080 --> 01:02:56,600 >> ALL RIGHT DO WE HAVE ANY 1821 01:02:56,600 --> 01:02:58,680 QUESTIONS OR COMMENTS ABOUT THIS 1822 01:02:58,680 --> 01:02:59,920 CONCEPT? 1823 01:02:59,920 --> 01:03:03,720 >> QUESTION. 1824 01:03:03,720 --> 01:03:07,440 THIS IS REBECCA WONG. 1825 01:03:07,440 --> 01:03:08,320 THANK YOU, ROSS. 1826 01:03:08,320 --> 01:03:10,720 I THINK THIS IS A GREAT IDEA. 1827 01:03:10,720 --> 01:03:12,480 I DON'T KNOW IF WE HAD ONE 1828 01:03:12,480 --> 01:03:14,240 BEFORE, I WAS WONDERING ABOUT 1829 01:03:14,240 --> 01:03:14,440 THAT. 1830 01:03:14,440 --> 01:03:15,880 IF THERE HAS BEEN A CENTER? 1831 01:03:15,880 --> 01:03:19,800 >> YES, WE'VE HAD ONE. 1832 01:03:19,800 --> 01:03:23,840 WE FIRST ISSUED THE RFA FORTH 1833 01:03:23,840 --> 01:03:27,040 COORDINATING CENTER IN 2017 AND 1834 01:03:27,040 --> 01:03:29,520 THE CONCEPT NEEDS TO BE 1835 01:03:29,520 --> 01:03:30,880 RECLEARED EVERY FIVE YEARS. 1836 01:03:30,880 --> 01:03:33,320 >> NOW A FOLLOW UP. 1837 01:03:33,320 --> 01:03:33,800 I'M SORRY. 1838 01:03:33,800 --> 01:03:34,760 DO YOU IMAGINE THIS NECESSARILY 1839 01:03:34,760 --> 01:03:38,120 THAT IT HAS TO BE AN ACADEMIC 1840 01:03:38,120 --> 01:03:41,080 INSTITUTION RESPONDING TO THIS? 1841 01:03:41,080 --> 01:03:42,760 >> NO, ABSOLUTELY NOT. 1842 01:03:42,760 --> 01:03:48,880 ANY INSTITUTION THAT HAS THE 1843 01:03:48,880 --> 01:03:50,160 REQUISITE CAPITAL, INSTITUTIONAL 1844 01:03:50,160 --> 01:03:50,960 CAPACITY AND ENVIRONMENT AND 1845 01:03:50,960 --> 01:03:54,040 WOULD HAVE THE APPROPRIATE 1846 01:03:54,040 --> 01:04:00,360 INVESTIGATORS. 1847 01:04:00,360 --> 01:04:03,360 >> THIS IS SHERRY BARKIN. 1848 01:04:03,360 --> 01:04:04,880 HE JUST HAVE A FOLLOW UP 1849 01:04:04,880 --> 01:04:05,720 QUESTION FOR THAT. 1850 01:04:05,720 --> 01:04:12,720 THANK YOU FOR THAT PRESENTATION. 1851 01:04:12,720 --> 01:04:14,680 CAN YOU TELL ME FROM THE LAST 1852 01:04:14,680 --> 01:04:17,400 ONE, IS THERE ANYTHING WE'VE 1853 01:04:17,400 --> 01:04:19,120 LEARNED FROM THAT MOVING 1854 01:04:19,120 --> 01:04:19,400 FORWARD? 1855 01:04:19,400 --> 01:04:20,800 >> THE BIGGEST THING IS WE'RE 1856 01:04:20,800 --> 01:04:22,600 THINKING ABOUT WHAT MEDIA THEY 1857 01:04:22,600 --> 01:04:24,760 USED WHETHER WE FIRST COMPETED 1858 01:04:24,760 --> 01:04:26,720 THIS, SOCIAL MEDIA HAS REALLY 1859 01:04:26,720 --> 01:04:27,400 ADVANCED. 1860 01:04:27,400 --> 01:04:30,640 A LOT OF OTHER METHODS OF 1861 01:04:30,640 --> 01:04:31,640 COMMUNICATION HAVE REALLY, 1862 01:04:31,640 --> 01:04:33,920 THINGS WE DIDN'T RELY ON AS MUCH 1863 01:04:33,920 --> 01:04:36,040 SO WE'RE REALLY HOPING TO SEE, 1864 01:04:36,040 --> 01:04:38,440 THAT THAT IS PART OF EFFECTIVE 1865 01:04:38,440 --> 01:04:39,640 DISSEMINATION AND TRANSLATION IS 1866 01:04:39,640 --> 01:04:41,360 LEARNING HOW TO USE ALL THESE 1867 01:04:41,360 --> 01:04:42,560 DIFFERENT CHANNELS AND WE'RE 1868 01:04:42,560 --> 01:04:44,520 REALLY HOPING TO SEE THAT'S 1869 01:04:44,520 --> 01:04:46,280 INVOLVE OVER THE NEXT 1870 01:04:46,280 --> 01:04:48,160 COMPETITIVE CYCLE. 1871 01:04:48,160 --> 01:04:49,560 >> THAT'S INTERESTING. 1872 01:04:49,560 --> 01:04:51,120 I'M SORRY, THIS IS REBECCA 1873 01:04:51,120 --> 01:04:51,520 AGAIN. 1874 01:04:51,520 --> 01:04:52,720 THAT'S EXACTLY WHAT I WAS 1875 01:04:52,720 --> 01:04:54,480 THINKING THAT GETTING TO THE NEW 1876 01:04:54,480 --> 01:04:55,360 TECHNOLOGY, THAT PROBABLY WE 1877 01:04:55,360 --> 01:04:59,480 NEED TO GET OUT OF ACADEMIC 1878 01:04:59,480 --> 01:05:01,040 WORLD AND THERE MIGHT BE OTHER 1879 01:05:01,040 --> 01:05:02,760 PEOPLE OUT THERE THAT CAN DO IT 1880 01:05:02,760 --> 01:05:04,480 PER, BUT I DON'T KNOW, I DON'T 1881 01:05:04,480 --> 01:05:06,040 HAVE ANYBODY IN MIND BUT I WAS 1882 01:05:06,040 --> 01:05:07,560 JUST THINKING OF SOMEBODY WHO 1883 01:05:07,560 --> 01:05:16,320 CAN THINK OUTSIDE OF THE BOX. 1884 01:05:16,320 --> 01:05:17,120 >> OKAY. 1885 01:05:17,120 --> 01:05:19,000 ANY OTHER QUESTIONS? 1886 01:05:19,000 --> 01:05:21,160 IF NOT, MAY I HAVE A MOTION FOR 1887 01:05:21,160 --> 01:05:23,280 APPROVAL? 1888 01:05:23,280 --> 01:05:25,440 >> MOVE TO APPROVE, PLEASE. 1889 01:05:25,440 --> 01:05:26,600 >> THANK YOU. 1890 01:05:26,600 --> 01:05:26,880 SECOND? 1891 01:05:26,880 --> 01:05:28,320 >> SECOND. 1892 01:05:28,320 --> 01:05:30,000 >> VERY GOOD. 1893 01:05:30,000 --> 01:05:31,640 PLEASE VOTE NOW USING YOUR 1894 01:05:31,640 --> 01:05:35,480 BUTTONS AT THE BOTTOM OF THE 1895 01:05:35,480 --> 01:05:45,680 ZOOM SCREEN. 1896 01:05:47,080 --> 01:05:55,840 >> 15 VOTES. 1897 01:05:55,840 --> 01:05:57,360 >> 16. 1898 01:05:57,360 --> 01:06:01,480 >> 16? 1899 01:06:01,480 --> 01:06:02,000 OKAY. 1900 01:06:02,000 --> 01:06:03,320 GREAT. 1901 01:06:03,320 --> 01:06:05,720 THANK YOU. 1902 01:06:05,720 --> 01:06:07,840 NEXT UP WE HAVE DR. DAVID 1903 01:06:07,840 --> 01:06:10,840 WINEBURG FROM THE PREGNANCY AND 1904 01:06:10,840 --> 01:06:17,200 PERI NAY NATOLOGY BRANCH ON 1905 01:06:17,200 --> 01:06:19,920 BRAIN DEVELOPMENT AND NEURO 1906 01:06:19,920 --> 01:06:20,160 OUTCOME. 1907 01:06:20,160 --> 01:06:22,880 >> SEEKS COUNCIL APPROVAL FOR A 1908 01:06:22,880 --> 01:06:24,600 INITIATIVE TITLES OPIOID 1909 01:06:24,600 --> 01:06:28,560 EXPOSURE AND EFFECTS ON PLACENTA 1910 01:06:28,560 --> 01:06:30,600 FUNCTION, BRAIN DEVELOPMENT AND 1911 01:06:30,600 --> 01:06:31,960 NEURAL OUTCOMES. 1912 01:06:31,960 --> 01:06:34,800 BRAIN DEVELOPMENT IN THE FETAL 1913 01:06:34,800 --> 01:06:42,280 ANNAND, AND NEONATAL BE INFLUEN, 1914 01:06:42,280 --> 01:06:43,960 IS AFFECTED BY MATERNAL 1915 01:06:43,960 --> 01:06:46,120 SUBSTANCE USE. 1916 01:06:46,120 --> 01:06:48,640 FURTHERMORE, DESPITE 1917 01:06:48,640 --> 01:06:52,680 LONG-STANDING NORMAL THAT THE 1918 01:06:52,680 --> 01:06:56,080 PLACENTA IS CRITICAL IN 1919 01:06:56,080 --> 01:06:58,240 DEVELOPMENT, THERE IS LITTLE TO 1920 01:06:58,240 --> 01:07:00,200 KNOW HOW IT CAN INFLUENCE AND 1921 01:07:00,200 --> 01:07:03,080 ALTER FETAL BRAIN DEVELOPMENT. 1922 01:07:03,080 --> 01:07:05,920 THE MECHANISTIC AND 1923 01:07:05,920 --> 01:07:08,960 UNDERSTANDING OF HOW FETAL 1924 01:07:08,960 --> 01:07:10,280 EXTERNAL SYSTEM AND BRAIN? 1925 01:07:10,280 --> 01:07:11,600 INTERACT IN RESPONSE TO OPIOID 1926 01:07:11,600 --> 01:07:14,480 AND POLY SUBSTANCE USE TO UP 1927 01:07:14,480 --> 01:07:18,040 PACT THE NEONATAL INFANT 1928 01:07:18,040 --> 01:07:19,240 DEVELOPMENT OUTCOMES IS UNKNOWN, 1929 01:07:19,240 --> 01:07:20,520 HOWEVER THIS KNOWLEDGE IS 1930 01:07:20,520 --> 01:07:23,160 CRITICAL TO ESTABLISHING 1931 01:07:23,160 --> 01:07:24,240 APPROPRIATE EARLY INTERVENTION 1932 01:07:24,240 --> 01:07:26,520 AND FOR ESTABLISHING CLINICAL 1933 01:07:26,520 --> 01:07:27,840 GUIDELINES FOR PAIN MANAGEMENT 1934 01:07:27,840 --> 01:07:28,920 IN PREGNANT PEOPLE. 1935 01:07:28,920 --> 01:07:31,800 THIS INITIATIVE WILL LEVERAGE 1936 01:07:31,800 --> 01:07:33,320 INNOVATIONS AND IMAGING 1937 01:07:33,320 --> 01:07:35,160 TECHNOLOGIES THAT HAVE ALLOWED 1938 01:07:35,160 --> 01:07:37,240 FOR SIGNIFICANT ADVANCES IN 1939 01:07:37,240 --> 01:07:39,640 DELINEATING STRUCTURAL AND 1940 01:07:39,640 --> 01:07:45,120 FUNCTIONAL TR TRAJECTORIES OF FL 1941 01:07:45,120 --> 01:07:45,400 DEVELOP. 1942 01:07:45,400 --> 01:07:48,920 AND THE FIRST SEVERAL MONTHS OF 1943 01:07:48,920 --> 01:07:49,160 INFANCY. 1944 01:07:49,160 --> 01:07:51,120 AND EVALUATION OF BLOOD BIO 1945 01:07:51,120 --> 01:07:53,160 MARKERS ARE POINTS FOR 1946 01:07:53,160 --> 01:07:55,680 APPLICATION TO ACCESSING THE 1947 01:07:55,680 --> 01:07:58,080 IMPACT OF OPIOID EXPOSURE THIS 1948 01:07:58,080 --> 01:07:59,720 INITIATIVE ALIGNS WITH THE 1949 01:07:59,720 --> 01:08:03,880 PRIORITIES OF THE PREGNANCY AND 1950 01:08:03,880 --> 01:08:06,960 PERINATOLAGY BRANCH OF NICHD AND 1951 01:08:06,960 --> 01:08:07,720 ADDRESSES THE STRATEGIC PLAN 1952 01:08:07,720 --> 01:08:10,120 GOALS FOR SETTING THE FOUNDATION 1953 01:08:10,120 --> 01:08:12,400 FOR HEALTHY PREGNANCY AND 1954 01:08:12,400 --> 01:08:14,600 LIFE-LONG WELLNESS AND IMPROVING 1955 01:08:14,600 --> 01:08:17,120 CHILD IN ADOLESCENT HEALTH AND 1956 01:08:17,120 --> 01:08:19,920 TRANSITION TO ADULT HOOD. 1957 01:08:19,920 --> 01:08:25,480 IMPORTANTLY, IT ALIGNS WITH THE 1958 01:08:25,480 --> 01:08:30,080 TRANS -- NITL AND OTHER CENTERS 1959 01:08:30,080 --> 01:08:31,680 AND OFFICES. 1960 01:08:31,680 --> 01:08:32,480 THANK YOU. 1961 01:08:32,480 --> 01:08:34,960 >> THANK YOU, DR. WINEBURG ARE 1962 01:08:34,960 --> 01:08:37,520 THERE QUESTIONS OR COMMENTS 1963 01:08:37,520 --> 01:08:43,800 ABOUT THIS CONCEPT? 1964 01:08:43,800 --> 01:08:46,960 >> HI, THIS IS THEY ARE YES 1965 01:08:46,960 --> 01:08:47,360 BARKIN THANK YOU. 1966 01:08:47,360 --> 01:08:49,360 CONNECT AT ALL WHAT WE WERE 1967 01:08:49,360 --> 01:08:49,960 LEARNING ABOUT THE BRAIN 1968 01:08:49,960 --> 01:08:58,240 INITIATIVE? 1969 01:08:58,240 --> 01:09:09,560 >> I THINK IT SINN SING SING IIS 1970 01:09:13,360 --> 01:09:14,960 AND I DON'T KNOW IF DR. BIANCHI 1971 01:09:14,960 --> 01:09:17,440 WHO SERVES UP THE CHAIN WOULD 1972 01:09:17,440 --> 01:09:18,720 LIKE TO COMMENT. 1973 01:09:18,720 --> 01:09:20,400 >> YES. 1974 01:09:20,400 --> 01:09:22,480 SO, I JUST ACTUALLY HAD A 1975 01:09:22,480 --> 01:09:24,640 DISCUSSION WITH REBECCA BAKER 1976 01:09:24,640 --> 01:09:28,520 THIS MORNING, WHO IS THE PROJECT 1977 01:09:28,520 --> 01:09:29,920 LEAD FOR HEAL. 1978 01:09:29,920 --> 01:09:32,000 WHAT WE REALLY FELT, WE'RE 1979 01:09:32,000 --> 01:09:37,760 ALWAYS TRYING TO USE SOME OF THE 1980 01:09:37,760 --> 01:09:39,720 HEAL FUNDING TO ADDRESS NEEDS IN 1981 01:09:39,720 --> 01:09:41,360 OUR POPULATIONS EITHER WITH 1982 01:09:41,360 --> 01:09:47,160 REGARD TO OPIOID MISUSE OR PAIN 1983 01:09:47,160 --> 01:09:55,400 IN POST CAESAREAN SECTION WOMEN. 1984 01:09:55,400 --> 01:09:58,080 IT IS NOT DIRECTLY LINKED BUT IT 1985 01:09:58,080 --> 01:10:00,040 IS INDIRECTLY LINKED SO THERE IS 1986 01:10:00,040 --> 01:10:03,760 SOME CROSSOVER WARDING THE HBDC 1987 01:10:03,760 --> 01:10:05,640 STUDY, THE HEALTHY BRAIN AND 1988 01:10:05,640 --> 01:10:06,920 COGNITIVE DEVELOPMENT. 1989 01:10:06,920 --> 01:10:09,760 EXCUSE ME. 1990 01:10:09,760 --> 01:10:14,800 BUT REALLY THE FOCUS OF THIS 1991 01:10:14,800 --> 01:10:18,280 PARTICULAR PROJECT WILL BE ON 1992 01:10:18,280 --> 01:10:21,360 HOW OPIOIDS AFFECT THE PLACENTA 1993 01:10:21,360 --> 01:10:24,840 AND IF THERE ARE ABNORMALITIES 1994 01:10:24,840 --> 01:10:27,240 IN PLACENTA DEVELOPMENT THAT 1995 01:10:27,240 --> 01:10:28,760 SUBSEQUENTLY AFFECT NEURAL 1996 01:10:28,760 --> 01:10:29,040 DEVELOPMENT. 1997 01:10:29,040 --> 01:10:31,200 THERE ARE A LOT OF PEOPLE 1998 01:10:31,200 --> 01:10:32,800 INVOLVED FROM THE NIH 1999 01:10:32,800 --> 01:10:35,600 PERSPECTIVE SO THERE WILL BE 2000 01:10:35,600 --> 01:10:36,720 INDIRECT CONNECTIONS AND LINKS 2001 01:10:36,720 --> 01:10:39,040 IS THAT FAIR TO SAY, DAVID? 2002 01:10:39,040 --> 01:10:40,080 >> ABSOLUTELY. 2003 01:10:40,080 --> 01:10:41,440 I THINK I'M ALWAYS TRYING TO 2004 01:10:41,440 --> 01:10:42,880 LOOK AT HOW THE WHOLE GETS 2005 01:10:42,880 --> 01:10:44,480 TOGETHER BECAUSE THERE ARE SO 2006 01:10:44,480 --> 01:10:47,000 AMERICAN INTERESTING INITIATIVES 2007 01:10:47,000 --> 01:10:48,880 MOVING FORWARD. 2008 01:10:48,880 --> 01:10:52,000 WHATS WAYS TO CROSS LINK AND 2009 01:10:52,000 --> 01:10:53,680 ASYNERGIES TO MAXIMIZE INPUT. 2010 01:10:53,680 --> 01:10:53,960 THANK YOU. 2011 01:10:53,960 --> 01:11:04,360 >> IT IS A GREAT POINT. 2012 01:11:05,800 --> 01:11:08,640 >> I'M VERY SUPPORTIVE OF THIS. 2013 01:11:08,640 --> 01:11:10,480 ESPECIALLY CONSIDERING THE 2014 01:11:10,480 --> 01:11:12,320 CRISIS WITH FENTANYL, CONCERNING 2015 01:11:12,320 --> 01:11:14,520 TRENDS AND THIS IS, I THINK, A 2016 01:11:14,520 --> 01:11:15,200 CRITICAL ISSUE TO ADDRESS. 2017 01:11:15,200 --> 01:11:18,120 IF THERE ARE NO OTHER COMMENTS, 2018 01:11:18,120 --> 01:11:20,400 I'M ALSO HAPPY TO MAKE A MOTION 2019 01:11:20,400 --> 01:11:21,520 TO APPROVE. 2020 01:11:21,520 --> 01:11:22,520 >> OKAY. 2021 01:11:22,520 --> 01:11:25,440 I THOUGHT I SAW DR. LANG BRIEFLY 2022 01:11:25,440 --> 01:11:27,080 UP THERE SAY IN DID BUT I WAS 2023 01:11:27,080 --> 01:11:28,720 GOING TO ASK HOW IT WENT WITH 2024 01:11:28,720 --> 01:11:31,440 THE HBCB STUDY BY DIANA ANSWERED 2025 01:11:31,440 --> 01:11:31,640 THAT. 2026 01:11:31,640 --> 01:11:33,640 >> OKAY, GOOD SO WE HAVE A 2027 01:11:33,640 --> 01:11:35,200 NOTION APPROVE DO WE HAVE A 2028 01:11:35,200 --> 01:11:39,760 SECOND? 2029 01:11:39,760 --> 01:11:40,360 >> SECOND. 2030 01:11:40,360 --> 01:11:41,320 >> THANK YOU. 2031 01:11:41,320 --> 01:11:43,720 COULD YOU PLEASE GO DOWN TO THE 2032 01:11:43,720 --> 01:11:46,240 ZOOM VOTING PANEL AND REGISTER 2033 01:11:46,240 --> 01:11:56,480 YOUR VOTES. 2034 01:12:01,960 --> 01:12:07,800 >> I'M COUNTING 15 VOTES. 2035 01:12:07,800 --> 01:12:17,840 16. 2036 01:12:18,400 --> 01:12:18,520 CAN. 2037 01:12:18,520 --> 01:12:20,880 >> OKAY THANK YOU. 2038 01:12:20,880 --> 01:12:25,000 NEXT DR. WINEBURG WILL ALSO 2039 01:12:25,000 --> 01:12:25,240 PRESENT. 2040 01:12:25,240 --> 01:12:25,440 DAVID. 2041 01:12:25,440 --> 01:12:26,880 >> PROGRAM SEEKS COUNCIL 2042 01:12:26,880 --> 01:12:28,720 APPROVAL FOR AN INITIATIVE 2043 01:12:28,720 --> 01:12:31,000 TITLED ADVANCING METHODS FOR 2044 01:12:31,000 --> 01:12:33,200 SAFE, NON-INVASIVE REAL TIME 2045 01:12:33,200 --> 01:12:35,160 ASSESSMENT OF PLACENTA 2046 01:12:35,160 --> 01:12:38,120 DEVELOPMENT AND FUNCTION ACROSS 2047 01:12:38,120 --> 01:12:38,880 PREGNANCY. 2048 01:12:38,880 --> 01:12:40,400 DESPITE INTENSIVE RESEARCH OF 2049 01:12:40,400 --> 01:12:42,680 EARLY RISK ASSESSMENT IN 2050 01:12:42,680 --> 01:12:44,000 PREGNANCY, THERE IS STAY 2051 01:12:44,000 --> 01:12:45,960 CRITICAL LACK OF EFFECTIVE TOOLS 2052 01:12:45,960 --> 01:12:48,680 AND METHODS OF SAFE REL TIME 2053 01:12:48,680 --> 01:12:50,320 ASSESSMENT OF PLACENTA 2054 01:12:50,320 --> 01:12:52,520 DEVELOPMENT ACROSS THE PREGNANCY 2055 01:12:52,520 --> 01:12:53,920 TIME COURSE. 2056 01:12:53,920 --> 01:12:57,520 THE NICHD LAUNCHED THE HUMAN 2057 01:12:57,520 --> 01:13:01,080 PLACENTA PRACTICE JECT, HPP IN 2058 01:13:01,080 --> 01:13:06,360 2014 TO ADDRESS THIS CRITICAL 2059 01:13:06,360 --> 01:13:07,720 GAP. 2060 01:13:07,720 --> 01:13:09,520 THEY'VE VESTED OVER $87 MILLION. 2061 01:13:09,520 --> 01:13:13,160 THERE IS A CROSS OF IMAGING AND 2062 01:13:13,160 --> 01:13:14,480 OMIX APPROACHES. 2063 01:13:14,480 --> 01:13:16,400 HOWEVER, MAKING THE JUMP TO 2064 01:13:16,400 --> 01:13:19,040 CLINICAL IMPLEMENTATION REQUIRES 2065 01:13:19,040 --> 01:13:21,120 ADDITIONAL STUDIES TO PROVIDE 2066 01:13:21,120 --> 01:13:22,080 CONFIRMATION AND VALIDATION. 2067 01:13:22,080 --> 01:13:24,440 IN CONNECTION, BY NECESSITY, THE 2068 01:13:24,440 --> 01:13:27,480 HPP AWARDS RENTED INDIVIDUAL 2069 01:13:27,480 --> 01:13:29,520 EFFORTS AND MOST LIKE AN INT 2070 01:13:29,520 --> 01:13:35,680 FREIGINTEGRATED APPROACH WILL HE 2071 01:13:35,680 --> 01:13:36,840 THE GREATEST POTENTIAL. 2072 01:13:36,840 --> 01:13:39,920 THIS IS AIMED AT VALIDATION AND 2073 01:13:39,920 --> 01:13:41,960 MULTI MODAL APPROACHES AND IS A 2074 01:13:41,960 --> 01:13:43,840 REQUISITE NEXT STEP OF THE 2075 01:13:43,840 --> 01:13:45,560 PROGRESSION OF THESE APPROACHES 2076 01:13:45,560 --> 01:13:46,640 TOWARDS CLINICAL ACCEPTANCE. 2077 01:13:46,640 --> 01:13:49,000 THE HPP HAVE STILL LATE RED 2078 01:13:49,000 --> 01:13:51,600 SEARCH GLOBALLY AND ADVANCES IN 2079 01:13:51,600 --> 01:13:53,000 CENTERS AROUND THE WORLD THIS 2080 01:13:53,000 --> 01:13:55,640 INITIATIVE WOULD BE OPEN TO ALL 2081 01:13:55,640 --> 01:13:58,440 INVESTIGATORS FOREIGN OR 2082 01:13:58,440 --> 01:13:59,120 DOMESTIC. 2083 01:13:59,120 --> 01:14:00,880 THIS INITIATIVE IS IN DIRECT 2084 01:14:00,880 --> 01:14:02,400 ALIGNMENT WITH NICHD'S THEME 2085 01:14:02,400 --> 01:14:04,480 THREE, SETTING THE FOUNDATION 2086 01:14:04,480 --> 01:14:07,200 FOR HEALTHY FLAG NANCYS AND 2087 01:14:07,200 --> 01:14:10,000 CROSS-CUTTING THEMES RELATED TO 2088 01:14:10,000 --> 01:14:11,200 PREPREG NANCY HEALTH, PREVENTION 2089 01:14:11,200 --> 01:14:14,920 OF ADVERSE OUTCOMES, EARLY 2090 01:14:14,920 --> 01:14:20,280 DETECTION AND EFFECT OF PA 2091 01:14:20,280 --> 01:14:30,920 PATHOGENS ON PREGNANT WOMEN THID 2092 01:14:33,960 --> 01:14:38,880 BE RELEVANT TO THE IMPACT OF 2093 01:14:38,880 --> 01:14:40,760 INFECTIOUS DISEASE AND 2094 01:14:40,760 --> 01:14:41,040 TREATMENT. 2095 01:14:41,040 --> 01:14:44,520 THANK YOU. 2096 01:14:44,520 --> 01:14:47,760 >> THANK YOU, AGAIN, 2097 01:14:47,760 --> 01:14:48,280 DR. WINEBURG. 2098 01:14:48,280 --> 01:14:49,960 ARE THERE QUESTIONS OR COMMENTS 2099 01:14:49,960 --> 01:15:00,280 ABOUT THIS CONCEPT? 2100 01:15:00,720 --> 01:15:00,960 OKAY. 2101 01:15:00,960 --> 01:15:03,160 IF NOT, MAY I HAVE A MOTION FOR 2102 01:15:03,160 --> 01:15:05,040 APPROVAL? 2103 01:15:05,040 --> 01:15:07,680 >> MOTION TO APPROVE. 2104 01:15:07,680 --> 01:15:09,840 >> SECOND? 2105 01:15:09,840 --> 01:15:11,080 >> SECOND. 2106 01:15:11,080 --> 01:15:12,080 >> THANK YOU. 2107 01:15:12,080 --> 01:15:13,680 OKAY, PLEASE VOTE NOW ON THE 2108 01:15:13,680 --> 01:15:23,880 ZOOM SCREEN. 2109 01:15:34,920 --> 01:15:37,040 >> WE HAVE 16 VOTES. 2110 01:15:37,040 --> 01:15:38,520 >> THANK YOU. 2111 01:15:38,520 --> 01:15:44,320 NEXT WE HAVE THE PREGNANCY AND 2112 01:15:44,320 --> 01:15:48,280 PERINATOLOGY BRANCH. 2113 01:15:48,280 --> 01:15:49,120 >> THANK YOU VERY MUCH. 2114 01:15:49,120 --> 01:15:52,720 PROGRAM SEEKS COUNCIL APPROVAL 2115 01:15:52,720 --> 01:15:54,480 FOR TITLE MATERNAL HEALTH 2116 01:15:54,480 --> 01:15:57,080 RESEARCH CENTERS FOR EXCELLENCE. 2117 01:15:57,080 --> 01:15:59,280 WE KNOW THE MORTALITY RATES ARE 2118 01:15:59,280 --> 01:16:01,240 THE HIGHEST OF ANY DEVELOPED 2119 01:16:01,240 --> 01:16:01,600 COUNTRIES. 2120 01:16:01,600 --> 01:16:04,840 THE CDC REPORTS THAT IN 2020, 2121 01:16:04,840 --> 01:16:06,400 861 WOMEN WERE IDENTIFIED AS 2122 01:16:06,400 --> 01:16:11,720 HAVING WIDE OF MATERNAL CAUSE IN 2123 01:16:11,720 --> 01:16:14,120 THE UNITED STATES AND IN 2124 01:16:14,120 --> 01:16:14,760 CONNECTION 50,000 WOMEN 2125 01:16:14,760 --> 01:16:16,880 EXPERIENCE MORBIDITY AND 2126 01:16:16,880 --> 01:16:17,520 MORTALITY EVERY YEAR TOMORROW 2127 01:16:17,520 --> 01:16:19,080 ADDRESS THIS PUBLIC HEALTH 2128 01:16:19,080 --> 01:16:20,800 CRISIS, THE NATIONAL INSTITUTE 2129 01:16:20,800 --> 01:16:22,520 OF HEALTH LAUNCHED THE 2130 01:16:22,520 --> 01:16:24,720 IMPLEMENTING AND MATERNAL HEALTH 2131 01:16:24,720 --> 01:16:27,800 AND PREGNANCY OUTCOME INITIATIVE 2132 01:16:27,800 --> 01:16:29,960 THAT DR. BIANCHI MENTIONED 2133 01:16:29,960 --> 01:16:30,320 YESTERDAY. 2134 01:16:30,320 --> 01:16:32,040 THE INITIATIVE SUPPORTS RESEARCH 2135 01:16:32,040 --> 01:16:35,320 AND HOW TO PREVENT MATERNAL 2136 01:16:35,320 --> 01:16:37,200 MORTALITY, DECREASE SEVERE 2137 01:16:37,200 --> 01:16:39,360 MORBIDITY AND PROMODE HEALTH 2138 01:16:39,360 --> 01:16:40,360 EQUITY. 2139 01:16:40,360 --> 01:16:42,520 IN 2022, THE PRESIDENT'S BUDGET 2140 01:16:42,520 --> 01:16:46,360 INCLUDED A 30 MILLION FOR NICHD 2141 01:16:46,360 --> 01:16:48,520 TO EXPAND THE IMPROVE INITIATIVE 2142 01:16:48,520 --> 01:16:50,520 AND LAUNCH THE CENTERS OF LESS 2143 01:16:50,520 --> 01:16:52,560 THAN SUPPORT RESEARCH FROM JECTS 2144 01:16:52,560 --> 01:16:54,520 THAT WILL INCORPORATE LOCAL 2145 01:16:54,520 --> 01:16:56,840 COMMUNITY NEEDS AND 2146 01:16:56,840 --> 01:16:57,400 PERSPECTIVES. 2147 01:16:57,400 --> 01:16:59,000 THE PURPOSE OF THIS INITIATIVE 2148 01:16:59,000 --> 01:17:00,960 IS TO ESTABLISH THESE MATERNAL 2149 01:17:00,960 --> 01:17:04,800 HEALTH CENTERS OF EXCELLENCE IN 2150 01:17:04,800 --> 01:17:06,120 GEOGRAPHICALLY DIVERSE REGIONS 2151 01:17:06,120 --> 01:17:07,400 AND IN PARTNERSHIP WITH THE 2152 01:17:07,400 --> 01:17:10,160 COMMUNITIES MOST AFFECTED THIS 2153 01:17:10,160 --> 01:17:12,440 INITIATIVE WILL USE AN 2154 01:17:12,440 --> 01:17:14,000 INTEGRATED APPROACH WITH SOCIAL, 2155 01:17:14,000 --> 01:17:16,040 BIO RESEARCH AND STRATEGIES TO 2156 01:17:16,040 --> 01:17:17,160 ADDRESS THE MULTIPLE 2157 01:17:17,160 --> 01:17:19,320 CONTRIBUTING FACTORS, INCLUDING 2158 01:17:19,320 --> 01:17:20,760 SOCIAL DETERMINANTS IN HEALTH 2159 01:17:20,760 --> 01:17:23,280 AND SYSTEMIC FACTORS SUCH AS 2160 01:17:23,280 --> 01:17:24,680 STRUCTURAL RACISM THAT LEAD TO 2161 01:17:24,680 --> 01:17:26,200 HEALTH DISPARITIES. 2162 01:17:26,200 --> 01:17:27,440 THE GOAL OF THIS INITIATIVE IS 2163 01:17:27,440 --> 01:17:31,680 FOR A TRANSDISCIPLINARY 2164 01:17:31,680 --> 01:17:34,080 RESEARCHER CONDUCT MULTI LAYERED 2165 01:17:34,080 --> 01:17:37,680 NOVEL APPROACHES THAT HAVE THE 2166 01:17:37,680 --> 01:17:39,760 ABILITY TO ADDRESS SEVERE 2167 01:17:39,760 --> 01:17:41,920 MATERNAL MORBIDITY AND FATALITY 2168 01:17:41,920 --> 01:17:43,240 AND DEATHS. 2169 01:17:43,240 --> 01:17:47,200 THIS CONCEPT ALIGNS WITH THE 2170 01:17:47,200 --> 01:17:49,160 PROPOSED INITIATIVE, THE 2171 01:17:49,160 --> 01:17:50,240 STRATEGIC PLAN, SPECIFICALLY 2172 01:17:50,240 --> 01:17:52,200 THEME THREE, SETTING THE 2173 01:17:52,200 --> 01:17:54,480 FOUNDATION FOR HEALTHY FLAG 2174 01:17:54,480 --> 01:17:56,160 NANCYS AND LIFE-LONG WELLNESS AS 2175 01:17:56,160 --> 01:17:59,280 WELL AS THE CROSS-CUTTING THEME 2176 01:17:59,280 --> 01:18:01,480 OF HEALTH DISPARITIES THIS ALSO 2177 01:18:01,480 --> 01:18:03,960 ALIGNS WITH THE PRIORITIES OF 2178 01:18:03,960 --> 01:18:06,400 MULTIPLE BRANCHES AT NICHD 2179 01:18:06,400 --> 01:18:07,480 INCLUDING THE PREGNANT YES, I 2180 01:18:07,480 --> 01:18:11,880 DID. AND PERIONATOLOGY BRANCH. 2181 01:18:11,880 --> 01:18:12,160 THANK YOU. 2182 01:18:12,160 --> 01:18:14,240 >> ARE THERE QUESTIONS OR 2183 01:18:14,240 --> 01:18:16,600 COMMENTS ABOUT THIS CONCEPT. 2184 01:18:16,600 --> 01:18:24,840 >> COMMENT. 2185 01:18:24,840 --> 01:18:26,360 TO SUPPORT THIS AND SAY IT IS A 2186 01:18:26,360 --> 01:18:27,200 FANTASTIC OPPORTUNITY. 2187 01:18:27,200 --> 01:18:29,680 HOW WILL THIS, ANY PLANS ABOUT 2188 01:18:29,680 --> 01:18:32,080 HOW THIS WILL WORK VIS A VIS SAY 2189 01:18:32,080 --> 01:18:36,000 THE MATERNAL FETAL MEDICINE 2190 01:18:36,000 --> 01:18:38,520 UNITS NETWORK THAT ALSO MAY BE 2191 01:18:38,520 --> 01:18:39,920 ADDRESSING SOME OF THESE ISSUES. 2192 01:18:39,920 --> 01:18:41,320 >> ABSOLUTELY. 2193 01:18:41,320 --> 01:18:44,600 WE'RE HOPING THIS WORK WITH BE 2194 01:18:44,600 --> 01:18:46,720 SYNERGISTIC WITH THE UNITS, 2195 01:18:46,720 --> 01:18:49,000 WHETHER AS WE DEVELOP THIS 2196 01:18:49,000 --> 01:18:50,760 FURTHER, WE CAN SEE A 2197 01:18:50,760 --> 01:18:52,040 COLLABORATIONS BETWEEN THE TWO, 2198 01:18:52,040 --> 01:18:53,920 BETWEEN THE RESEARCH CENTERS AND 2199 01:18:53,920 --> 01:18:58,840 THE MATERNAL FETAL MEDICINE UNIT 2200 01:18:58,840 --> 01:19:04,080 AS WE MOVE FORWARD S DEFINITELY 2201 01:19:04,080 --> 01:19:11,040 THINK THERE WILL BE SYNERGISTIC. 2202 01:19:11,040 --> 01:19:14,680 >> ONE POPULATION WE HAVEN'T YET 2203 01:19:14,680 --> 01:19:16,320 FOCUSED ON ARE AMERICAN INDIANS 2204 01:19:16,320 --> 01:19:18,600 AND ALASKA NATIVES AND WE ARE 2205 01:19:18,600 --> 01:19:20,760 SCHEDULED TO HAVE A TRIBAL 2206 01:19:20,760 --> 01:19:25,480 CONSULTATION THIS MONTH IN 2207 01:19:25,480 --> 01:19:30,240 ADVANCE SO THIS IS AN AREA FOR 2208 01:19:30,240 --> 01:19:35,360 THOSE THAT DON'T KNOW, AMERICAN 2209 01:19:35,360 --> 01:19:38,200 INDIANS AND ACLASS NATIVES HAVE 2210 01:19:38,200 --> 01:19:40,680 ALMOST AS HIGH IN TERMS OF BLACK 2211 01:19:40,680 --> 01:19:47,120 WOMEN IN SEVERE MORBIDITY AND 2212 01:19:47,120 --> 01:19:53,640 MORTALITY . 2213 01:19:53,640 --> 01:19:54,640 IT IS IMPORTANT TO REACH OUT 2214 01:19:54,640 --> 01:19:56,040 THOUGH THESE POPULATIONS AND 2215 01:19:56,040 --> 01:19:59,360 THEY'RE NOT NECESSARILY INCLUDE 2216 01:19:59,360 --> 01:20:01,320 AND A BIG PART OF THE FOCUS OF 2217 01:20:01,320 --> 01:20:03,600 THE CENTERS FOR EXCELLENCE IS TO 2218 01:20:03,600 --> 01:20:05,560 HAVE COMMUNITY ENGAGEMENT AND 2219 01:20:05,560 --> 01:20:09,680 INVOLVEMENT BUT WE RECOGNIZE THE 2220 01:20:09,680 --> 01:20:11,240 MFMUs ARE DOING THAT SO HE 2221 01:20:11,240 --> 01:20:12,880 WILL: COORDINATING AND 2222 01:20:12,880 --> 01:20:14,920 INTEGRATING RESOURCES WHEREVER 2223 01:20:14,920 --> 01:20:15,120 WE CAN. 2224 01:20:15,120 --> 01:20:15,480 >> THANK YOU. 2225 01:20:15,480 --> 01:20:16,920 IT IS A REALLY GREAT 2226 01:20:16,920 --> 01:20:17,240 OPPORTUNITY. 2227 01:20:17,240 --> 01:20:19,120 SOME OF THESE STUDIES THAT MAY 2228 01:20:19,120 --> 01:20:21,080 BE DONE IN ONE SETTING IS LIKE, 2229 01:20:21,080 --> 01:20:23,360 WILL THIS REALLY WORK IN THE 2230 01:20:23,360 --> 01:20:26,760 COMMUNITY WITH IMPLEMENTATION, 2231 01:20:26,760 --> 01:20:29,400 SO I REALLY AGREE WITH THIS AND 2232 01:20:29,400 --> 01:20:31,440 THE SYNERGY BETWEEN THOSE AND 2233 01:20:31,440 --> 01:20:31,960 SUPPORT THIS. 2234 01:20:31,960 --> 01:20:32,240 THANK YOU. 2235 01:20:32,240 --> 01:20:40,440 >> THANK YOU. 2236 01:20:40,440 --> 01:20:42,120 >> DR. BARKIN. 2237 01:20:42,120 --> 01:20:45,280 >> I'M EXCITED ABOUT THIS. 2238 01:20:45,280 --> 01:20:46,400 PRO QUESTIONS. 2239 01:20:46,400 --> 01:20:48,480 THE FIRST IS, WHEN DOES A MOTHER 2240 01:20:48,480 --> 01:20:48,680 BEGIN? 2241 01:20:48,680 --> 01:20:50,880 >> SO FOR THIS SPECIFIC 2242 01:20:50,880 --> 01:20:52,720 INITIATIVE, WE'RE FOCUSING ON 2243 01:20:52,720 --> 01:20:55,240 THE PREGNANCY AND THE PREGNANCY 2244 01:20:55,240 --> 01:20:59,720 OUTCOMES WITHIN THE ONE YEAR 2245 01:20:59,720 --> 01:21:00,560 POST-PARTUM PERIOD. 2246 01:21:00,560 --> 01:21:01,560 WE ARE OTHER INITIATIVES THAT 2247 01:21:01,560 --> 01:21:03,640 WILL BE ADDRESSING THE LIFE-LONG 2248 01:21:03,640 --> 01:21:05,200 PERSPECTIVE BUT FOR THIS WE'RE 2249 01:21:05,200 --> 01:21:06,400 FOCUSING ON THE TIME PERIOD WITH 2250 01:21:06,400 --> 01:21:08,440 THE HIGHEST RISK OF MORBIDITY 2251 01:21:08,440 --> 01:21:09,320 AND MORTALITY. 2252 01:21:09,320 --> 01:21:10,000 >> THANK YOU. 2253 01:21:10,000 --> 01:21:12,400 THE SECOND HAS TO DO WITH, I SEE 2254 01:21:12,400 --> 01:21:14,680 THAT YOUR CONCEPTUALIZING IT IN 2255 01:21:14,680 --> 01:21:17,440 A REALLY INTEGRATED WAY, IT IS 2256 01:21:17,440 --> 01:21:19,280 BIO BEHAVIORAL, BIO SOCIAL 2257 01:21:19,280 --> 01:21:21,120 BEHAVIORAL AND ALSO IN CONTEXT, 2258 01:21:21,120 --> 01:21:23,360 AS DR. TITO WAS TALK ABOUT. 2259 01:21:23,360 --> 01:21:26,680 MY QUESTION THERE IS ABOUT, WHEN 2260 01:21:26,680 --> 01:21:28,760 YOU SAY INVOLVING THE COMMUNITY, 2261 01:21:28,760 --> 01:21:31,360 DO YOU HAVE A CONTEXT, IS IT A 2262 01:21:31,360 --> 01:21:33,800 COMMUNITY ENGAGED APPROACH WHERE 2263 01:21:33,800 --> 01:21:35,560 THERE WILL BE MULTIPLE PARTNERS 2264 01:21:35,560 --> 01:21:38,400 THAT ARE TRULY TRANSDISCIPLINARY 2265 01:21:38,400 --> 01:21:40,600 AFFECTING HOUSING AND FOOD 2266 01:21:40,600 --> 01:21:41,720 SECURITY, FOR EXAMPLE. 2267 01:21:41,720 --> 01:21:44,720 >> SO, WE WILL HAVE COMMUNITY 2268 01:21:44,720 --> 01:21:45,920 PARTNERSHIPS, SO WE WOULD LIKE 2269 01:21:45,920 --> 01:21:47,240 THE COMMUNITY TO BE INVOLVED 2270 01:21:47,240 --> 01:21:48,960 FROM THE BEGINNING, FROM THE 2271 01:21:48,960 --> 01:21:51,080 UNSEPTION OF THE CENTERS OF 2272 01:21:51,080 --> 01:21:54,000 EXCELLENCE AND TO REFLECT A TRUE 2273 01:21:54,000 --> 01:21:56,160 PARTNERSHIP WITH THE RESEARCHERS 2274 01:21:56,160 --> 01:21:57,520 IN THAT AREA. 2275 01:21:57,520 --> 01:22:01,440 THERE'S POTENTIAL FOR US TO 2276 01:22:01,440 --> 01:22:03,160 INCLUDE OTHER AGENCIES WITHIN 2277 01:22:03,160 --> 01:22:04,920 HHS SO THAT WOULD BE SOMETHING 2278 01:22:04,920 --> 01:22:06,560 THAT WE ARE CONSIDERING AND WE 2279 01:22:06,560 --> 01:22:08,080 ARE IN COMMUNICATION WITH OTHER 2280 01:22:08,080 --> 01:22:09,680 AGENCIES TO PARTNER WITH US. 2281 01:22:09,680 --> 01:22:11,680 >> THAT'S EXCELLENT. 2282 01:22:11,680 --> 01:22:13,520 I STRONGLY ENCOURAGE THAT. 2283 01:22:13,520 --> 01:22:14,440 THANK YOU. 2284 01:22:14,440 --> 01:22:16,080 >> THANK YOU. 2285 01:22:16,080 --> 01:22:22,720 >> OTHER QUESTIONS? 2286 01:22:22,720 --> 01:22:26,960 IF NOT, MAY I HAVE A MOTION FOR 2287 01:22:26,960 --> 01:22:27,240 APPROVAL? 2288 01:22:27,240 --> 01:22:28,240 >> NOTION APPROVE. 2289 01:22:28,240 --> 01:22:28,800 >> THANK YOU. 2290 01:22:28,800 --> 01:22:29,720 >> SECOND. 2291 01:22:29,720 --> 01:22:31,760 >> THANK YOU. 2292 01:22:31,760 --> 01:22:33,640 PLEASE VOTE NOW USING THE 2293 01:22:33,640 --> 01:22:35,520 BUTTONS AT THE BOTTOM OF THE 2294 01:22:35,520 --> 01:22:44,600 PANEL. 2295 01:22:44,600 --> 01:22:51,480 >> WE HAVE 1 16 YESES. 2296 01:22:51,480 --> 01:22:54,280 >> THANK YOU. 2297 01:22:54,280 --> 01:23:01,800 NEXT WE HAVE NICHD LABORATORY OF 2298 01:23:01,800 --> 01:23:04,120 DEVELOPMENTAL BIOLOGY. 2299 01:23:04,120 --> 01:23:10,280 ROBBIE. 2300 01:23:10,280 --> 01:23:11,480 >> CAN YOU HEAR ME? 2301 01:23:11,480 --> 01:23:15,600 >> YES, WE CAN HEAR YOU NOW. 2302 01:23:15,600 --> 01:23:17,320 >> THANK YOU, DENNIS. 2303 01:23:17,320 --> 01:23:19,600 PROGRAM SEEKS APPROVAL FOR AN 2304 01:23:19,600 --> 01:23:21,600 INITIATIVE TITLES NICHD 2305 01:23:21,600 --> 01:23:24,760 LABORATORY OF DEVELOPMENTAL 2306 01:23:24,760 --> 01:23:27,240 BIOLOBIOLOGY. 2307 01:23:27,240 --> 01:23:29,880 IT IS A RESOURCE THAT SPOT 2308 01:23:29,880 --> 01:23:31,280 SUPPORTS PROJECTS WHICH ENHANCE 2309 01:23:31,280 --> 01:23:35,560 THE CAPABILITIES OF ON GOING 2310 01:23:35,560 --> 01:23:38,080 BASIC TRANSLATION OF CLINICAL 2311 01:23:38,080 --> 01:23:40,560 RESEARCH IN THE FIELD OF HUMAN 2312 01:23:40,560 --> 01:23:41,840 DEVELOPMENTAL BIOLOGY. 2313 01:23:41,840 --> 01:23:44,520 THIS RESEARCH COLLECTS, PREPARES 2314 01:23:44,520 --> 01:23:46,560 AND DISTRIBUTES HUMAN TISSUES 2315 01:23:46,560 --> 01:23:48,800 AND TO THE SCIENTIFIC COMMUNITY. 2316 01:23:48,800 --> 01:23:51,800 THIS RESOURCE HAS SERVED THE 2317 01:23:51,800 --> 01:23:53,360 SCIENTIFIC COMMUNITY FOR THE 2318 01:23:53,360 --> 01:23:55,760 PAST 55 YEARS AND THE RESOURCE 2319 01:23:55,760 --> 01:23:58,240 NEEDS TO BE SUSTAINED AS IT 2320 01:23:58,240 --> 01:24:00,080 FACILITATES ACCESS TO OTHER WAYS 2321 01:24:00,080 --> 01:24:03,200 TO FIND FETAL TISSUES WHILE 2322 01:24:03,200 --> 01:24:06,480 ADHERING TO THE HIGHEST ETHICAL 2323 01:24:06,480 --> 01:24:09,920 AND REGULATORY STANDARDS. 2324 01:24:09,920 --> 01:24:13,920 THERE IS TISSUES, DIFFERENT 2325 01:24:13,920 --> 01:24:16,600 TIMES WITH DNA AND PROTEINS. 2326 01:24:16,600 --> 01:24:18,920 OVER THE LAST FEW YEARS IT HAS 2327 01:24:18,920 --> 01:24:21,440 PRODUCED -- ESSENTIAL FOR MAKER 2328 01:24:21,440 --> 01:24:24,240 PROJECTS SUCH AS IMPORT, ROAD 2329 01:24:24,240 --> 01:24:26,880 MAP AND BRAIN SCAN, A CLASS OF 2330 01:24:26,880 --> 01:24:28,080 DEVELOPING HUMAN BRAIN AND 2331 01:24:28,080 --> 01:24:30,600 MULTIPLE AND EXPANDED PROJECTS. 2332 01:24:30,600 --> 01:24:33,440 A SINGLE CENTRALIZED RESOURCE 2333 01:24:33,440 --> 01:24:34,960 ENSURE THE MATERIAL IS COLLECTED 2334 01:24:34,960 --> 01:24:38,040 AND PROCESSED APPROPRIATELY AND 2335 01:24:38,040 --> 01:24:38,360 CONSISTENTLY. 2336 01:24:38,360 --> 01:24:41,840 THIS IS BEING DEVELOPED IN OTHER 2337 01:24:41,840 --> 01:24:43,280 COMPANIES, SUSTAINING THIS 2338 01:24:43,280 --> 01:24:44,280 IMPORTANT RESOURCE. 2339 01:24:44,280 --> 01:24:46,960 THE PROPOSED CONCEPT YOU A LINED 2340 01:24:46,960 --> 01:24:50,360 TO THE NICHD STRATEGIC PLAN 2020 2341 01:24:50,360 --> 01:24:52,200 THEME ONE, UNDERSTANDING THE 2342 01:24:52,200 --> 01:24:55,600 BASIS OF DEVELOPMENT, THEME TWO, 2343 01:24:55,600 --> 01:24:57,800 PROMOTING REPRODUCTIVE HEALTH 2344 01:24:57,800 --> 01:25:00,600 AND THEME THREE, HEALTHY AND 2345 01:25:00,600 --> 01:25:01,600 LIFE LONG WELLNESS. 2346 01:25:01,600 --> 01:25:04,240 THE CONCEPT ALIGNS WITH 2347 01:25:04,240 --> 01:25:06,720 PRIORITIES OF MULTIPLE BRANCHES 2348 01:25:06,720 --> 01:25:08,360 WITHIN NICHD. 2349 01:25:08,360 --> 01:25:12,440 DEVELOPMENTAL BIOLOGY AND 2350 01:25:12,440 --> 01:25:16,000 ANOMALIES BRANCH, THAT IS 2351 01:25:16,000 --> 01:25:17,680 FERTILITY BRANCH AND 2352 01:25:17,680 --> 01:25:20,360 INTELLECTUAL DEVELOPMENTAL AND 2353 01:25:20,360 --> 01:25:23,360 DISABILITIES BRANCH, AND 2354 01:25:23,360 --> 01:25:27,800 PREGNANCY GROWTH AND NUTRITION 2355 01:25:27,800 --> 01:25:31,280 BRANCH. 2356 01:25:31,280 --> 01:25:34,200 THANK YOU. 2357 01:25:34,200 --> 01:25:35,680 >> THANK YOU, ROBBIE. 2358 01:25:35,680 --> 01:25:38,080 ARE THERE QUESTIONS OR COMMENTS 2359 01:25:38,080 --> 01:25:39,560 ABOUT THIS CONCEPT? 2360 01:25:39,560 --> 01:25:41,560 >> YEAH. 2361 01:25:41,560 --> 01:25:43,880 I JUST HAD A QUICK QUESTION. 2362 01:25:43,880 --> 01:25:46,920 HOW OFTEN DOES THIS LABORATORY 2363 01:25:46,920 --> 01:25:49,280 NEED APPROVAL FROM COUNCIL? 2364 01:25:49,280 --> 01:25:52,160 >> EVERY FIVE YEARS THIS WAS 2365 01:25:52,160 --> 01:25:53,560 LAST APPROVED IN 2017. 2366 01:25:53,560 --> 01:25:54,720 >> OKAY. 2367 01:25:54,720 --> 01:25:55,600 ALL RIGHT. 2368 01:25:55,600 --> 01:25:56,160 THANK YOU VERY MUCH. 2369 01:25:56,160 --> 01:25:58,720 IT SEEMS LIKE A GREAT RESOURCE 2370 01:25:58,720 --> 01:26:00,360 CONSIDERING THAT IT'S BEEN IN 2371 01:26:00,360 --> 01:26:03,680 EXISTENCE FOR 55 YEARS, SO THANK 2372 01:26:03,680 --> 01:26:11,160 YOU VERY MUCH. 2373 01:26:11,160 --> 01:26:12,600 >> I ALSO THINK THIS IS A GREAT 2374 01:26:12,600 --> 01:26:13,880 RESOURCE TO HAVE. 2375 01:26:13,880 --> 01:26:16,440 MY ONLY QUESTION IS, IS THERE A 2376 01:26:16,440 --> 01:26:19,040 SINGLE SITE FOR THE REPOSITORY? 2377 01:26:19,040 --> 01:26:24,160 I ASK BECAUSE THERE WAS A 2378 01:26:24,160 --> 01:26:29,840 DISASTER THAT OCCURRED FIVE, 10 2379 01:26:29,840 --> 01:26:32,040 YEARS AGO WITH BRAIN BANKS AND I 2380 01:26:32,040 --> 01:26:33,960 WONDER IF THAT WOULD BE USEFUL 2381 01:26:33,960 --> 01:26:34,400 AT THIS TIME. 2382 01:26:34,400 --> 01:26:36,160 >> CURRENTLY IT IS ONLY ONE 2383 01:26:36,160 --> 01:26:42,040 SITE. 2384 01:26:42,040 --> 01:26:45,920 >> ANY OTHER QUESTIONS? 2385 01:26:45,920 --> 01:26:48,120 >> JUST ADD TO THAT, QUICKLY, I 2386 01:26:48,120 --> 01:26:49,920 WOULD JUST ADD TO CONSIDER THIS, 2387 01:26:49,920 --> 01:26:54,080 AT LEAST, AS YOU'RE FUNDING THE 2388 01:26:54,080 --> 01:26:56,920 SITE, TO HAVE SOME REDUNDANCY. 2389 01:26:56,920 --> 01:27:01,280 >> OKAY SO NOTED. 2390 01:27:01,280 --> 01:27:03,240 NO OTHER QUESTIONS, MAY I HAVE A 2391 01:27:03,240 --> 01:27:04,840 MOTION FOR APPROVAL? 2392 01:27:04,840 --> 01:27:05,560 >> MOTION. 2393 01:27:05,560 --> 01:27:06,680 >> SECOND? 2394 01:27:06,680 --> 01:27:08,120 >> SECOND. 2395 01:27:08,120 --> 01:27:09,040 >> VERY GOOD. 2396 01:27:09,040 --> 01:27:19,520 PLEASE CAST YOUR VOTES NOW. 2397 01:27:28,800 --> 01:27:37,280 >> I'M SHOWING 15 YE YESES. 2398 01:27:37,280 --> 01:27:37,960 >> VERY GOOD. 2399 01:27:37,960 --> 01:27:40,280 THANK YOU, ROBBIE. 2400 01:27:40,280 --> 01:27:43,440 NEXT UP WE HAVE DR. IZENBURG 2401 01:27:43,440 --> 01:27:48,880 FROM THE FERTILITY AND INFERT 2402 01:27:48,880 --> 01:27:50,400 INFERTILITY BRANCH. 2403 01:27:50,400 --> 01:27:51,840 >> GOOD AFTERNOON. 2404 01:27:51,840 --> 01:27:54,240 PROGRAM SEEKS COUNCIL APPROVAL 2405 01:27:54,240 --> 01:27:58,080 OF AN INITIATIVE TITLED THE 2406 01:27:58,080 --> 01:27:59,680 RETROPRODUCTIVE SCIENTIST 2407 01:27:59,680 --> 01:28:00,600 DEVELOPMENT PROGRAM, A NATIONAL 2408 01:28:00,600 --> 01:28:01,800 CAREER DEVELOPMENT PROGRAM 2409 01:28:01,800 --> 01:28:07,320 DESIGNED TO PROVIDE SUPPORT FOR 2410 01:28:07,320 --> 01:28:07,880 OBSTETRICIAN GYNECOLOGISTS 2411 01:28:07,880 --> 01:28:10,520 WHITED TO A CAREER CONDUCTING 2412 01:28:10,520 --> 01:28:12,720 BASIC TRANSLATIONAL RESEARCH ON 2413 01:28:12,720 --> 01:28:14,800 WOMEN'S HEALTH-RELATED ISSUES. 2414 01:28:14,800 --> 01:28:17,840 THE GOAL OF THE RSDP IS TO 2415 01:28:17,840 --> 01:28:19,040 DEVELOP PHYSICIAN SCIENTISTS 2416 01:28:19,040 --> 01:28:20,880 BASED IN ACADEMIC SETTINGS WHO 2417 01:28:20,880 --> 01:28:23,960 CAN EMPLOY CUTTING EDGE 2418 01:28:23,960 --> 01:28:25,040 TECHNOLOGIES TO ADDRESS 2419 01:28:25,040 --> 01:28:29,960 IMPORTANT PROBLEMS IN OB-GYN AND 2420 01:28:29,960 --> 01:28:31,840 RELATED SUB SPECIALTIES AND 2421 01:28:31,840 --> 01:28:33,160 ULTIMATELY INCREASE THE PIPELINE 2422 01:28:33,160 --> 01:28:35,320 OF TRANSLATIONAL RESEARCHERS WHO 2423 01:28:35,320 --> 01:28:37,280 CONTRIBUTE TO THE SCIENTIFIC 2424 01:28:37,280 --> 01:28:39,760 MISSION OF NICHD. 2425 01:28:39,760 --> 01:28:41,200 SINCE UNSEPTION, OVER 112 2426 01:28:41,200 --> 01:28:43,400 CLINICAL FELLOWS OR SCHOLARS IN 2427 01:28:43,400 --> 01:28:46,880 A RANGE OF SPECIALTIES HAVE 2428 01:28:46,880 --> 01:28:48,320 PARTICIPATED. 2429 01:28:48,320 --> 01:28:49,520 APPROXIMATELY 75% OF THE 2430 01:28:49,520 --> 01:28:51,480 SCHOLARS SUBSEQUENTLY APPLIED 2431 01:28:51,480 --> 01:28:53,800 FOR RESEARCH GRANTS WITH HALF 2432 01:28:53,800 --> 01:28:56,400 RECEIVING AN AWARD. 2433 01:28:56,400 --> 01:29:00,080 08% OF FORMER SCHOLARS REMAINED 2434 01:29:00,080 --> 01:29:02,160 IN ACADEMIC OR RESEARCH RELATED 2435 01:29:02,160 --> 01:29:04,120 POSITIONS WITH MANY IN 2436 01:29:04,120 --> 01:29:04,600 LEADERSHIP ROLES. 2437 01:29:04,600 --> 01:29:08,720 OUR GOAL FOR THIS INITIATIVE IS 2438 01:29:08,720 --> 01:29:10,360 PARTICIPATION, RESEARCHER OF 2439 01:29:10,360 --> 01:29:12,120 DIVERSE BACKGROUNDS AS MENTORS 2440 01:29:12,120 --> 01:29:14,880 AND SCHOLARS, INCLUDING RACIAL 2441 01:29:14,880 --> 01:29:17,040 AND ETHNIC MINORITIES, PERSONS 2442 01:29:17,040 --> 01:29:19,160 WITH DISABILITIES AND WOMEN THIS 2443 01:29:19,160 --> 01:29:23,240 CONCEPT ALIGNS WITH THE NICHD 2444 01:29:23,240 --> 01:29:26,080 STRATEGIC PLAN THEME TWO AND 2445 01:29:26,080 --> 01:29:27,080 FACILITATES TRAINING AND 2446 01:29:27,080 --> 01:29:29,480 DEVELOPMENT OF AN INCLUSIVE AND 2447 01:29:29,480 --> 01:29:30,640 SCIENTIFIC WORKFORCE. 2448 01:29:30,640 --> 01:29:33,240 THANK YOU. 2449 01:29:33,240 --> 01:29:34,160 >> THANK YOU. 2450 01:29:34,160 --> 01:29:35,600 QUESTIONS OR COMMENTS ABOUT THIS 2451 01:29:35,600 --> 01:29:44,000 CONCEPT? 2452 01:29:44,000 --> 01:29:44,320 DR. MATSIK. 2453 01:29:44,320 --> 01:29:46,320 >> YES, I JUST WANTED TO SAY 2454 01:29:46,320 --> 01:29:47,920 THIS IS A GREAT PROGRAM. 2455 01:29:47,920 --> 01:29:49,680 HAVING TRAINED TWO INDIVIDUALS 2456 01:29:49,680 --> 01:29:51,760 WHO ARE -- WHO CAME THROUGH THE 2457 01:29:51,760 --> 01:29:53,160 PROGRAM AND STILL ARE DOING 2458 01:29:53,160 --> 01:29:56,640 RESEARCH AND HAVE GOTTEN NIH 2459 01:29:56,640 --> 01:29:58,760 GRANTS, I THINK IT IS A GREAT 2460 01:29:58,760 --> 01:30:01,160 PROGRAM AND I'M VERY ENCOURAGING 2461 01:30:01,160 --> 01:30:04,080 THAT IT IS BEING RENEWED. 2462 01:30:04,080 --> 01:30:05,280 >> THANK YOU. 2463 01:30:05,280 --> 01:30:07,440 >> DR. ROWICH. 2464 01:30:07,440 --> 01:30:09,680 >> REMEMBER AT A PREVIOUS 2465 01:30:09,680 --> 01:30:11,880 MEETING WE HAD AN IN DEPTH 2466 01:30:11,880 --> 01:30:13,880 DISCUSSION ABOUT THE PEDIATRIC 2467 01:30:13,880 --> 01:30:15,120 SCIENTIST DEVELOPMENT PROGRAM. 2468 01:30:15,120 --> 01:30:18,080 I'M WONDERING, DOES RSDP UNDER 2469 01:30:18,080 --> 01:30:21,880 GO THE SAME REVIEW AT RSDP. 2470 01:30:21,880 --> 01:30:29,040 >> IT UNDER G SCIENTIFIC 2471 01:30:29,040 --> 01:30:29,280 REVIEW. 2472 01:30:29,280 --> 01:30:32,800 AM I INTERPRETING THE QUESTION 2473 01:30:32,800 --> 01:30:33,040 CORRECTLY? 2474 01:30:33,040 --> 01:30:34,120 >> EXACTLY. 2475 01:30:34,120 --> 01:30:37,040 I'M CURIOUS BUT A WE WENT INTO 2476 01:30:37,040 --> 01:30:40,760 THE DETAILS OF THE VIEW FOR DSDP 2477 01:30:40,760 --> 01:30:45,080 SO THIS HAS AN ENCOURAGING SCORE 2478 01:30:45,080 --> 01:30:48,120 FROM EXTERNAL. 2479 01:30:48,120 --> 01:30:50,120 >> THIS IS THE CONCEPT THAT THE 2480 01:30:50,120 --> 01:30:51,120 PROGRAMS WOULD GET EXCELLENT 2481 01:30:51,120 --> 01:30:51,320 SCORES. 2482 01:30:51,320 --> 01:30:55,560 >> SORRY, I MISSED INTO. 2483 01:30:55,560 --> 01:30:56,440 MISUNDER STOOD. 2484 01:30:56,440 --> 01:30:57,880 THAT'S MY MISTAKE. 2485 01:30:57,880 --> 01:31:03,880 I TAKE BACK M COMMENT. 2486 01:31:03,880 --> 01:31:05,200 >> ANY OTHER ECONOMIES? 2487 01:31:05,200 --> 01:31:07,640 IF NOT, A MOTION FOR APPROVAL? 2488 01:31:07,640 --> 01:31:08,280 >> MOTION. 2489 01:31:08,280 --> 01:31:13,000 >> THANK YOU. 2490 01:31:13,000 --> 01:31:14,880 SECOND? 2491 01:31:14,880 --> 01:31:15,440 >> SECOND. 2492 01:31:15,440 --> 01:31:16,120 >> THANK YOU. 2493 01:31:16,120 --> 01:31:26,280 PLEASE VOTE NOW. 2494 01:31:26,280 --> 01:31:30,280 >> I'M SHOWING 16 YESES. 2495 01:31:30,280 --> 01:31:32,120 >> THANK YOU. 2496 01:31:32,120 --> 01:31:38,120 NEXT UP, DEVELOPMENTAL BIOLOGY 2497 01:31:38,120 --> 01:31:44,440 FOR SMALL RESEARCH GRANTS FOR 2498 01:31:44,440 --> 01:31:48,000 GABRIELLEA RESEARCH. 2499 01:31:48,000 --> 01:31:50,040 >> CANCERS ARE THE LEADING 2500 01:31:50,040 --> 01:31:51,960 CAUSES OF DEATH AMONG CHILDREN 2501 01:31:51,960 --> 01:31:54,480 AND PRESENT WIDE RANGE OF 2502 01:31:54,480 --> 01:31:56,920 PEDIATRIC CONDITIONS WITH CON 2503 01:31:56,920 --> 01:31:58,680 FLEX IDEOLOGIES TO WHICH LITTLE 2504 01:31:58,680 --> 01:32:00,720 IS KNOWN TOMORROW ACCELERATE 2505 01:32:00,720 --> 01:32:02,920 RESEARCH ON THESE CONDITIONS AND 2506 01:32:02,920 --> 01:32:05,960 IN RESPONSE TO THE MILLER KIDS 2507 01:32:05,960 --> 01:32:07,160 FIRST ACT THE FUND ESTABLISHED 2508 01:32:07,160 --> 01:32:10,640 THE MILLER KIDS FIRST PEDIATRIC 2509 01:32:10,640 --> 01:32:12,400 RESEARCH PROGRAM THIS PROGRAM IS 2510 01:32:12,400 --> 01:32:18,000 LED BY NICHD, NCI, NHLBI AND 2511 01:32:18,000 --> 01:32:20,240 NHGRI ALONG WITH A WORKING GROUP 2512 01:32:20,240 --> 01:32:23,080 OF REPRESENTATIVES FROM 12 NIH 2513 01:32:23,080 --> 01:32:24,400 INSTITUTES, THE OFFICE OF THE 2514 01:32:24,400 --> 01:32:26,160 DIRECTOR AND THE CENTERS FOR 2515 01:32:26,160 --> 01:32:28,240 DISEASE CONTROL AND PREVENTION. 2516 01:32:28,240 --> 01:32:29,760 THE KIDS FIRST PROGRAM HAS 2517 01:32:29,760 --> 01:32:32,040 DEVELOPED A DATA RESOURCE 2518 01:32:32,040 --> 01:32:34,320 CENTER, DATA RESOURCES IN THE 2519 01:32:34,320 --> 01:32:38,360 CLOUD, SEQUENCING CENTERS AND 2520 01:32:38,360 --> 01:32:42,640 SUPPORT TOTAL GEANOME AND OTHER 2521 01:32:42,640 --> 01:32:46,440 DATA FROM COHORTS OF BIRTH 2522 01:32:46,440 --> 01:32:50,720 DEFECT AND PEDIATRIC CANCER 2523 01:32:50,720 --> 01:32:52,880 PATIENTS THEIR THEIR FAMILIES. 2524 01:32:52,880 --> 01:32:53,640 SAMPLES FROM THE CHILDREN 2525 01:32:53,640 --> 01:32:55,640 AFFECTED WITH CANCER OR 2526 01:32:55,640 --> 01:32:57,160 STRUCTURAL BIRTH DEFECTS ARE 2527 01:32:57,160 --> 01:32:58,400 AVAILABLE FOR ANALYSIS. 2528 01:32:58,400 --> 01:33:01,000 MORE THAN 30,000 ADDITIONAL 2529 01:33:01,000 --> 01:33:11,040 WHOLE JE GENOME RESOURCES, THE 2530 01:33:11,040 --> 01:33:12,440 LARGEST COLLECTION OF PETE I 2531 01:33:12,440 --> 01:33:16,480 CAN'TPEDIATRICDATA. 2532 01:33:16,480 --> 01:33:19,240 BUT RESOURCES HAVE BEEN RIDGED 2533 01:33:19,240 --> 01:33:23,920 IN SCOPE AND LIMITED TO 2534 01:33:23,920 --> 01:33:25,320 DEVELOPMENT OF DATA RESEARCH. 2535 01:33:25,320 --> 01:33:27,640 THIS PROPOSAL FOCUSES ON THE 2536 01:33:27,640 --> 01:33:29,480 ANALYSIS OF THE DATA SETS MADE 2537 01:33:29,480 --> 01:33:31,120 AVAILABLE BY KIDS FIRST. 2538 01:33:31,120 --> 01:33:33,640 THE INTENT IS TO PROMODE 2539 01:33:33,640 --> 01:33:35,680 MERITORIOUS RESEARCH PROJECTS 2540 01:33:35,680 --> 01:33:37,400 THAT INVOLVED SECONDARY ANALYSIS 2541 01:33:37,400 --> 01:33:40,520 OF DATA SETS ASSEMBLED AND 2542 01:33:40,520 --> 01:33:42,040 DISSEMINATED BY THE KIDS FIRST 2543 01:33:42,040 --> 01:33:42,360 PROGRAM. 2544 01:33:42,360 --> 01:33:43,920 THESE DATA AND OTHER RESOURCES 2545 01:33:43,920 --> 01:33:45,880 HAVE BEEN DEVELOPED TO PROMOTE 2546 01:33:45,880 --> 01:33:47,960 DATA SHARING, DATA ANALYSIS AND 2547 01:33:47,960 --> 01:33:50,000 DATA VISUALIZATION TO ENABLE A 2548 01:33:50,000 --> 01:33:51,560 DEEPER EXPLORATION OF THE 2549 01:33:51,560 --> 01:33:53,960 ORIGINS ARE OF BIRTH DEFECTS AND 2550 01:33:53,960 --> 01:33:55,680 CHILDHOOD CANCERS AND ULTIMATELY 2551 01:33:55,680 --> 01:34:01,240 AN UNDERSTANDING OF THE ETIOLOGY 2552 01:34:01,240 --> 01:34:03,680 OF THESE CONDITIONS, THUS 2553 01:34:03,680 --> 01:34:06,160 EMPOWERING BETTER PREVENTION, 2554 01:34:06,160 --> 01:34:07,680 DIAGNOSTICS AND TREATMENTS FOR 2555 01:34:07,680 --> 01:34:11,000 THESE PEDIATRIC CONDITIONS. 2556 01:34:11,000 --> 01:34:13,280 >> THANK YOU. 2557 01:34:13,280 --> 01:34:16,720 ARE THERE QUESTIONS OR COMMENTS? 2558 01:34:16,720 --> 01:34:20,480 >> YES, I JUST WANTED TO SAY HOW 2559 01:34:20,480 --> 01:34:23,640 SUPPORTIVE I AM OF THIS CONCEPT. 2560 01:34:23,640 --> 01:34:26,480 IT'S BEEN GOING ON, WE'VE 2561 01:34:26,480 --> 01:34:29,240 REVIEWED SEVERAL PROPOSALS IN 2562 01:34:29,240 --> 01:34:31,200 THE PAST ON COUNCIL, AND YOU 2563 01:34:31,200 --> 01:34:32,440 KNOW, I'M SURE YOU ARE ALL AWARE 2564 01:34:32,440 --> 01:34:41,040 THERE ARE A NUMBER OF GENOME 2565 01:34:41,040 --> 01:34:48,320 SEQUENCING PROJECTS AND THEY 2566 01:34:48,320 --> 01:34:49,760 INVOLVE CHILDREN SO THIS MILLER 2567 01:34:49,760 --> 01:34:51,920 KIDS FORCE PROGRAM IS SO UNIQUE 2568 01:34:51,920 --> 01:34:53,560 AND IMPORTANT TO FOCUS ON KIDS 2569 01:34:53,560 --> 01:34:56,120 WITH BIRTH DEFECTS IN CHILDREN 2570 01:34:56,120 --> 01:34:58,920 SO I THINK THE ANALYSIS IS SO 2571 01:34:58,920 --> 01:34:59,200 IMPORTANT. 2572 01:34:59,200 --> 01:35:00,960 IF CHILD HEALTH DOES DO THIS, IT 2573 01:35:00,960 --> 01:35:02,600 IS NOT GOING TO GET DONE. 2574 01:35:02,600 --> 01:35:03,640 SO THANK YOU. 2575 01:35:03,640 --> 01:35:07,600 >> THANK YOU. 2576 01:35:07,600 --> 01:35:12,120 >> OTHER QUESTIONS? 2577 01:35:12,120 --> 01:35:13,880 IF NOT, MAY I HAVE A MOTION TO 2578 01:35:13,880 --> 01:35:14,080 APPROVE. 2579 01:35:14,080 --> 01:35:16,640 >> SO MOVED. 2580 01:35:16,640 --> 01:35:18,840 >> SECOND? 2581 01:35:18,840 --> 01:35:19,480 >> SECOND. 2582 01:35:19,480 --> 01:35:20,320 >> THANK YOU. 2583 01:35:20,320 --> 01:35:30,800 PLEASE REGISTER YOUR VOTES. 2584 01:35:35,280 --> 01:35:39,160 >> I'M SHOWING 16 YESES. 2585 01:35:39,160 --> 01:35:43,360 >> VERY GOOD, THANK YOU. 2586 01:35:43,360 --> 01:35:46,440 NEXT UP, THE CONTRACEPTION' 2587 01:35:46,440 --> 01:35:49,160 SEARCH BRANCH WHO WI WILL PRESET 2588 01:35:49,160 --> 01:35:53,240 BIOLOGICAL TEST FACILITY. 2589 01:35:53,240 --> 01:35:54,520 >> THE PURPOSE OF THIS 2590 01:35:54,520 --> 01:35:57,000 INITIATIVE IS TO PROVIDE 2591 01:35:57,000 --> 01:35:58,640 INVESTIGATOR A MEANS TO REQUEST 2592 01:35:58,640 --> 01:36:01,040 FROM A CONTRACT RESEARCH THAT 2593 01:36:01,040 --> 01:36:04,560 SILLITY IN THE DEVELOPMENT OF 2594 01:36:04,560 --> 01:36:08,600 CONTRACEPTIVESES, A PRODUCT WITH 2595 01:36:08,600 --> 01:36:11,440 ANTI-HIV OR ANTI-INIF HE CANTIVE 2596 01:36:11,440 --> 01:36:11,760 PROBABILITIES. 2597 01:36:11,760 --> 01:36:14,040 IT IS NOT LIMITED TO 2598 01:36:14,040 --> 01:36:15,880 PHARMACOLOGY, TOXICOLOGY AND 2599 01:36:15,880 --> 01:36:18,200 FERTILITY STUDIES. 2600 01:36:18,200 --> 01:36:26,280 CONTRACTOR UTILIZED A WIDE 2601 01:36:26,280 --> 01:36:29,520 VARIETY OF ANIMAL SPECIES. 2602 01:36:29,520 --> 01:36:32,120 THE OVER REACH IS TO GENERATE 2603 01:36:32,120 --> 01:36:34,560 NEW ENTRY INTO THE FIELD WITH 2604 01:36:34,560 --> 01:36:36,160 PRELIMINARY DATA FOR A FIRST 2605 01:36:36,160 --> 01:36:37,320 OPPORTUNITY AND SENIOR 2606 01:36:37,320 --> 01:36:38,960 INVESTIGATORS FOR THEIR NEXT 2607 01:36:38,960 --> 01:36:39,800 FUNDING OPPORTUNITY. 2608 01:36:39,800 --> 01:36:43,640 CURRENT FUNDING WILL NOT BE A 2609 01:36:43,640 --> 01:36:46,840 PRESECONDPREREQUISITE TO APPLY. 2610 01:36:46,840 --> 01:36:49,000 IT PROVIDES JUNIOR AND SENIOR 2611 01:36:49,000 --> 01:36:53,560 INVESTIGATORS INCLUDING INVIE 2612 01:36:53,560 --> 01:36:58,600 TROAND PHARMA STUDIES, FERTILITY 2613 01:36:58,600 --> 01:37:01,000 TESTING, TOXICOLOGY AND 2614 01:37:01,000 --> 01:37:01,520 FORMULATION. 2615 01:37:01,520 --> 01:37:04,360 DATA FROM THESE SERVICE REQUEST 2616 01:37:04,360 --> 01:37:07,680 CONTRIBUTE FROM R-01 AND FUNDING 2617 01:37:07,680 --> 01:37:10,760 FROM USAID THIS SERVICE REQUEST 2618 01:37:10,760 --> 01:37:13,200 WILL BE RECEIVE FOR MULTI 2619 01:37:13,200 --> 01:37:15,760 PREVENTION TECHNOLOGIES AND IT 2620 01:37:15,760 --> 01:37:18,040 IS EXPECTED SOME OF THESE ARE OF 2621 01:37:18,040 --> 01:37:20,560 INTEREST AND VALUE TO THE 2622 01:37:20,560 --> 01:37:22,720 PEDIATRIC INFECTIOUS DISEASE 2623 01:37:22,720 --> 01:37:23,200 BRANCH. 2624 01:37:23,200 --> 01:37:26,120 THIS ALIGN WITH THE PLAN, THEM 2625 01:37:26,120 --> 01:37:28,720 TWO, REPRODUCTIVE HEALTH AND 2626 01:37:28,720 --> 01:37:29,840 THEME FOUR FOR THE DEVELOPMENT 2627 01:37:29,840 --> 01:37:32,560 OF SAFE AND EFFECTIVE 2628 01:37:32,560 --> 01:37:32,920 THERAPEUTICS. 2629 01:37:32,920 --> 01:37:36,720 AS WELL AS THE CONTRACEPTIVE 2630 01:37:36,720 --> 01:37:38,240 RESEARCH PRIOR OF DEVELOPING NEW 2631 01:37:38,240 --> 01:37:41,800 AND IMPROVED CONTRACEPTIVESES. 2632 01:37:41,800 --> 01:37:42,120 THANK YOU. 2633 01:37:42,120 --> 01:37:43,280 >> THANK YOU. 2634 01:37:43,280 --> 01:37:44,680 QUESTIONS OR COMMENTS ABOUT THIS 2635 01:37:44,680 --> 01:37:52,440 CONCEPT? 2636 01:37:52,440 --> 01:38:00,000 IF NOT, MAY I HAVE A MOME MOTIOR 2637 01:38:00,000 --> 01:38:00,280 APPROVAL? 2638 01:38:00,280 --> 01:38:00,520 >> MOTION. 2639 01:38:00,520 --> 01:38:01,840 >> SECOND? 2640 01:38:01,840 --> 01:38:02,120 >> SECOND. 2641 01:38:02,120 --> 01:38:02,680 >> THANK YOU. 2642 01:38:02,680 --> 01:38:13,240 PLEASE REGISTER YOUR VOTES NOW. 2643 01:38:14,600 --> 01:38:19,360 >> I'M SHOWING 16 YESES. 2644 01:38:19,360 --> 01:38:22,600 >> VERY GOOD. 2645 01:38:22,600 --> 01:38:25,360 AND TO FINISH UP THE CONCEPTS, 2646 01:38:25,360 --> 01:38:27,240 WE HAVE DR. CHRIS LINDSEY WHO IS 2647 01:38:27,240 --> 01:38:29,160 ALSO FROM THE CONTRACEPTION 2648 01:38:29,160 --> 01:38:30,880 RESEARCH BRANCH AND WILL PRESENT 2649 01:38:30,880 --> 01:38:32,080 CHEMICAL SCREENING AND 2650 01:38:32,080 --> 01:38:33,720 OPTIMIZATION FACILITY. 2651 01:38:33,720 --> 01:38:33,920 CHRIS. 2652 01:38:33,920 --> 01:38:35,800 >> HELLO. 2653 01:38:35,800 --> 01:38:37,520 PROGRAM SAKES COUNSEL APPROVAL 2654 01:38:37,520 --> 01:38:39,520 FOR AN INITIATIVE TITLED 2655 01:38:39,520 --> 01:38:41,040 CHEMICAL SCREENING AND 2656 01:38:41,040 --> 01:38:42,680 OPTIMIZATION FACILITY, WHOSE 2657 01:38:42,680 --> 01:38:44,320 PURPOSE IS TO PROVIDE 2658 01:38:44,320 --> 01:38:45,520 INVESTIGATORS A MEANS TO REQUEST 2659 01:38:45,520 --> 01:38:47,480 SERVICES FROM A STATE OF THE ART 2660 01:38:47,480 --> 01:38:49,760 CONTRACT RESEARCH FACILITY WITH 2661 01:38:49,760 --> 01:38:51,360 THE CAPABILITIES AND CHRISTMAS 2662 01:38:51,360 --> 01:38:53,800 TO ADVANCE NON-HORMONAL 2663 01:38:53,800 --> 01:38:55,800 CONTRACEPTIVE AND/OR 2664 01:38:55,800 --> 01:38:56,960 REPRODUCTIVE HEALTH RELATE RED 2665 01:38:56,960 --> 01:38:58,480 SEARCH PROGRAMS. 2666 01:38:58,480 --> 01:39:00,600 REQUESTED SERVICES INCLUDE 2667 01:39:00,600 --> 01:39:03,440 ROUTINE EXPRESSION, HIGH 2668 01:39:03,440 --> 01:39:05,480 THROUGH-PUT SCREENING, STRUCTURE 2669 01:39:05,480 --> 01:39:07,120 ACTIVITY RELATIONSHIPS AND 2670 01:39:07,120 --> 01:39:08,680 SCALABLE CANTIES. 2671 01:39:08,680 --> 01:39:11,160 THE OVER ARCHING GOAL IS TO 2672 01:39:11,160 --> 01:39:12,040 FACILE AT THIS TIME NEW 2673 01:39:12,040 --> 01:39:13,720 INVESTIGATOR ENTRY INTO THESE 2674 01:39:13,720 --> 01:39:15,680 FIELD BUS GENERATING PRELIMINARY 2675 01:39:15,680 --> 01:39:17,080 DATA FOR A FIRST FUNDING 2676 01:39:17,080 --> 01:39:18,360 OPPORTUNITY AND PROVIDING 2677 01:39:18,360 --> 01:39:20,360 BRIDGING STUDIES FOR SENIOR 2678 01:39:20,360 --> 01:39:21,880 INVESTIGATORS FOR THEIR NEXT 2679 01:39:21,880 --> 01:39:22,920 FUNDING OPPORTUNITY. 2680 01:39:22,920 --> 01:39:28,640 CURRENT FUND STAG TUS WILL NOT G 2681 01:39:28,640 --> 01:39:31,680 STATUS WILL NOT AND PREREQUISITE 2682 01:39:31,680 --> 01:39:32,240 TO AEMPLOYEE. 2683 01:39:32,240 --> 01:39:33,560 THIS IS FOLLOWING A CALL FROM 2684 01:39:33,560 --> 01:39:36,200 THE PUBLIC FOR NON-HORMONAL 2685 01:39:36,200 --> 01:39:37,680 THERAPIES THAT PEOPLE CAN USE 2686 01:39:37,680 --> 01:39:40,680 THROUGHOUT THEIR REPRODUCTIVE 2687 01:39:40,680 --> 01:39:40,960 LIVES. 2688 01:39:40,960 --> 01:39:42,520 PROGRAM SEEKS TO CONTINUE THIS 2689 01:39:42,520 --> 01:39:42,760 EFFORT. 2690 01:39:42,760 --> 01:39:45,040 SERVICE PROVIDED IN THE LAST 2691 01:39:45,040 --> 01:39:46,240 CYCLE TO SEVERAL JUNIOR AND 2692 01:39:46,240 --> 01:39:48,320 SENIOR INVESTIGATORS INCLUDE, 2693 01:39:48,320 --> 01:39:50,560 CHEMICAL OPTIMIZATION, MATERIALS 2694 01:39:50,560 --> 01:39:53,560 SUMP AS DNA, ANTIBODIES AND 2695 01:39:53,560 --> 01:39:55,600 NATURAL PRODUCTS, HIGH THROUGH 2696 01:39:55,600 --> 01:39:58,360 PUT SCREENING AND MULTI GRAM 2697 01:39:58,360 --> 01:40:00,840 QUANTITIES TO IDENTIFY SMALL 2698 01:40:00,840 --> 01:40:02,840 MOLECULES THIS CONTRIBUTED TO I 2699 01:40:02,840 --> 01:40:05,240 WARDED APPLICATIONS THIS CONCEPT 2700 01:40:05,240 --> 01:40:08,840 CLEARANCE ALIGN WITH THE NICHD 2701 01:40:08,840 --> 01:40:11,040 STRATEGIC PLAN THEME TWO 2702 01:40:11,040 --> 01:40:13,080 REPRODUCTIVE HEALTH, AND THEME 2703 01:40:13,080 --> 01:40:16,920 4, SAFE AND EFFECTIVE 2704 01:40:16,920 --> 01:40:17,920 THERAPEUTICS AND THE DEVELOPMENT 2705 01:40:17,920 --> 01:40:21,920 OF NEW AND IMPROVED 2706 01:40:21,920 --> 01:40:22,560 CONTRACEPTIVES. 2707 01:40:22,560 --> 01:40:25,400 CONCERNING ALIGNMENT WITH THE 2708 01:40:25,400 --> 01:40:27,400 HIV PRIORITIES, IT IS 2709 01:40:27,400 --> 01:40:28,200 CONCEIVABLE THIS TECHNOLOGY THAT 2710 01:40:28,200 --> 01:40:33,840 IS A CONTRACEPTIVE WITH 2711 01:40:33,840 --> 01:40:42,880 ANTI-INIF INFECTIVE POSE COULDE 2712 01:40:42,880 --> 01:40:44,120 RECEIVED BUT IS NOT KNOWN. 2713 01:40:44,120 --> 01:40:45,880 >> THANK YOU. 2714 01:40:45,880 --> 01:40:47,080 ANY QUESTIONS OR COMMENTS. 2715 01:40:47,080 --> 01:40:49,120 >> COULD YOU EXPLAIN, CHRIS, IT 2716 01:40:49,120 --> 01:40:51,200 SOUNDS LIKE THIS IS A RENEWAL. 2717 01:40:51,200 --> 01:40:52,320 HOW IS THIS DIFFERENT THAN THE 2718 01:40:52,320 --> 01:40:54,480 ONE WE JUST HEARD ABOUT WITH BIO 2719 01:40:54,480 --> 01:40:56,680 LOGIC TESTING AND DO THESE WORK 2720 01:40:56,680 --> 01:40:56,960 TOGETHER. 2721 01:40:56,960 --> 01:40:58,680 >> SO THAT'S A GREAT QUESTION. 2722 01:40:58,680 --> 01:41:00,720 SO THE WHERE TO SOMEWHAT 2723 01:41:00,720 --> 01:41:01,040 DISTINGUISHED. 2724 01:41:01,040 --> 01:41:03,000 FOR THE BIOLOGICAL TEST FACILITY 2725 01:41:03,000 --> 01:41:07,560 AS A CONCEPT WOULD BE PRIORI 2726 01:41:07,560 --> 01:41:10,200 PRIORITIZING IN-VIVO STUDIES 2727 01:41:10,200 --> 01:41:14,240 OPPOSED TO THE CHEMICAL FACILITY 2728 01:41:14,240 --> 01:41:18,480 IS PRIORITIZING, AS A MEDICINAL 2729 01:41:18,480 --> 01:41:19,840 CHEMIST, CHEMICAL OPTIMIZATION. 2730 01:41:19,840 --> 01:41:21,320 A LITTLE BIT OF OVERLAP BUT FOR 2731 01:41:21,320 --> 01:41:23,200 THE MOST PART THAT'S WHERE WE 2732 01:41:23,200 --> 01:41:24,320 DISTINGUISH IT. 2733 01:41:24,320 --> 01:41:27,560 SO INVIVO TESTING WOULD BE IN 2734 01:41:27,560 --> 01:41:29,880 THE BIOLOGICAL TESTING STUDY, 2735 01:41:29,880 --> 01:41:32,480 OPTIMIZATION OF A DEFINED 2736 01:41:32,480 --> 01:41:35,880 CHEMICAL ENTITY WOULD BE IN THE 2737 01:41:35,880 --> 01:41:37,120 CHEMICAL OPTIMIZATION FACILITY. 2738 01:41:37,120 --> 01:41:38,240 >> THANK YOU FOR CLARIFYING. 2739 01:41:38,240 --> 01:41:42,920 >> YOU'RE WELCOME. 2740 01:41:42,920 --> 01:41:46,360 >> ANY OTHER QUESTIONS FOR 2741 01:41:46,360 --> 01:41:46,760 CHRIS? 2742 01:41:46,760 --> 01:41:51,480 IF NOT, MAY I HAVE A MOTION FOR 2743 01:41:51,480 --> 01:41:51,720 APPROVAL? 2744 01:41:51,720 --> 01:41:55,400 >> I MAKE A MOTION TO APPROVE. 2745 01:41:55,400 --> 01:41:55,680 >> SECOND. 2746 01:41:55,680 --> 01:41:57,080 >> THANK YOU. 2747 01:41:57,080 --> 01:41:58,920 ARE PLEASE REGISTER YOUR VOTES 2748 01:41:58,920 --> 01:42:09,200 ON THE ZOOM PANEL. 2749 01:42:10,400 --> 01:42:15,560 >> I'M SHOWING 16 YESES. 2750 01:42:15,560 --> 01:42:16,600 >> OKAY. 2751 01:42:16,600 --> 01:42:17,840 VERY GOOD. 2752 01:42:17,840 --> 01:42:19,840 THANKS, EVERYBODY THIS CONCLUDES 2753 01:42:19,840 --> 01:42:22,160 THE OPEN SESSION OF OUR AGENDA. 2754 01:42:22,160 --> 01:42:23,720 AT THIS TIME WE NEED TO TAKE A 2755 01:42:23,720 --> 01:42:26,000 QUICK 15-MINUTE BREAK TO MAKE 2756 01:42:26,000 --> 01:42:27,480 THE TRANSITION FROM THE OPEN 2757 01:42:27,480 --> 00:00:00,000 SESSION TO THE CLOSED SESSION.